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SUMMARY 
 
Innate immunity is the first line of defense against invading microorganisms and 
provides clues to adaptive immunity for the development of memory for subsequent 
infections. Insects, similar to other invertebrates, do not have adaptive immunity and 
thus rely on their innate immune system to combat infections. We have analyzed the role 
of the peptidoglycan (PGN) receptor protein (PGRP) family and other components of 
innate immune signaling pathways in the immune defense of the mosquito Anopheles 
gambiae, the main vector of human malaria in sub-Saharan Africa. The PGRP gene family 
consists of seven genes with ten PGRP domains. We have shown that from all PGRP 
genes only PGRPLC has a role in the resistance to bacterial infections of both Gram 
types. In our experiments we have used the Gram-positive bacterium Staphylococcus aureus 
and the Gram-negative bacterium Escherichia coli. The PGRPLC gene encodes at least 
three isoforms that derive from infection-driven alternative splicing of a pool of 
immature transcripts. Each isoform contains a different PGRP domain, encoded by three 
exons that all contribute equally to the PGN binding pocket. Structural modeling of the 
PGRPLC isoforms revealed a potential for all isoforms to bind both types of PGN, the 
Lys-type, which is mostly found in Gram-positive bacteria and the DAP-type, mostly 
found in Gram-negative bacteria. The isoform PGRPLC3 seems to be the most 
important in the defense against both bacteria species, although PGRPLC1 also has a 
crucial role in the defense against S. aureus. 
Bacterial defense is mediated by the NF-κB transcription factor REL2, which is the 
ortholog of the Drosophila Relish. The REL2 gene also encodes two protein isoforms: 
REL2-S, which only has the NF-κB domain, and REL2-F, which carries an I-κB 
inhibitory domain and a death domain in addition. REL2-F functions together with the 
receptor adaptor protein IMD to deal with S. aureus infections, whereas REL2-S has a 
role in the defense against E. coli. The PGRPLC/IMD/REL2-F pathway (IMD) is also 
partly responsible for the losses of Plasmodium berghei, which can be observed during the 
first stages of malaria infection of A. gambiae. P. berghei is a rodent malaria parasite, which 
has been used as a model in our studies. Whether the pathway is able to recognize the 
malaria parasite through PGRPLC or another associated receptor is still unclear. Another 
possibility is that the pathway is activated by the proliferation of commensal bacteria in 
the mosquito gut following a blood meal. However, we have shown that more than one 
of the three main isoforms of PGRPLC are required for the reaction to P. berghei. Other 
PGRP genes, which  have been proven to play a role during infection with P. berghei,  are 
PGRPLA2, which also mediates parasite killing, and the almost identical and thus hardly 
indistinguishable PGRPS2 and S3, which appear to inhibit parasite killing. This is 
possibly achieved by negative regulation of the IMD pathway through sequestration of 
PGN, which derives from the commensal bacteria and constitutively activates the 
pathway.  
We have shown that REL1, the second NF-κB transcription factor of A. gambiae, 
which is orthologous to the Drosophila Dorsal (Dif does not exist in Anopheles), is not 
involved in the mosquito resistance to bacterial infections. This fact provides additional 
evidence that the REL2-associated pathways are of utmost importance in the A. gambiae 
defense to bacteria. In addition, REL1 has no role in the documented P. berghei killing. 
However, silencing of the REL1 inhibitor CACT (the ortholog of the Drosophila Cactus) 
during a parasite infection leads to a very strong refractoriness phenotype: most of the 
midgut-invading ookinetes are eliminated (presumably by lysis) and the remaining of the 
ookinetes are melanized. We thus assume that under wild-type infection conditions the 
parasite is either evading recognition by the REL1-associated receptors or actively 
modulating activation of REL1.  
In conclusion, the data reported in this PhD thesis suggest significant divergence of 
immune signaling between the mosquito A. gambiae and the fruit fly D. melanogaster. The 
observed differences most likely reflect their different lifestyles and, consequently, 
different infectious agents, which the two insects encountered during their evolutionary 
lifetimes. In mosquitoes one of these agents is the malaria parasite.  
 
 
ZUSAMMENFASSUNG: 
 
Angeborene Immunität ist die primäre Verteidigungsstrategie gegen eindringende 
Mikroorganismen und liefert dem adaptiven Immunsystem Signale für die Entwicklung 
von  Gedächniszellen für  nachfolgende Infektionen. Ähnlich wie andere Invertebraten, 
verfügen Insekten nicht über eine adaptive Immunreaktion und verlassen sich deshalb 
voll auf ihr angeborenes Immunsystem, um Infektionen zu bekämpfen. Wir haben 
analysiert, welche  Rolle die Familie der Peptidoglycan (PGN) Rezeptor Proteine (PGRP) 
und andere Komponenten der angeborenen Immunsignalkaskaden bei der 
Immunantwort des Moskitos Anopheles gambiae spielen. A. gambiae ist der Hauptüberträger  
der  menschlichen Malaria im  südlich der Sahara gelegenen Teil Afrikas. Die Genfamilie 
der PGRPs besteht aus sieben Genen mit zehn PGRP Domänen. Wir konnten zeigen, 
dass von allen PGRP Genen nur PGRPLC eine Rolle in der Verteidigung gegen 
bakterielle Infektionen, egal welchen Gramtyps, spielt. In unseren Experimenten haben 
wir das grampositive Bakterium Staphylococcus aureus und das gramnegative Bakterium 
Escherichia coli benutzt. Das PGRPLC Gen kodiert mindestens 3 Isoformen, die – je nach 
Infektion – aus einem Pool von unreifen Transkripten durch alternatives Splicing 
gebildet werden. Jede Isoform hat eine andere PGRP Domäne, welche jeweils von drei 
Exons kodiert wird, die alle gleich viel zur PGN Erkennungstasche beitragen. 
Strukturelle Modelle von PGRPLC zeigten, dass alle Isoformen dazu in der Lage sind, 
beide Arten von PGN zu binden, wobei die Lys-Form hauptsächlich in grampositiven 
Bakterien und die DAP-Form hauptsächlich in gramnegativen Bakterien vorkommt. Die 
PGRPLC3 Isoform scheint die wichtigste Rolle bei  der Verteidigung gegen die beiden 
bakteriellen Formen zu haben, obwohl PGRPLC1 auch eine wichtige Rolle bei  der 
Verteidigung gegen S. aureus zu spielen scheint. 
Die Verteidigung gegen Bakterien wird von dem NF-κB Transkriptionsfaktor 
REL2 bewerkstelligt, welcher das Ortholog des Drosophila Relish Gens ist. Das REL2 Gen 
kodiert zwei Protein Isoformen: REL2-S, das lediglich  die NF-κB Domäne hat, und 
REL2-F, das zusätzlich noch eine inhibierende I-κB und eine Death Domäne hat. REL2-
F arbeitet mit dem Rezeptor-Adaptor Protein IMD zusammen, um S. aureus Infektionen 
zu bekämpfen, wogegen REL2-S eine Rolle in der Verteidigung gegen E. coli spielt. Die 
PGRPLC/IMD/REL2-F Signalkaskade (IMD) ist auch teilweise verantwortlich für die 
Verluste, die Plasmodium berghei,  ein Nager Malariaparasit, während der ersten Stadien der 
Malaria Infektion in A.gambiae erleidet. Dieser Malariaparasit ist  als Modelsystem für 
unsere Studien verwendet  worden. Ob die IMD Signalkaskade auch fähig ist, den 
Malariaparasiten direkt durch PGRPLC oder einen anderen beteiligten Rezeptor  zu 
erkennen, ist immer noch unklar. Nach einer Blutmahlzeit vermehren sich die residenten 
Bakterien im Moskitodarm. Es ist durchaus möglich, dass die Signalkaskade dadurch 
aktiviert wird. Unabhängig davon, konnten wir zeigen, dass mehr als eine der drei 
PGRPLC Isoformen benötigt werden, um eine Reaktion auf P. berghei hervorzurufen. 
Weitere PGRP Gene, die nachweislich eine Rolle während der Infektion mit P. berghei 
spielen, sind PGRPLA2 und PGRPS2 und S3. PGRPLA2 begünstigt den Kampf gegen 
den Parasiten, während PGRPS2 und S3, die nahezu identisch und deshalb kaum zu 
unterscheiden sind, den Kampf gegen den Parasiten zu behindern scheinen. Letzteres 
könnte durch Sequestration des PGN der residenten Bakterien erreicht werden, welches 
zu einer Inhibierung der IMD Signalkaskade führen würde.  
Wir haben gezeigt, dass der zweite NF-κB Transkriptionsfaktor in A. gambiae, 
REL1, der ein Ortholog des Drosophila Dorsal ist (Dif existiert nicht in Anopheles), nicht in 
der Moskito Verteidigung gegen bakterielle Infektionen involviert ist. Dieser Umstand 
beweist noch einmal mehr, welche große Bedeutung den REL2 Signalkaskaden in A. 
gambiae im Kampf gegen die Bakterien zukommt. Zudem scheint REL1 keine Rolle in 
der Verteidigung gegen P. berghei zu spielen. Setzt man jedoch den REL1 Inhibitor  
CACT (das Ortholog des Drosophila Cactus) während einer Malaria Infektion außer Kraft, 
so kommt es zu einem sehr stark refraktorischen Phenotypus: Die meisten der 
Ookineten, die versuchen in den Moskito Mitteldarm einzudringen, werden eliminiert 
(vermutlich lysiert) und die restlichen Ookineten werden melanisiert. Wir vermuten, dass 
unter den Bedingungen einer natürlich hervorgerufenen Infektion der Parasit entweder 
die Erkennung durch die Rezeptoren der REL1 Signalkaskade vermeidet oder aber 
gezielt  die Aktivierung von REL1 verhindert. 
Zusammenfassend lässt sich sagen, dass die Daten, die in dieser Doktorarbeit 
angeführt  werden, eine signifikante Abweichung der Signalkaskaden des Moskito A. 
gambiae von denen der Fruchtfliege D. melanogaster beschreiben. Die beobachteten 
Unterschiede  lassen sich wahrscheinlich auf die unterschiedlichen Lebensumstände und 
infektiösen Organismen zurückführen, denen diese zwei Insekten während ihrer 
Evolution ausgesetzt waren. Für den Moskito war einer dieser Organismen der Malaria 
Parasit.   
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INTRODUCTION  
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 1.1 MALARIA 
Historical perspective. 
Alphonse Laveran (1845-1922) discovered the malaria parasite over a hundred years 
ago in the 1880s, and by 1897 Sir Ronald Ross (1857-1932) had elucidated the complex 
development of the malarial parasite in the mosquito. Already at that time, there was an 
effective drug to fight malaria: Quinine. However, over a hundred years later, we still do not 
know enough about the disease to be able to defeat it permanently. 
Among human diseases, malaria still is one of the top killers - it is the leading cause of 
pediatric morbidity and mortality in Africa. It looms virtually everywhere in the tropics, but 
also occurs in many temperate regions. It threatens travelers and immigrants with no 
previous exposure to the malady as the immunological status of a person has a strong 
bearing on the severity of the disease. Since the advent and rise of global tourism imported 
non-endemic cases have been on the rise (estimates calculate about 12,000 annual cases in 
Europe).  
Concerted malaria control programs were developed in the late 1940s and during the 
1950s and 1960s an ambitious worldwide campaign to eradicate malaria was initiated. The 
control measures put in place in the WHO member countries had tremendous initial success 
and malaria incidence came down considerably. Indoor residual spraying with DDT was the 
principle method by which malaria transmission was eradicated or greatly reduced on the 
periphery of its transmission range (Hemingway, Field et al. 2002). However, at the end of 
the 1960s, the concept of malaria eradication was formally given up and the countries 
switched to sustainable control, largely because insecticide resistance swept through 
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 mosquito vector species, crippling the eradication efforts. In the following decades a 
resurgence of malaria ensued due to the spread of resistance to malaria drugs and 
insecticides. 
In 1998, the ‘Roll Back Malaria’ (www.rbm.who.int/) global partnership was founded 
to implement and coordinate malaria counter measures on a global scale, yet again. This 
partnership was initiated by UNICEF, the UN Development Program, the World Bank and 
the WHO. One of its main goals is to halve the burden of malaria by 2010. It has grown to 
include governments of countries affected by the disease, non-governmental organizations, 
academic institutions, international private sector representatives and research groups.  
 
 
Fig. 1.1.1 Global distribution of malaria transmission risk, 2003 (source: The World Malaria Report 2005 by the 
Roll Back Malaria Partnership) 
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 At the end of 2004, 107 countries and dependent territories had areas at risk of malaria 
transmission (Fig. 1.1.1), and according to the World Malaria Report 2005 by the Roll Back 
Malaria Partnership, some 3.2 billion people, half the world’s population, lived in such areas. 
Malaria affects the standard of education and the economy in endemic countries. 
Possible counter measures that are supported by the Roll Back Malaria initiative and have 
been proven effective are the improvement of health education; a better case management 
with prompt access to effective treatment (waiting even six hours for treatment can mean 
the difference between life and death to a child with cerebral malaria); the extensive use of 
pyrethroid-impregnated bed nets for mosquito control; early detection of and response to 
malaria epidemics; and a good coordination of all of the above. 
 
Impact and significance on Global Health. 
Malaria has always been a global problem (Fig. 1.1.2) – endemic in 107 countries with 
more than 300 to 500 million clinical cases and 1.5 to 2.7 million deaths worldwide each year. 
Most of these malaria infections can be attributed to Plasmodium falciparum and Plasmodium 
vivax. This makes malaria the second most frequent infectious disease in the world, second 
only to tuberculosis. Ninety percent of fatal malaria cases are in Africa, where malaria 
accounts for twenty percent of all childhood deaths. The region hit hardest by malaria is sub-
Saharan Africa. About 60 percent of worldwide malaria cases, 75 percent of falciparum 
malaria cases and more than 80 percent of malaria deaths occur there. Outside Africa, some 
two-thirds of the cases occur in just three countries: Brazil, India and Sri Lanka. 
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Fig. 1.1.2 Estimated incidence of clinical malaria episodes (caused by any species) country level averages, 2004 
(source: The World Malaria Report 2005 by the Roll Back Malaria Partnership) 
 
As mentioned above, children are the part of the population that is hit the hardest by 
malaria; even if they survive, the disease can cripple their intellectual and physical 
development. The disease contributes greatly to anemia among children, hampering their 
growth and development. During pregnancy, malaria results in maternal illness and severe 
anemia and contributes to low birth weight among newborns - one of the leading risk factors 
for infant mortality. All this results in a severe slowing of the development and growth of 
national economies, perpetuating poverty. Malaria truly is a disease of the poor. 
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 Clinical features of malaria. 
After a passage through liver cells, the time depending on the parasite species, 
Plasmodium infects red blood cells (RBC) and multiplies within them in an asexual cycle. 
Upon parasite maturation, RBCs rupture and the metabolic byproducts are released into the 
blood stream with the new plasmodia that cause a fever bout which subsides when the 
parasite invade new RBCs (generally within 3-5 hours). The cycle of fever fits is very 
strenuous and the time between them can vary from a few to 72 hours (Table 1.1.1). 
 
Table 1.1.1: Different types of malaria 
 Malaria tertiana Malaria quartana Malaria tropica 
Parasite P. vivax & P. ovale P. malariae P. falciparum 
Regions temperate zones tropics tropics & subtropics
start fast quickly very fast 
length 3-4 h 4-5 h irregular Fever bout 
recurrence every 48 h every 72 h irregular 
recovery without treatment after 12 fever fits (3 weeks) 
after 20 fever fits 
(8 weeks) 
mostly deadly within 
short time 
recurrence if not treated often within first 5 years 
often within first 
year 
often in case of 
survival – with same 
gravity and danger 
 
The clinical features of malaria can vary from person to person depending on their 
immunological history and the type of malaria. Generally, the incubation period from the 
time of infection to full-blown malaria lasts one to four weeks. The encountered classic 
symptoms include a persistent fever, shivering, joint pains, headaches and vomiting. Severe 
and complicated malaria causes renal failure, hypoglycemia, anemia, pulmonary edema, 
shock and coma with potentially fatal consequences. 
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  Malaria can be cured if diagnosed on time and treated adequately. However, only 60% 
of those suffering from malaria have prompt access to appropriate treatment within 24 
hours of the onset of symptoms.  
P. falciparum may persist in the blood at low non-clinical levels (due to partially effective 
immunity or incomplete drug treatment) and then increase to cause obvious illness.  
If untreated, the disease can progress causing a variety of serious complications such as 
blockage of blood vessels leading to cerebral malaria, coma and death. For sufferers without 
partial immunity (e.g. Western travelers, migrant workers), it is possible for death to occur 
within 24 hours from the first appearance of symptoms. 
In contrast, P. vivax can lie dormant in the liver and relapse up to several years after the 
initial illness. The nature of the relapse ‘trigger’ is unknown. P. vivax does not adhere to 
blood vessels and therefore does not cause the associated complications. 
 
 
1.2  ANOPHELES GAMBIAE 
 
The malaria vector. 
There are more than 2,500 known mosquito species worldwide. However, only around 
50 to 60 species of Anopheles mosquitoes are capable of transmitting malaria parasites 
between humans.  
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 Life cycle. 
Anophelines, like all other mosquitoes, undergo complete metamorphosis with four 
distinct developmental stages in the course of their lifetime: egg, larvae, pupae and adult (Fig. 
1.2.1). The pre-adult stages complete their life cycle in water. The length of the mosquito’s 
life cycle depends on temperature and species characteristics. Some species have adapted to 
go through their life cycle in as little as four days whereas other species take as long as one 
month.  
Eggs: It is only the adult females that bite man and other animals for a blood meal 
after which they lay their eggs in standing or slow-moving water that can be found in a 
variety of sources ranging from small containers to vast expanses of marshland. In her 
lifespan a female mosquito will lay eggs approximately one to three times. 
Larval stage: Within 24 to 48 hours, the laid eggs hatch into larvae (also termed 
wrigglers). The larval stage is always aquatic and larvae feed on organic matter, micro-
organisms and each other. They only shuttle to the surface to obtain oxygen through a 
snorkel-like breathing apparatus. There are four larval stages (instars), at the end of each one 
the larvae molt; after the fourth molt, they become pupae. Larval development usually takes 
from 7 to 10 days. 
Pupal stage: The pupal stage does not feed but unlike most insect pupae it is 
extremely active. Pupae also live near the surface of the water, breathing air through two 
horn-like tubes (called siphons) that are on their back. 
Adult (Imago) stage: The adult hatches from the pupal case using air pressure after a 
few days. The life span of an adult mosquito depends on several factors: temperature, 
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 humidity, sex of the mosquito and time of year. Most males live for a very short time, about 
a week; females can live for about a month, depending on the aforementioned factors. 
 
 
Fig. 1.2.1: The four stages of the mosquito life cycle are: egg, pupa, larva, and adult (imago). © S. Meister 2005 
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 1.3 PLASMODIUM SPECIES 
 
The malaria parasite. 
There are four species of the apicomplexan, protozoan parasite genus Plasmodium that 
can cause malaria in humans: P. falciparum, P. vivax, P. ovale and P. malariae. Only two are 
highly prevalent, P. falciparum and P. vivax. Though P. vivax malaria is the most common, the 
malaria brought on by Plasmodium falciparum is the most lethal and accounts for around 90% 
of malaria deaths in Africa and about 50% in South East Asia/Latin America.  
All human malaria is spread by female anopheline mosquitoes which have piercing 
mouthparts and need a supply of blood in order to produce and lay eggs. Malaria can also be 
transmitted, more rarely, by blood transfusion, contaminated needles and syringes and in 
rare cases from mother to child before and/or during birth. 
 
Life cycle. 
Stage I (sporozoite and merozoite stages): When a parasite-infected mosquito bites, 
the sporozoite form of the parasite gets injected into the human bloodstream and moves 
into the liver - within ~30 minutes – where it reproduces in an asexual proliferation cycle for 
5 days or more, depending on the species (P. falciparum or P. vivax). During this phase 
hundreds of thousands of merozoite stage parasites are produced. 
Stage II (merozoite and trophozoite stages): Merozoites break out from the liver, 
enter the bloodstream, and within minutes invade the RBC to grow and multiply asexually 
via the trophozoite stage, producing more merozoites. Every 36-72 hours (depending on the 
species) the infected RBCs rupture, releasing metabolic byproducts and more parasites into 
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 the blood stream causing fever, chills and anemia - all the clinical symptoms associated with 
malaria. The released parasites then invade other RBC, beginning a new cycle. Eventually, up 
to 10% of all RBC become infected.  
Stage III (gametocyte stage): At some point during the course of the infection, most 
notably when the asexual proliferation slows down, the merozoites grow but do not divide, 
and produce the sexual parasite stages in a subset of infected RBC. These are the 
gametocytes, which are the gamete precursors and are distinguishable as males 
(Microgametocyte) and females (Macrogametocyte). These gametocytes rest inert in the 
vertebrate host blood and only upon being ingested by a biting mosquito will they initiate the 
mosquito part of the parasite life cycle. A population of mature P. falciparum gametocytes has 
a half-life of 2.5 days and, depending on its size, may persist at levels infective to mosquitoes 
for periods as long as 22 days (Smalley and Sinden 1977). 
Stage IV (gamete, zygote and ookinete stages):  Upon being taken up with a 
bloodmeal by a biting female mosquito, the gametocytes transform into gametes. The male 
gametocyte undergoes exflagellation and produces up to 8 male gametes (microgametes). 
Female gametocytes produce only one female gamete (macrogamete) each. Gametogenesis 
occurs within 10−15 min following the uptake of the bloodmeal and is triggered by the drop 
in temperature and change in pH. Within 30 min, microgametes must actively find and 
fertilize the macrogametes. Gamete pairs fuse to form a zygote which then develops into the 
motile ookinete and sequentially traverses the mosquito peritrophic membrane and midgut 
epithelial mono-layer to encyst on the opposite,  basal side. 
Stage V (oocyst and sporozoite stages): On the hemolymph side of the mosquito 
midgut epithelium, underneath the basal lamina, the ookinete will develop to a sporozoite-
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 filled oocyst which will take 8−15 days (depending on the Plasmodium species) to mature. 
During this maturation process a meiotic cycle is followed by several rounds of mitosis to 
produce several thousand haploid sporozoites. Upon maturation, the oocyst ruptures and 
releases the sporozoites which travel through the mosquito hemolymph to reach the salivary 
glands. 
Stage VI (sporozoite stage): At the salivary glands, the sporozoite stage parasites 
traverse the second mosquito epithelium, this time in the basal to apical direction, and 
accumulate within the gland ducts. From there, the parasites get injected into the next 
human host with the mosquito saliva, which contains a complex mixture of anti-hemostatic, 
anti-inflammatory and immunomodulatory compounds. The dual host cycle of the parasite 
then starts anew. 
 
Fig. 1.3.1 Life cycle of the parasite Plasmodium falciparum. The developmental stages of the parasite cycle in the 
human host (I - III) are labeled in blue and the developmental stages in the mosquito vector (IV – VI) are 
labeled in red. (modified from (Wirth 2002)) 
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1.4 MOSQUITO-PARASITE INTERACTIONS 
 
Hematophagy or blood feeding is a behavior shared between various arthropod taxa. 
In mosquitoes it is exhibited by nonautogenous females that require a blood meal for egg 
production. Pathogens such as the human malaria parasite profit from this circumstance and 
use the mosquito as a vehicle to travel between vertebrate hosts. 
The interactions between Plasmodium and Anopheles are rather complicated and not well 
understood. The mosquito is far from being a willing vehicle to the parasite, contrary to the 
initial notion of the parasite just passing swiftly and without damage through the mosquito. 
The developmental steps the parasite has to undergo are many and complex, and can fail on 
a number of levels as indicated by the huge amount of parasite losses in the mosquito (Fig. 
1.4.1).  
 
Fig. 1.4.1 Parasite losses in the mosquito vector (modified from (Sinden 1999)). 
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 Some researchers would claim that the anthropocentric view of humans as hosts and 
mosquitoes as vectors is incorrect. Firstly, the adaptation of the parasite to humans has in all 
likelihood only occurred recently in evolutionary time. Secondly, as a consequence, the 
parasite is much better adapted and causes less damage to the mosquito, whereas the so-
called human host suffers immensely. Lastly, the all important sexual part of the parasite life-
cycle occurs in the mosquito and the proliferation in the human is purely asexual.  
 
Susceptibility and refractoriness of mosquitoes to parasites. 
Because development of the parasite in the mosquito is delicate, most malaria parasites 
develop successfully only in a few mosquito species and therefore, only a limited number of 
Plasmodium – Anopheles combinations can cause malaria in humans or other animals. This 
number of effective combinations is further narrowed by mosquito biting preferences and 
vectorial capacity (the varying ability of individual mosquitoes of the same species to sustain 
parasite development). For example, a mosquito might passively lack some requirement for 
successful parasite development, such as Xanthurenic acid to activate Plasmodium berghei (a 
rodent parasite) gametogenesis in the midgut (Billker, Lindo et al. 1998), and/or it might 
actively mount a strong immune response against the parasite. The hypothesis of mosquitoes 
mounting immune responses against the malaria parasite is supported by laboratory selection 
of mosquito strains that are refractory to the parasites. In these strains the parasites are killed 
while traversing the midgut epithelium, e.g. by melanization in the L3-5 strain (Collins, Sakai 
et al. 1986) (Fig. 1.4.2c) or by lysis in the SUAF2 strain (Vernick, Fujioka et al. 1995) (Fig. 
1.4.2b). 
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 Refractoriness thus appears to have a genetic basis and occurs in the wild. It is thought 
to be conveyed by natural resistance alleles (Niare, Markianos et al. 2002) that limit parasite 
development in the vector to relatively small numbers of oocysts, typically fewer than ten 
(Pringle 1966; Billingsley, Medley et al. 1994). However, the genetic control of refractoriness 
appears to be complex. Not only does it involve several quantitative trait loci (QTL), but the 
relative contribution of each QTL varies with the parasite species (Zheng, Cornel et al. 1997; 
Zheng, Wang et al. 2003). However, these aspects make it quite clear that the mosquito-
parasite interactions are a promising target for malaria control efforts.  
 
 
Fig. 1.4.2 Modes of parasite killing in the mosquito midgut. a. Infected wild-type midgut b. Lysis of the 
Plasmodium parasite in a infected midgut of the SUAF2 strain (Vernick, Fujioka et al. 1995) c. Melanized 
parasites in the midgut of the L3-5 strain (Collins, Sakai et al. 1986) 
 
Mosquito midgut invasion. 
As shown in Fig. 1.4.1, parasite losses in the mosquito are documented at three 
decisive developmental transitional stages: the gamete-to-ookinete, the ookinete-to-oocyst 
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 and the midgut sporozoite-to-salivary gland sporozoite transitions (Sinden 1999; Sinden 
2002; Alavi, Arai et al. 2003). However, the most serious reduction occurs at the ookinete-to-
oocyst transition at which point the parasite numbers often drop to single digits, 
necessitating the key amplification step that follows (Fig. 1.4.1; Fig. 1.4.3). 
Different routes of midgut invasion have been reported for various mosquito–parasite 
species combinations, P. berghei ookinetes penetrate the midgut epithelium of A. gambiae and 
A. stephensi using a combination of inter and intracellular routes (Han, Thompson et al. 2000; 
Vlachou, Zimmermann et al. 2004) whereas P. falciparum has been reported to invade A. 
stephensi mosquito midguts solely via the intracellular route (Baton and Ranford-Cartwright 
2004; Baton and Ranford-Cartwright 2005).  
Recent work has shown that many ookinetes are eliminated inside the midgut 
epithelium through the action of mosquito immune factors such as TEP1 (Thioester 
containing protein 1) (Blandin, Shiao et al. 2004) and LRIM1 (Leucine-rich repeat protein 1) 
(Osta, Christophides et al. 2004). TEP1, which is produced by hemocytes and secreted in the 
hemolymph, binds to the surface of the parasites mediating their lysis. LRIM1 is thought to 
act in the same fashion, however, CTL4 (and to a lesser extend CTLMA2) protect the 
remaining parasites from the action of LRIM1, assuring their development to oocysts that 
some days later will release sporozoites in the mosquito hemolymph (Fig. 1.4.3a). However, 
in the absence of CTL4 by genetic knockdown, LRIM1 promotes killing of the remaining 
parasites, which are subsequently melanized in a reaction thought to be mediated by 
phenoloxidases (Fig. 1.4.3b). 
Thus, it is reasonably established now, that the mosquito immune reactions are indeed 
in part responsible for this decrease (Blandin, Shiao et al. 2004; Meister, Koutsos et al. 2004; 
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 Osta, Christophides et al. 2004; Meister, Kanzok et al. 2005). However, how some parasites 
manage to escape these immune reactions remains vaguely elusive and is a central questions 
among the research community. 
 
 
Fig. 1.4.3 Anopheles-Plasmodium interactions in the mosquito midgut (a) TEP1 and LRIM1 eliminates many 
ookinetes inside the midgut epithelium. CTL4 protects the remaining parasites from the action of LRIM1. (b) 
After CTL4 knockdown by RNAi, LRIM1 promotes killing of the remaining parasites, which are subsequently 
melanized (from (Meister, Koutsos et al. 2004)). 
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 1.5 INSECT INNATE IMMUNITY 
 
Adaptive vs. innate immunity. 
Innate Immunity has developed as a first line of efficient defense against microbial 
invaders and as such it is common to all metazoans. Characteristic of it is the detection of 
surface patterns of microorganisms by “pattern recognition receptors” (PRR) (Janeway 1989) 
that have conserved the memory of motives (or patterns) associated with the 
microorganisms such as i.e. peptidoglycan, lipopolysaccharide, lipoteichoic acids, 
lipoproteins, bacterial CpG DNA, and flagellin. These receptors rapidly activate signaling 
pathways and effector mechanisms such as phagocytosis, proteolytic cascades and of course 
the synthesis of antimicrobial peptides (AMPs) that quickly limit the infection (Medzhitov 
and Janeway 2000; Janeway and Medzhitov 2002). 
Adaptive immunity was acquired later in evolution (it is shared by ~45,000 vertebrate 
species) by the ancestors of cartilaginous fish and introduced the advantage of individual 
immune memory. The adaptive immunity is able to create an almost limitless variety of cells 
and molecules to recognize and eliminate an equally vast variety of foreign invaders. It 
achieves this feat by: (1) somatic gene rearrangement to create a large repertoire of receptors, 
(2) the clonal multiplication of antigen-specific effector cells targeting the invading pathogen 
and (3) the generation of memory cells to prevent re-infection. 
To sum it up: adaptive immunity is built on innate immunity as its foundation. It 
depends on innate immunity for its activation, and consequently it is possible for the 
majority of species on earth to do just fine without adaptive immunity. However, a 
hypothetical  species with adaptive immunity but no innate immunity seems rather unlikely. 
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Innate immunity. 
Drosophila has served as the model system for innate immune responses in insects for 
many years (Hoffmann 2003). It resists challenges from various microorganisms remarkably 
well, relying solely on its innate immunity. For this reason the basics of insect innate immune 
systems shall first be discussed drawing from our knowledge of Drosophila. 
 
The insects’ first line of defense against infections is the structural barriers of the body, 
mainly the hardened exoskeleton, but also the chitinous trachea and the peritrophic matrix 
of the midgut. To protect insect interior tissues, breaches are quickly sealed by coagulation 
(Theopold, Li et al. 2002) and melanization reactions (Soderhall and Cerenius 1998). 
Should the pathogens however manage to penetrate these structural barriers into the 
open circulatory system in which the organs and tissues are bathed in the hemolymph, they 
encounter the insects’ immune reaction by the fat body and hemocyte cells. There are 
constitutively present molecules in the hemolymph(prophenoloxidase (PPO), coagulation 
factors, pattern recognition molecules and opsonins) which sometimes require post-
translational activation like proteolytic cleavage.  
Upon binding to pathogens, the recognition proteins (or opsonins) immediately trigger 
mainly two types of innate immune responses: (1) cellular responses: phagocytosis and 
encapsulation, and (2) humoral responses: secretion of AMPs, melanization and coagulation. 
Depending on the intensity of infection, these responses may be sufficient to clear the 
microorganisms from the insects’ hemolymph within a few minutes. 
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 Humoral immunity: AMPs. 
As mentioned before, the binding of PRRs to pathogen-specific molecules activates 
signaling cascades that, within hours after infection, cause the transcriptional activation of 
hundreds of immune-inducible molecules, including AMPs (Dimopoulos, Christophides et al. 
2002). AMPs represent the best-characterized insect humoral reaction and are mostly 
produced by the fat body and the hemocytes, although various barrier epithelia, such as 
tracheae, anterior midgut, the genital tract and the Malpighian tubules are also capable of 
producing these peptides (Lehane, Wu et al. 1997; Richman, Dimopoulos et al. 1997; Tzou, 
Ohresser et al. 2000). They are typically small, cationic and structurally diverse peptides 
(Bulet, Hetru et al. 1999) and can reach micromolar concentrations in the insect hemolymph 
(Lowenberger 2001).  
The effector mechanisms vary between different AMP families; however, in general, 
AMPs are believed to be attracted to the negatively charged surface of microbes killing them 
by damaging the structure of their cytoplasmic membrane, for example by permeabilization 
or by forming voltage-dependent channels (Bulet, Hetru et al. 1999; Shai 2002). Once 
induced, AMPs can persist in the hemolymph for at least 3 weeks, and may provide 
protection against reoccurring infections for the rest of the insect life.  
Eight distinct classes of AMPs have been discovered mainly in the fruit fly D. 
melanogaster by biochemical analysis (Imler and Bulet 2005). They can be grouped into three 
families based on their main biological targets in Drosophila:  
1. gram-positive (Gram+) bacteria 
Defensin (Dimarcq, Hoffmann et al. 1994) 
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 2. gram-negative (Gram-) bacteria  
Cecropins (Kylsten, Samakovlis et al. 1990) 
Drosocin (Bulet, Dimarcq et al. 1993) 
Attacins (Asling, Dushay et al. 1995) 
Diptericin (Wicker, Reichhart et al. 1990) 
MPAC/AttacinC (Imler and Bulet 2005) 
3. fungi  
Drosomycin (Fehlbaum, Bulet et al. 1994) 
Metchnikowin (Levashina, Ohresser et al. 1995) 
Gambicin (Vizioli, Bulet et al. 2001) of A. gambiae is active against both Gram+ and 
Gram- bacteria. 
 
Cellular immunity: phagocytosis, encapsulation & melanization. 
Hemocytes are the major cell type in the hemolymph responsible for phagocytosis 
(Hillyer, Schmidt et al. 2003) and encapsulation (Meister and Lagueux 2003). In phagocytosis, 
specialized blood cells recognize, internalize and destroy microbial invaders (Aderem and 
Underhill 1999). The process is paramount for clearing of invading bacteria in the early 
stages of infections.  
Opsonic ligands have to bind to the microorganism in order for them to be recognized 
by phagocytic cells. One of the receptors involved in the phagocytosis of Gram- bacteria in 
Drosophila is the PRR and Imd pathway mediator PGRP-LC, pointing to a link between 
humoral and cellular immune reactions (Ramet, Manfruelli et al. 2002). In Anopheles, a 
member of the thioester containing protein family, TEP1, acts like an opsonizing 
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 complement factor by binding to bacteria and promoting their phagocytosis (Levashina, 
Moita et al. 2001).  
Bigger objects that cannot be phagocytosed such as eggs of parasitoid wasps in 
Drosophila are encapsulated by the hemocyte cells.  In this reaction, the hemocytes attach to 
the surface and extend long lamellae to cover and inactivate the object. They thus cause 
death by asphyxiation and/or attack with free radicals (Nappi and Vass 1998). The next step 
often is the activation of the PPO cascade to crosslink and thus neutralize everything in a 
melanin capsule in a reaction called melanotic encapsulation (Fig 1.5.1). 
In Drosophila, there have been three hemocyte types described: plasmatocytes, 
lamellocytes and crystal cells (Meister and Lagueux 2003) They are mostly attached to tissues, 
such as muscle, tracheae, fat body, midgut and Malpighian tubules (Hillyer and Christensen 
2002). Plasmatocytes are performing the phagocytosis (Aderem and Underhill 1999) and 
represent the main population of hemocytes. Encapsulation is carried out by lamellocytes 
(Nappi and Vass 1998), and finally, PPO-producing crystal cells are thought to mediate 
melanization of encapsulated bodies (Meister and Lagueux 2003). 
Although we are starting to understand hematopoiesis and blood cell differentiation in 
Drosophila (Evans, Hartenstein et al. 2003), attempts to establish a unified system to classify 
hemocytes in other insects have not been feasible to date (Brehelin, Zachary et al. 1978; 
Hillyer and Christensen 2002).  
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Fig. 1.5.1 Scheme of the signaling cascade leading to the activation of melanization in insects. CLIPA, 
clip domain serine protease A; CTL C-type Lectin; LPS, Lipopolysaccharide; PAMP, pathogen 
associated molecular pattern; PGN, Peptidoglycan; PPAE, PPO activating enzyme ; PPO, 
Prophenoloxidase; PO, Phenoloxidase. 
 
A. gambiae: a new model for studying innate immunity. 
Although Drosophila serves as the model system for innate immune response study in 
insects (Hoffmann 2003), results from Drosophila cannot necessarily be expected to also be 
true for Anopheles, as the two dipterans diverged approximately 250 million years ago 
(Wiegmann, Yeates et al. 2003) and have adopted quite different lifestyles. The most 
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 important differences are hematophagy and the aquatic developmental stages in Anopheles. 
However, the use of Anopheles as a model system for innate immunity suffered from the 
complexity of rearing, and thus the lack of robust genetics, genetic manipulation techniques 
and biochemistry. Taken together this permitted only a limited view of the immune reactions 
in this important vector of human malaria. 
However, advances in Anopheles genomics and functional genomics during the last four 
years have led to a rapid development in the field. Genome sequencing (Holt, Subramanian 
et al. 2002) allowed for a large-scale comparative genomic analysis of gene families involved 
in the Drosophila immune system (Christophides, Zdobnov et al. 2002). This analysis revealed 
significant divergences between the Drosophila and Anopheles genomes highlighted by a lack of 
orthologs and an excess of gene family expansions in the recognition and effector gene 
modules. This may reflect the adaptation to specific environmental requirements imposed by 
the different lifestyles of the respective insect species. The signal transduction gene families, 
however, are remarkably conserved (Christophides, Vlachou et al. 2004), suggesting that 
successful defense strategies remain conserved during the evolution of the two insects. In 
other words, the recognition and response arsenal of the immune system had to be adjusted 
and expanded to deal with the different encountered immune challenges in the variable 
ecological niches. 
 
Defense against the parasite. 
A growing number of studies have shown that the malaria parasite causes 
transcriptional upregulation of immunity genes during its various developmental transitions 
in the mosquito. This suggests that the innate immune system may account for large parts of 
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 the documented parasite losses (Fig. 1.4.1) (Richman, Bulet et al. 1996; Dimopoulos, 
Richman et al. 1997; Dimopoulos, Seeley et al. 1998; Dimopoulos, Christophides et al. 2002; 
Tahar, Boudin et al. 2002; Christophides, Vlachou et al. 2004). 
 
 
Fig. 1.5.2 Anopheles immune reaction against the Plasmodium parasite during its sexual developmental cycle in 
the mosquito midgut and hemolymph. Mosquito molecules acting in a positive, protagonistic (+) or negative, 
antagonistic (-) way towards the parasite are listed in boxes. The reactions facilitated by them include parasite 
melanization, lysis and local epithelial responses. (a) Following gamete development and fertilization, (b) 
Plasmodium ookinetes (ook) traverse the cytoplasm of several midgut cells (1, 2 and 3) before emerging 
basolaterally underneath the basal lamina (BL). (d) There, the parasite develops into an oocyst (ooc) to produce 
thousands of sporozoites (spz). (e) Upon rupture of the oocyst, the sporozoites are released and then invade 
the salivary gland. CP, capping protein; IMD, immune deficiency gene; PM, peritrophic matrix; PO, 
phenoloxidases; REL2, Relish 2; SOD, superoxide dismutase (from (Vlachou and Kafatos 2005)). 
 
There are several mosquito immune reactions directed against the parasite (Fig. 1.5.2) – 
the best example probably being the Plasmodium ookinete melanization in the genetically 
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 selected A. gambiae strain L3-5 (Collins, Sakai et al. 1986). The fact that this reaction is 
dependent on the mosquito-parasite combination (P. cynomolgi, P. berghei and allopatric strains 
of P. falciparum are melanized, but sympatric P. falciparum populations are not (Collins, Sakai 
et al. 1986; Paskewitz, Brown et al. 1988)) points to the possibility that parasite-specific 
recognition is involved and that the parasite itself has some mechanism of immune evasion. 
The L3-5 strain very effectively melanizes injected Sephadex beads (Paskewitz and 
Riehle 1994) which indicates that melanization is not necessarily coupled or dependent on 
parasite recognition and killing. Another mechanism of parasite killing that has been 
reported for the SUAF2 strain is lysis in the cytoplasm of the midgut epithelial cells (Vernick, 
Fujioka et al. 1995). 
More recent studies have focused on the role of innate immunity genes in parasite 
melanization and lysis in the mosquito midgut. Knockdown (KD) of the hemocyte-specific 
complement-like protein TEP1 by RNAi was found to greatly increase the number of 
developing oocysts  as TEP1 binds to P. berghei ookinetes and mediates their lysis. On the 
other hand, silencing of TEP1 in the L3-5 strain inhibits melanization (while also increasing 
the number of developing oocysts) (Blandin, Shiao et al. 2004). TEP1 was previously shown 
to be one of the factors involved in the phagocytosis of bacteria (Levashina, Moita et al. 
2001). 
Another recently identified factor in parasite killing in the mosquito midgut is LRIM1. 
When silenced, the oocyst numbers are substantially increased, similar to the TEP1 KD 
(Osta, Christophides et al. 2004). LRIM1 has been shown to be upregulated upon bacterial 
challenge (Dimopoulos, Christophides et al. 2002) and Plasmodium infection (Osta, 
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 Christophides et al. 2004) but no LRIM1 orthologs have been identified in other species to 
date. 
Neither TEP1 nor LRIM1 are sufficient to halt the parasites progress, reinforcing the 
idea that parasite survival in susceptible mosquitoes may be due to specific immune evasion 
on the parasites part. In fact, two C-type lectins (CTLs) – CTL4 and CTLMA2 – seem to be 
recruited by P. berghei to protect it from LRIM1-mediated killing. Silencing of either of these 
CTLs leads to killing and melanization of almost all P. berghei ookinetes in the mosquito 
midgut (Osta, Christophides et al. 2004). 
Other genes implicated in the mosquito cellular epithelial reaction to parasite invasion 
are serine proteases that have been shown to be transcriptionally activated and involved in 
ookinete killing and melanization (Dimopoulos, Christophides et al. 2002; Volz, Osta et al. 
2005). The serine protease inhibitor, SRPN10, is highly and specifically induced in Anopheles 
midgut cells upon parasite invasion (Danielli, Kafatos et al. 2003) and can serve as an 
excellent marker of this event. At least two other serpins SRPN2 (Michel, Budd et al. 2005) 
and SRPN6 (Abraham, Pinto et al. 2005), are negative factors of ookinete killing and 
melanization.  
Transcriptomic microarray analysis of the local epithelial response as revealed that as 
much as 7% of the surveyed mosquito transcriptome may be regulated upon parasite 
invasion – this includes genes involved in cytoskeletal remodeling, apoptosis, immune 
responses, the redox state, cell adhesion and the extracellular matrix (Vlachou, Schlegelmilch 
et al. 2005). An interesting gene (RFABG) discovered in this study encodes lipophorin a lipid 
transport vehicle that is a positive factor of parasite oocyst and mosquito egg development. 
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 In summary, the picture emerging is that the development and advancement of the 
parasite depends on positive (e.g. CTL4, CTLMA2) and negative (e.g. TEP1, LRIM1) 
mosquito factors. This is consistent with the notion of parasite melanization in the L3-5 
strain being complex and depending on multiple quantitative trait loci (Zheng, Cornel et al. 
1997). Suspiciously, the TEP1 gene sequence, which is in the Pen2 region, displays high 
variability between refractory and susceptible mosquitoes (Blandin, Shiao et al. 2004); and 
the Pen1 region shows clusters of extensive sequence polymorphisms that may relate to the 
refractory phenotype (Thomasova, Ton et al. 2002). Also, strong physiological differences 
have been shown to exist between the refractory L3-5 and the susceptible G3 strain, most 
notably an elevated level of reactive oxygen species contributing to parasite melanotic 
encapsulation in the L3-5 strain (Kumar, Christophides et al. 2003).  
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 1.6 IMMUNE SIGNALING PATHWAYS IN 
DROSOPHILA  
 
Studies in D. melanogaster studies have shown that the production of AMPs is the result 
of the activation of two distinct pathways: the Toll and the Imd pathway (Hoffmann 2003).  
 
The Toll pathway. 
Toll was originally discovered as being involved in the dorsoventral pattern formation 
during embryonic Drosophila development (Anderson, Bokla et al. 1985); it soon became 
evident that it was also involved in innate immune responses against fungi (Lemaitre, Nicolas 
et al. 1996) and Gram+ bacteria (Fig. 1.6.1).  
The receptor responsible for recognition of fungi is reported to be the GNBP3 
receptor, whose null mutation hades is sensitive to fungal infections (Ferrandon, Imler et al. 
2004). Downstream signaling of the recognition event proceeds through the Persephone 
protease (Psh) (Ligoxygakis, Pelte et al. 2002), which is negatively regulated by the blood 
serpin Necrotic (Nec) (Levashina, Langley et al. 1999), to cleave the ligand and activator of 
the Toll receptor, the cytokine-like polypeptide Spaetzle (Spz) (Lemaitre, Nicolas et al. 1996; 
Weber, Tauszig-Delamasure et al. 2003). 
The activation of the other Toll signaling branch by Gram+ bacteria (Fig. 1.6.1) 
involves two extracellular proteins thought to be brought into a complex by PAMP 
recognition. The first is the peptidoglycan recognition protein, PGRP-SA (Michel, Reichhart 
et al. 2001) and the second is GNBP1 (Gram-negative binding protein 1) (Gobert, Gottar et 
al. 2003). This process ultimately leads to proteolytic cleavage of Spz and activation of Toll. 
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 At least three cytoplasmic proteins, MyD88, Tube and Pelle are recruited by the 
intracellular part of Toll – potentially the intracytoplasmic so-called TIR (Toll/IL-2 receptor) 
homology domain. Pelle is a serine-threonine kinase believed to play an indirect role in the 
phosphorylation and subsequent proteolytic degradation of Cactus, a member of the IκB 
family of proteins. The degradation of Cactus results in the nuclear translocation of NF-κB 
transcription factors, Dorsal and Dif, which are bound to intact Cactus and thus retained in 
the cytosol (Belvin and Anderson 1996).  
Whereas Dorsal is essential for developmental processes, Dif is mostly implicated in 
the transcription of AMPs and other defense genes through specific binding to cis-acting 
elements (κB motifs) found in the promoter sequences of these genes. 
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Fig. 1.6.1 The Toll and Imd immune signaling pathways in D. 
melanogaster (modified from (Meister, Koutsos et al. 2004)) 
 
 
The Imd pathway. 
Gram- bacterial infections are predominantly dealt with by activation of the Imd 
(immune deficiency) pathway, named after its first characterized mutation (Lemaitre, 
Kromer-Metzger et al. 1995; Lemaitre, Nicolas et al. 1996).  Two PRRs have been shown so 
far to trigger responses of the Imd pathway: the membrane spanning PGRP-LC (Choe, 
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 Werner et al. 2002; Gottar, Gobert et al. 2002) and the extracellular PGRP-LE (Takehana, 
Katsuyama et al. 2002; Takehana, Yano et al. 2004). The intermediate steps of signal 
transduction (if any) between PGRP-LE and the Death domain carrying Imd are unknown. 
PGRP-LC and Imd have recently been shown to interact directly (Choe, Lee et al. 2005). 
Downstream of Imd the signal is transduced by two paths: one involves the Drosophila 
homologs of the mammalian IκB kinase complex (IKK) (Silverman, Zhou et al. 2000) and 
the other the caspase Dredd (Stoven, Ando et al. 2000). Downstream, they lead to the 
proteolytic cleavage and activation of Relish (Dushay, Asling et al. 1996), a third member of 
the NF-κB family of transcription factors.  
Full length Relish contains an amino-terminal DNA binding domain and a 
carboxyterminal IκB domain, which acts similarly to the Toll pathway inhibitor Cactus, 
preventing the nuclear translocation of the transcription factor domain when the pathway is 
inactive (Dushay, Asling et al. 1996). After proteolytic removal of the IκB domain, Relish 
translocates into the nucleus and induces transcription of AMPs. 
 
The elegant simplicity of the two different pathways responding either to Gram- or 
Gram+ and fungal infections is slightly misleading, however. Recent studies have highlighted 
that this initial clear separation of the two pathways, is to a large extent an oversimplification 
of the reality of complex feedback and crosstalk interactions between pathways (Hoffmann 
2003; Hultmark 2003). 
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 1.7 THE FAMILY OF PGRP RECEPTORS 
    
Peptidoglycan structure. 
Peptidoglycan (PGN) is a cell wall component of both Gram+ (90%) and Gram- 
(10%) bacterial cell walls. While all bacteria have PGN, the amount, location, and specific 
composition may vary. For example, PGN is associated with lipoteichoic acid in a thick 
exposed layer around the bacterial cell wall of Gram+ bacteria, whereas in Gram- bacteria it 
is only in a thin layer overlaid by a much thicker layer of LPS.  
PGN is composed of parallel glycan strands and cross-linking peptide moieties. The 
glycan strands consist of two alternating sugar residues: β-1,4-linked N-Acetylglucosamine 
(NAG) and N-Acetyl Muramic Acid (NAM) (Fig 1.7.1). NAM is found only in bacteria and 
blue-green algae. 
The peptide moiety consists of only 3 to 6 different, alternating L- and D-amino acids, 
where the D configuration is typical of PGN. Position 3 in all Gram- bacteria and in the 
Gram+ bacilli (genus Bacillus and Clostridium) is occupied by m-Diaminopimelic Acid (m-Dap) 
(Fig 1.7.1, right). Most other Gram-positive bacteria (e.g. Gram+ cocci) have L-Lysine in this 
position (Fig. 1.7.1, left). The Dap-type PGN peptides are usually directly cross-linked, 
whereas the Lys-type PGN peptides are usually linked through an “interpeptide bridge” that 
varies in length and amino acid composition in different bacteria (Schleifer and Kandler 
1972). PGN has been classified into two Groups, six Subgroups and 16 Variations by 
(Schleifer and Kandler 1972). 
PGN can be cleaved by several enzymes of bacterial and animal heritage. Chicken type 
Lysozyme has muramidase activity (N-acetylmunramide glycanohydrolase (EC 3.2.1.17)) – it 
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 cleaves the glycosidic link between NAG and NAM in the polysaccharide chain (Chipman 
and Sharon 1969) (Fig. 1.7.1, blue arrows). Enzymes with N-acetylmuramoyl-L-alanine 
amidase activity (NAMLAA–activity (EC3.5.1.28)) are enzymes specifically cleaving the 
lactylamide bond between Muramic Acid and the peptide chain (Fig 1.7.1, red arrows). 
Examples of peptides with NAMLAA activity are the zinc dependent bacteriophage T7 
Lysozyme (Cheng, Zhang et al. 1994; Dziarski 2004), and PGRP-SC1B of D. melanogaster the 
(Mellroth, Karlsson et al. 2003). Mammalian proteins with NAMLAA activity are the mouse 
(Gelius, Persson et al. 2003) and human PGRP-L (Gelius, Persson et al. 2003; Wang, Li et al. 
2003) that are found in different tissues and body fluids (Valinger, Ladesic et al. 1982; De 
Pauw, Neyt et al. 1995; Hoijer, Melief et al. 1996). 
 
 
Fig. 1.7.1. Structure of Lys-type and Dap-type peptidoglycan (adapted from: (Dziarski 2004)). Amide bonds 
cleaved by NAMLAA enzymatic activity are indicated by arrows and glycosidic links cleaved by lysozyme 
muramidase activity are marked with a star. 
 
It has been known for a long time that PGN promotes an inflammatory response. 
Initially was derived from intraperitoneal injection of PGN from Gram+ bacteria that 
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 promoted inflammation. In cell culture models, PGN has been demonstrated to stimulate 
the production of inflammatory cytokines in monocytes, macrophages, neutrophils, and 
epithelial cells. Later, muramyl dipeptide (MDP), a subcomponent of PGN, was found to be 
the minimal chemical structure required for adjuvant activity (reviewed in (Stewart-Tull 
1980)).  
 
PGRPs in Drosophila and other insects. 
The first PGRP was purified from the hemolymph of the silkworm Bombyx mori 
(Yoshida, Kinoshita et al. 1996). It was a 19 kDa protein that bound Gram+ bacteria and 
PGN and activated the prophenoloxidase (PPO) cascade. A few years later it was cloned 
(Ochiai and Ashida 1999) as well as an ortholog from the moth Trichoplusia ni (Kang, Liu et 
al. 1998). The discovery of mammalian PGRPs showed that these proteins are highly 
conserved from insects to mammals. 
Sequencing of the fruit fly D. melanogaster genome facilitated the identification of a 
family of 13 highly diversified PGRP homologs transcribed to at least 17 PGRP proteins 
(Werner, Liu et al. 2000). In general, members of this PGRP gene family share one or more 
well-conserved PGRP domains and can be classified as short (S), which encode secreted 
proteins, and as long (L), which encode transmembrane and intracellular protein products. 
As mentioned previously, one of the short, secreted Drosophila PGRPs, PGRP-SA, is 
essential for activation of the Toll/Dif signaling pathway in response to Gram+ bacteria, 
such as M. luteus, but not fungi (Michel, Reichhart et al. 2001). A recent report also places the 
soluble PGRP-SD upstream of the Toll receptor in the Gram+ bacteria recognition pathway 
(Bischoff, Vignal et al. 2004). The PGRP-LC receptor, on the other hand, acts through the 
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 alternative IMD/Relish pathway in response to Gram- bacteria (Choe, Werner et al. 2002; 
Gottar, Gobert et al. 2002).  
PGRPs have been found in a wide range of organisms: silkworm (Bombyx mori (Yoshida, 
Kinoshita et al. 1996)), fruit fly (D. melanogaster (Werner, Liu et al. 2000)), honey bee (Apis 
mellifera (Evans 2004)), human (Homo sapiens (Kang, Liu et al. 1998; Liu, Xu et al. 2001)) and 
mouse (Mus musculus (Kang, Liu et al. 1998; Kiselev, Kustikova et al. 1998)). The PGRP 
domains share a conserved cysteine motif important for protein function. Six Cysteines, 
conserved in all mammalian PGRPs, have been found in bovine PGRP to form a disulfide 
motif of 1-6, 2-5 and 3-4 pairings (Tydell, Yount et al. 2002). This is consistent with the 
pattern in the moth PGRP, which has two disulfide bridges corresponding to 1-6 and 2-5 
pairings (Ochiai and Ashida 1999). Importantly, in the Drosophila PGRP-SA loss-of-function 
mutation, semmelweis, which abolishes anti-Gram+ bacterial responses, Cys-80 (corresponding 
to the conserved cysteine 4) is changed to Tyr, thus disrupting the 3-4 highly conserved 
disulfide bond (Michel, Reichhart et al. 2001). In the rest of the Drosophila PGRPs, Cysteines 
3 and 4 are present in all proteins with the sole exception of PGRP-LE. Notably PGRP-SA 
and all known Lepidopteran PGRPs have residues permitting a 1-6 cysteine pairing, similar 
to their mammalian homologs. 
Other important amino acid residues in conserved relative locations in the PGRP 
domains are a threonine and a tyrosine that are important for amidase activity and two 
histidines and a cysteine that coordinate the catalytic zinc ion (Reiser, Teyton et al. 2004). 
Five PGRPs in Drosophila have all these requirements: PGRP-SC1A, -SC2, -SB1, -SB2 and –
LB. PGRP-LB has been also shown experimentally to possess lytic activity against sensitized 
Escherichia coli (Kim, Byun et al. 2003) and more recently to specifically degrade Gram- 
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 bacterial PGN to down regulate the Imd pathway (Zaidman-Remy, Herve et al. 2006). 
PGRP-SC1 and PGRP-SC2 have been shown to have a similar function in larvae (Bischoff, 
Vignal et al. 2006) . 
The rest of the Drosophila PGRPs (PGRP-SA, -SD, -LA, -LC, -LD, -LE) and the short 
human and mouse PGRP-Ss lack the zinc-binding residues, but are likely to have retained 
the ability to bind PGNs, as shown for short mammalians PGRPs (Liu, Xu et al. 2001) and 
Drosophila’s PGRP-SA (Werner, Liu et al. 2000) 
 
PGRP-LC in D. melanogaster. 
The long, transmembrane PGRP-LC receptor signaling responds to Gram- bacteria to 
induce production of certain antimicrobial peptides through the IMD/Relish pathway (Choe, 
Werner et al. 2002; Gottar, Gobert et al. 2002). A genome-wide RNAi screen in Drosophila 
cells in culture also pointed to PGRP-LC as a key player for phagocytosis of Gram- but not 
Gram+ bacteria (Ramet, Manfruelli et al. 2002). 
The three different PGRP domains (LCa, LCx, and LCy) of the PGRP-LC gene are 
spliced to a common invariant part of the gene to produce at least three transcript and 
protein isoforms. The 21 to 24 kDa PGRP domains are located extracellularly, and the 
invariant domain is intracellular (Werner, Borge-Renberg et al. 2003). It was recently shown 
that the intracellular domain, though not having any significant homology to other known 
domains, is mediating contact with the Imd protein (Choe, Lee et al. 2005). Only the PGRP-
LCx variant is absolutely required for activation of the IMD/Relish pathway (Choe, Werner 
et al. 2002; Werner, Borge-Renberg et al. 2003; Kaneko, Goldman et al. 2004) . The PGRP-
LCa form is, in addition to LCx, involved in the responses to small monomeric 
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 peptidoglycan subunits as shown in studies using RNAi (Kaneko, Goldman et al. 2004), 
possibly by forming heterodimers with the LCx form. The role of the third splice form, LCy, 
is still elusive because RNAi knockdown of its expression does not affect the IMD/Relish 
signaling upon challenge with PGN (Werner, Borge-Renberg et al. 2003; Kaneko, Goldman 
et al. 2004). 
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AIMS OF THE THESIS 
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 Most of our knowledge about innate immunity pathways to date was gathered in 
Drosophila melanogaster, where invading pathogens activate at least two distinct signaling 
pathways: the Toll and the Imd pathway. The Toll pathway is activated by Gram+ (Gram-
positive) and fungal infections whereas the Imd pathway responds to Gram- (Gram-negative) 
bacteria. The infectious non-self agents are recognized by PRRs interacting with cell wall 
components. Peptidoglycan Recognition Receptor Proteins (PGRPs) have been placed 
upstream of both the Toll and the Imd pathway. 
The first objective of this thesis was to use a comparative genomics approach to 
investigate differences and similarities in the Toll and Imd innate immune signaling pathways 
between D. melanogaster and Anopheles gambiae, the main vector of malaria in sub-Saharan 
Africa. 
The second objective was to then analyze the role of the PGRP family of pattern 
recognition receptors at the top of these two pathways, and to scrutinize the role of 
PGRPLC in particular. To these ends, the function of the receptor gene family in resistance 
to bacterial infections and in defense to malaria was to be examined by RNAi in cultured 
cells and whole mosquitoes.  
The third objective was to uncover the tasks of the transcriptional regulators of the 
immune pathways, REL1 and REL2. The effector target genes of these NF-κB transcription 
factors and their roles in bacterial and malarial defense were to be uncovered by means of 
RNAi, survival assays and microarrays. 
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MATERIALS & METHODS 
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 3.1 MOSQUITO / PARASITE 
 
A. gambiae rearing. 
The susceptible strains 4a r/r, G3 and the refractory strain L3-5 (Collins, Sakai et al. 
1986), were reared at 27°C at a relative humidity of 75%, with a 12/12h light/darkness cycle. 
Larvae were raised in 0,1% marine salt water and fed with ground cat food. Adults were fed 
ad libitum on wet cotton soaked in a 15% sucrose solution. For the production of eggs, 
female mosquitoes were allowed to take a blood meal on anaesthetized Balb/c or CD1 mice. 
This method was described in (Richman, Bulet et al. 1996). 
 
Gene silencing in adult A. gambiae.  
dsRNA was produced as described in this chapter. A nano-injector (Nanoject, 
Drummond) was used to introduce 69nl of dsRNAs (207ng at a concentration of 3 mg/ml) 
in water in the thorax of one to two-day old CO2-anesthetized adult female mosquitoes, 
which were then allowed to recover for four days. Only after this recovery time they were 
subjected to subsequent assays. This method was first described in (Blandin, Moita et al. 
2002).  
 
Bacterial infection & survival of the mosquito. 
GFP-expressing E. coli OP-50 was a gift from J.J. Ewbank (INSERM, Marseille-
Luminy, France). Bacillus subtilis, M. luteus and S. aureus were kind gifts from Philippe Bulet 
(IBMC, Strasbourg, France). Bacteria were cultured to OD600 = 0.7, pelleted, washed and 
resuspended in phosphate-buffered saline (PBS) to final concentrations (E. coli at 
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 OD600=0.01, S. aureus at OD600=0.4). 69 nl of the bacterial suspension or PBS for controls 
was injected into the mosquito thorax with a nano-injector (Nanoject, Drummond) while the 
mosquitoes were anesthetized with CO2 and allowed to recover. Dead mosquitoes were 
counted daily and removed over a period of 7 days. The results generally are representative 
of at least three independent experiments, each carried out with around 50 mosquitoes per 
tested group. 
 
A. gambiae infection with the malaria parasite. 
For malaria infections, mosquitoes were fed for 30 min at 21°C on CD1 mice infected 
with transgenic GFP-fluorescing P. berghei strains expressing GFP at the ookinete and early 
oocyst stages (Vlachou, Zimmermann et al. 2004) and all developmental stages (sexual and 
asexual) (Franke-Fayard, Trueman et al. 2004). After 5-7 days, midguts of the mosquitoes 
were dissected, fixed for 30min in 4% formaldehyde in 1xPBS, washed 3 times with 1xPBS 
and mounted on glass slides in Vectashield mounting medium. The number of GFP 
fluorescing oocysts and black melanized ookinetes per midgut were counted on a 
fluorescence microscope. 
 
A. gambiae challenge with fungi. 
Beauveria bassiana was a kind gift of Dominique Ferrandon, CNRS, IBMC, Strasbourg, 
France. The dark green fungus (Fig. 3.1.1 right) was extracted from a mosquito naturally 
overcome with it. For lack of better background knowledge, it was treated exactly like B. 
bassiana with regards to procedures and protocols. That seemed to work just fine. 
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 note of caution: B. bassiana is extremely detrimental to most insects. Special care has to be taken to do all 
work under sterile conditions to avoid contamination of laboratory insect lines! 
Infection of mosquitoes with B. bassiana
Genes of interest were knocked down by RNAi in adult female mosquitoes as 
described above. On the fourth day after KD, mosquitoes were knocked down on ice and 
put onto a malt-agar plate (Fig. 3.1.1) on which 8 days earlier B. bassiana had been plated out. 
The plate can be kept up to 3 weeks at room temperature. Gently shake the plate with the 
mosquitoes on it and then return them to their container. Keep the mosquitoes in a room 
dedicated to B. bassiana infections separate from the other mosquito strains you are 
maintaining. 
 
 
Fig 3.1.1 B. bassiana (left) and unknown fungi extracted from mosquitoes (right) grown on malt-agar plates. 
 
Extraction of spores 
Several malt-agar plates of >3 weeks old B. bassiana are harvested by adding 10-15ml of 
ddH2O on to the plates and scratching the surface with a sterile spatula. Pour the juice over 
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 autoclaved glass wool (in a sterile glass funnel) into a centrifuge bottle. Wash the plates twice 
with 10-15 ml of ddH2O and centrifugate 10 min at 4000 rpm. Discard the supernatant and 
wash the pellet twice with ddH2O. Dissolve the pellet in 100-250 µl of ddH2O and count the 
number of spores in  a Thoma (or Neubauer) counter by diluting an aliquot x100, x1000 or 
more. Add sterile 50% glycerol to have a final concentration of 107 spores/ml in 25% 
glycerol and store the spores at -80˚C. 
 
Plating out of spores 
Plate out 50 µl of 107 spores/ml on a malt-agar plate and grow at room temperature 
(Fig. 3.1.1).  
 
Malt-agar plates 
(1l medium, for ~25 plates of 10 cm dish) 
Peptone:  1g (Select peptone GIBCO BRL Cat No. 30392-021) 
Glucose: 20g (α-D(+)glucose monohydrate ROTH Art 6780) 
Malt:  20g (Sigma M-0383) 
Select agar: 15g (Invitrogen Cat No 30392-023) 
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 3.2 FRUIT FLY DROSOPHILA 
MELANOGASTER 
 
Fruit fly rearing. 
Drosophila melanogaster was reared on “Drosophila Quick Mix Medium” in standard 
Drosophila vials (both from Blades Biological Ltd (http://www.blades-bio.co.uk/home.htm)) 
at 21˚C (RT). The white mutant strain was ordered from Blades Biological Ltd and the 
PGRP-SA (semmelweis) (Michel, Reichhart et al. 2001) and PGRP-LC/TM6B (Gottar, 
Gobert et al. 2002) mutant strains were obtained from Julien Royet, IMBC du CNRS, 
Strasbourg, France. 
 
Bacterial infection & survival of Drosophila. 
GFP-expressing Gram- Escherichia coli OP-50 were a gift from J.J. Ewbank (INSERM, 
Marseille-Luminy, France). Gram+ Staphylococcus aureus were kind gifts from Philippe Bulet 
(IBMC, Strasbourg, France).  
Bacteria were cultured to OD600 = 0.7, pelleted, washed and resuspended in phosphate-
buffered saline (PBS) to final concentrations (E. coli at OD600=0.1, S. aureus at OD600=0.01). 
69 nl of the bacterial suspension or PBS for controls were injected into the Drosophila thorax 
with a nano-injector (Nanoject, Drummond) while the fruit flies were anesthetized with CO2. 
Dead fruit flies were counted daily and removed over a period of at least 7 days. The results 
generally are representative of at least three independent experiments, each carried out with 
more than 50 fruit flies per batch. 
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 3.3 DNA METHODS 
 
cDNA production. 
Total RNA was extracted from A. gambiae tissue with TRIzol reagent (Invitrogen, San 
Diego, CA) and treated with DNAseI. After Phenol-Chloroform extraction and photo-
spectrometric concentration determination, first strand cDNA synthesis was performed 
using 1µl of 0.5 µg/µl oligo dT primer (Sigma) with ~5µg of total RNA preparations 
(though cDNA synthesis was successfully performed with as little as 0.2µg total RNA from 
single mosquitoes).  
The mixture (10µl) was denatured at 68°C for 7 min and a cDNA synthesis reaction 
mix was added (1µl Reverse Transcriptase (SuperScript™II Rnase H- Reverse Transcriptase 
(Invitrogen) or MLV Reverse Transcriptase (Gibco BRL)); 1.5µl dNTPs (10mM) (peqlab); 
1.5µl DTT (Gibco BRL); 4µl 5x “First Strand” Buffer (Gibco BRL); 1µl RNAse Inhibitor 
(Roche)) and incubated at 42°C. After 50 min the Reverse Transcriptase was inactivated by 
heating the mixture for 15 min at 70°C. 
The cDNA was then treated with 100µg RNAseA per for 30’ at 37°C, a 
Phenol/Chloroform Extraction performed and resuspended in an appropriate volume of 
ddH2O. 
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 3.4 RNA METHODS 
 
total RNA extraction. 
9 volumes of TRIZOL are used for one volume of tissue (or 400µl TRIZOL for 1-20 
mosquitoes) according to manufacturer’s instructions. Total RNA is resuspended in ~70µl 
ddH2O. 
 
Semiquantitative RT-PCR. 
cDNA was produced as described above. Several dilutions of cDNA and numbers of 
PCR cycles were usually tested. The PCR reactions (50µl) were performed using 10pmol of 
gene-specific primers, 0.1 U of Amplitaq (Roche), 1µl 10mM (10nmol) dNTPs and 5µl of 
10x PCR Buffer including 1.5mM MgCl2 (Roche).  
After electrophoresis, the agarose gel was stained with the sensitive SYBR green dye 
(Molecular Probes) for 30-45min and analyzed with a fluorimager (Fuji FLA-2000). 
 
Quantitative real-time RT-PCR. 
The SYBR Green PCR Master Mix is a convenient premix of all the components, 
except primers, template and water necessary to perform real-time PCR using SYBR® 
Green I Dye. Direct detection of polymerase chain reaction (PCR) product is monitored by 
measuring the increase in fluorescence caused by the binding of SYBR Green dye to double-
stranded (ds) DNA.  
cDNA template was diluted 1:10 or 1:20 and triplets of the same reaction were 
analyzed. PCR reactions were performed according to the ABI Bulletin #2, whereby 25µl 
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 reactions were analyzed according to the “Relative Standard Curve Method” with the 
ribosomal protein S7 as internal calibrator. In this method, target quantity for experimental 
samples is determined from the standard curve and divided by the target quantity of the 
calibrator S7. Thus, the calibrator becomes the 1x sample, and all other quantities are 
expressed as x-fold difference relative to the calibrator.  
For each experimental sample, the amount of target and calibrator were determined 
from the corresponding standard curve. Then, the target amount was divided by the 
calibrator amount to obtain a normalized target amount. 
An Applied Biosystems 7500 Real-Time PCR System was used according to 
manufacturer's instructions. One PCR reaction (25µl) consisted of 12.5µl 2xSYBR® Green 
PCR Master Mix, pretested concentration (mostly 900 nM) of forward and reverse primers, 
and cDNA template dilutions.  
Thermal cycling parameters were  
1. 95°C, 10min  
2. 40 cycles of:  95°C, 15sec; 
60°C, 1min 
 
dsRNA production for RNAi. 
dsRNA is either produced by 1. using the pLL10 vector or 2. PCR with T7 primers. 
1.  Target gene fragments are cloned into the vector pLL10 (derived from the 
pLL17 vector with the pLL7 polylinker (Levashina, Moita et al. 2001)) and thus flanked by 
T7 polymerase promoters. The construct is linearized on either end of the insert with the 
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 appropriate restriction enzymes in two separate reactions. The linearized constructs serve as 
template for the RNA transcription using the MEGAscript T7 Kit (Ambion).  
After overnight incubation of the T7 reaction mixture at 37°C, the reactions are treated 
with DNaseI and cleaned up by Phenol:Chloroform extraction or with the RNeasy kit 
(QIAGEN). The ssRNAs is resuspended in 20µl RNase-free water. The concentration of the 
ssRNAs is determined by spectrometric concentration analysis (OD260).  
Minus- and plus- RNA strands are diluted to the concentration of 3µg/µl, mixed and 
denatured in a big beaker of boiling water for 5min. The mixture is then allowed to cool 
down to RT and anneal (several hours, preferably ON). The resulting dsRNA is analyzed on 
1.5% agarose gel supplemented with 0,5µg/ml Ethidium bromide. 
2.  PCR amplicons obtained from PCRs with primers tailed with the T7 
promoter sequences (GAATTAATACGACTCACTATAGGG) at their 5’ end are cleaned 
up with the QIAquick Gel extraction kit or QIAquick PCR Purification kit (QIAGEN) and 
resuspended in nuclease free water. The purified PCR amplicons are then used to synthesize 
dsRNA with the MEGAscript T7 Kit (Ambion).  
Just like in method 1, the reaction is treated with DNaseI and cleaned up by 
Phenol:Chloroform extraction or with the RNeasy kit (QIAGEN). The dsRNA is 
resuspended in 20µl RNase-free water, but not denatured and annealed by a boiling and 
cooling cycle. 
The concentration of the dsRNA is determined by photo-spectrometric concentration 
analysis (OD260) and adjusted to 3µg/µl by concentration with a vacuum centrifuge. The 
dsRNA is also analyzed on a >1.5% agarose gel supplemented with 0,5µg/ml Ethidium 
bromide. 
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 3.5 MICROARRAYS 
 
EST and oligonucleotide microarray analysis. 
Mosquito EST microarray construction, hybridization and analysis were performed as 
described (Dimopoulos, Christophides et al. 2002). Developmental profiling was performed 
using embryonic, 4th larval instars, pupal and newly emerged female adult stages of A. 
gambiae, Suakoko strain. A pool of total RNA prepared from all stages was used as reference 
sample. For immune challenges, 2 to 3-day old female mosquitoes of the Plasmodium-
susceptible strain 4a r/r (Collins, Sakai et al. 1986) were pricked with either a sterile needle or 
dipped in thick suspension of E. coli or S. aureus. Total RNA was collected 12 hrs after 
challenge.  
 
For malaria infection experiments, 4a r/r mosquitoes were fed on control Balb/c mice 
or on mice infected with P. berghei, and mosquito RNA samples collected at 24 hrs, 28 hrs, 6 
days, 11 days and 16 days post-infection.  
 
Cell line 4a3B (Muller, Dimopoulos et al. 1999) was challenged with 
paraformaldehyde-fixed E. coli and S. aureus (OD 0,05), PGN (10 µg/ml) and H2O2 (2 M). 
Duplicated RNA samples were collected 12 hrs after challenge and hybridized to arrays as 
described (Dimopoulos, Christophides et al. 2002). RNA prepared from naïve cells was used 
as reference.  
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 Microarray construction/printing. 
4k Microarray slides were printed as described (Dimopoulos, Christophides et al. 2002). 
Oligonucleotide primers were designed to amplify individual genes from a cDNA library or 
adult genomic DNA (average probe-length 500bp). PCR products were purified with ion 
exchange columns (Macherey-Nagel GmbH & Co. KG, Dueren, Germany) and spotted at 
500ng/µl in 3X SSC. Spotting was performed on aminosilane coated glass slides using the 
Omnigrid arrayer (GeneMachines, San Carlos, CA) and Telechem Stealth Pins (Telechem 
International, Sunnyvale, CA). 
 
Sample amplification. 
First Strand Synthesis: 100pmol T7-d(T)24 primer and 5µg total RNA are used to 
produce cDNA with 5’ T7 overhangs. The reaction mix consists of  4 µl 5x first strand 
synthesis buffer (Gibco BRL); 2 µl DTT 0.1 M (Gibco BRL); 1ul dNTP mix 10 mM (Gibco 
BRL); 1 µl 200 U/µl SuperScript™II Rnase H- Reverse Transcriptase (Invitrogen) or MLV 
Reverse Transcriptase (Gibco BRL). Incubate at 37°C for 1 hour. 
Second Strand Synthesis: To the reaction is added: 10 ul 5x Second Strand Synthesis 
Buffer  
1 µl dNTP mix 10 mM 
0.35 ul DNA Ligase  10 U/µl 
1.3 µl DNA Polymerase I 10 U/µl 
0.7 µl RNase H 10 U/µl 
16.7 µl DEPC-H2O 
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 Incubate sample at 16°C for 2h and add 100µl H2O for a final volume of 150µl. Stop 
the reaction by adding 10µl 0.5 M EDTA and clean up the cDNA by with Phenol-
Chloroform. 
cDNA Amplification: Use the T7 RNA Polymerase (Ambion T7 Megascript kit) to 
amplify the cDNA. For that 6µl ds-cDNA sample are mixed with 1.5µl 10x Reaction Buffer, 
1.5µl of each ribonucleotide (ATP, CTP, GTP, UTP) and 1.5µl T7 Polymerase enzyme 
mixture. The final volume is 15µl. After 4h at 37°C, 0.5µl DNaseI are added and the sample 
incubated at 37°C for 15min. Then chill on ice, clean up the amplified RNA with the 
QIAGEN RNeasy mini kit, determine cmRNA concentration and purity 
spectrophotometrically (the expected yield is 60 to 100µg) and dilute it to a final 
concentration of 1 µg/µl. 
 
Sample labeling. 
The following mix is prepared on ice and being placed at 70°C for 5 min: 
5µl  poly A+ RNA 1 µg/µl  
1µl  random hexamers 3 µg/µl  
1µl oligo dT 1 µg/µl  
3µl  H2O (final reaction volume10 µl) 
Then add: 
4µl Superscript II First Strand Synthesis Buffer 
2µl 0.1 M DTT 
2µl Cy-3 or Cy-5 
0.4µl dT-NTP mix (25mM dA, dC, dG; 10 mM dT) 
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 1.5µl Superscript II 
and incubate at 42°C for 2 h. Stop the reaction with 1µl 1M NaOH / 20 mM EDTA 
and incubate at 70°C for 5 min. 7. Add 60µl H2O to Cy-3 reaction, combine with Cy-5 
reaction and add 10µl 3M NaAcetate, pH ~5. Then purify the labeled cDNA through a Qia-
quick PCR purification column (Quiagen) (elution volume: 2x30µl) and add poly(A) DNA 
(herring sperm) to a 0.4 µg/µl final concentration in the hybridization solution. 9. Then dry 
the sample in speed-vac and resuspend into the desired volume of hybridization solution 
(50µl) just before applying onto the array or store at 4°C in the dark for later user. 
 
Array hybridization & data acquisition. 
Slides were pre-hybridized in 5xSSC, 0.1% SDS, and 1% BSA at 42oC for 45 min; 
washed at RT with deionized water, dipped in 100% isopropanol; and dried. Equal volumes 
of Cy-3 and Cy-5 labeled samples were combined in hybridization buffer, supplemented with 
Poly(A)-DNA and hybridized to microarray slides at 42°C over night. Hybridized arrays 
were washed, air-dried and scanned using the ScanArray 3000 (GSI Lumonics, Billerica, MA). 
 
Data analysis. 
Two independent experiments with dye swaps were performed. Expression ratios were 
calculated and analyzed using the TM4 microarray software package 
(www.tigr.org/software/tm4/). Following spot quality filtering, expression data were 
normalized using the Lowess (locfit) algorithm, and clustered with k-Mean and hierarchical 
clustering with the TMEV software (TIGR) (Hegde, Qi et al. 2000). Elements with at least 
500 signal intensities were considered. 
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 3.6 PROTEIN METHODS 
 
Protein expression in E. coli. 
Escherichia coli bacteria are transformed by making them electro-competent. 1 µl of a 
1:100 plasmid dilution is added to the freshly thawed bacteria in a ice-cold electro-
transformation vial. This is exposed to electricity for 4.5 seconds (or until sparks are 
produced. Bacteria are then incubated in 1ml of SOC bacterial growth medium for 1 hour at 
37˚C and consequently plated out on LB agar plates with the appropriate antibiotic 
(Kanamycin in the case of pEMT-11, pEMT-13 or pEMT-60 vectors (refer to chapter 10.4)).  
From the LB agar plate a single colony is picked and grown overnight in different 
growth media (with appropriate antibiotic) at 37˚C and constant shaking to an OD600 of 0.5 
to 0.7. Expression of the vector insert is then induced by addition of IPTG to a final 
concentration of 0.01 to 0.1 mM and a 1 to 3 hours incubation at 37˚C with constant 
shaking. 
The growth medium is then replaced with 1x PBS, 0.1% Triton and a Protease Inhibitor 
Cocktail (“Complete EDTA-free” Tablets from Roche). Sonicate the bacteria on ice and 
spin down at 4˚C at maximal speed. Run a Tris-glycine SDS-polyacrylamide protein gel 
(Sambrook and T. 1989) with a lane for the non-induced bacteria, the induced bacteria, the 
induced supernatant and the inclusion bodies of the induced bacteria. 
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Fig. 3.6.1 IPTG induced 
expression of PGRPS1 
 
Ideally there will be a fat protein band of the expected size visible in the lanes 
representing the induced bacteria and the induced supernatant (compare to Fig 3.6.1). This 
will mean that your protein is expressed and soluble. In all other cases the conditions 
(bacterial strains, growth media, IPTG concentration and incubation time) need to be varied. 
 
Protein gel electrophoresis. 
Clean equipment and glass plates with isopropanol. Prepare the required amount of 
resolving gel in small Becher according to Maniatis 2004 Table 10.2A.1.  
Pour resolving gel and overlay it with Isopropanol to eliminate bubbles and air-contact 
and let it polymerize for 20-30 minutes at RT (you can then leave the gel ON at 4˚C if 
desired, but overlay the gel with ddH2O and pack in saran wrap to prevent it from drying).  
Decant the isopropanol and wash with ddH2O to remove unpolymerized acrylamide - 
drain fluids thoroughly with a paper towel. 
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 Prepare the required amount of stacking gel according to Maniatis 2004 Table 10.2A.1, 
pour and slowly gel combs. Let it polymerize for 20-30 min at RT. While stacking gel is 
polymerizing, boil samples in loading buffer for 3 minutes to denature proteins. After 
polymerization, remove combs under running tab water, set up, load and run gel (0.03 A per 
mini-gel; 100 V initially and 135 V as soon as proteins reached resolving gel). 
After run, remove gel from glass with razorblade and mark upper left corner by 
removing it and either use for Western blotting or stain gel in Coomassie from 1h to 24h at 
RT. Rinse gel in water and destain in Destaining solution with tissue to take up the blue 
color – gel can be kept in Destaining solution for weeks. 
 
Laemmli loading buffer (3X stock): 
 1M Tris-Cl pH 6.8  2.4 ml 
 20% SDS   3 ml 
 Glycerol (100%)  3 ml 
 B-mercaptoethanol  1.6 ml 
 Bromophenol blue  0.006g 
 DTT    0.45g 
10 ml (store 4°C) 
Coomassie-Destaining Solution:   
 30% Methanol  300 ml  
 10% Acetic acid  100 ml  
 60% H2O  fill up to 1 liter 
 
 
Western blotting. 
Blotting: 
Separate the protein samples using protein gel electrophoresis as described above. In 
the meantime, prepare a sheet of Hybond-P® protein transfer membrane. Cut the 
membrane and 2 Whatman 3MM paper to the size of the resolving gel and pre-wet the 
membrane in ~5ml 100% methanol for ~10 sec. Wash the membrane in ~50 ml of distilled 
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 water for five minutes and equilibrate the membrane in 50ml protein transfer buffer for at 
least 10 minutes. After the protein gel is done, remove the stacking gel and orient the 
resolving gel by clipping a corner.  
Assemble the electro-blotting cassette and place the blotting setup (top to bottom: 
whatman-gel-membrane-whatman) between the electrodes in the blotting unit (according to 
the manufacturer’s instructions) wetting everything with the transfer buffer. Transfer with 
220mA for 30-45 min. 
Following the transfer, remove the membrane from the blotting cassette, mark the 
orientation of the gel on the membrane and the molecular marker bands with a pencil and 
rinse the membrane briefly in PBS. Trim the membrane/blot. 
(Optional: check transfer with PonceauS solution.  Stain the blot for 5-10 minutes at RT – the bands 
come up in red. (PonceauS solution can be reused multiple times – store at RT in the dark) Wash off with H2O 
after staining. Mark molecular weight marker bands with pencil). 
Blots may be used immediately or stored for later use (membrane should be air dried 
before storage. Blots may be stored between sheets of Whatman 3MM paper wrapped in 
Saran Wrap at 2-8˚ C for up to 3 months. Once dry, the membrane will require pre-wetting 
with Methanol/H2O). 
Immunodetection: 
Pre-wet the membrane in 100% methanol if previously dried, then wash 5 minutes in 
distilled water. Block non-specific binding sites on the membrane in by incubating for one 
hour at RT in ~50ml PBS-T with 5% (w/v) dried skimmed milk (if done over night, at 4˚C).  
Rinse membrane twice briefly in PBS-T (as large a volume of wash buffer as possible: 
>=1-2 ml/cm2) and wash the blot for 5 minutes with an excess volume of PBS-T. 
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 Incubate the blot with the primary antibody at the optimized dilution in PBS-T for 1 h 
(good first approximation for antibody dilution: 1:500 to 1:20000) – the primary antibody 
can also be incubated ON at 4˚C.  
Briefly rinse the blot in PBS-T and wash twice for 10 minutes with excess PBS-T. 
Incubate the blot with appropriate secondary antibody at the recommended dilution in 
PBS-T for 1 h. Do NOT incubate secondary antibody over night – even 45 min at RT is 
enough.  
Briefly rinse in PBS-T and wash three times 10 min in excess PBS-T. Proceed with the 
appropriate detection system. (for HRP: Western Lightning Chemiluminescence Reagent 
(Perkin Elmer) and expose to Kodak Film (X-OMAT or Bioluminescence Film (more 
expensive)) for ~30sec and develop the film. If necessary repeat exposure with varied 
exposure time for optimal signal. 
Protein sample loading buffer: 
4ml  distilled H2O  
1ml 0.5M Tris-HCl, pH 6.8 
0.8ml  Glycerol 
1.6ml  10% (w/v) Sodium dodecyl sulphate (SDS) 
0.4ml  β-Mercaptoethanol 
0.5ml 0.05% (w/v) Pyronin Y (e.g. Sigma code P-7017)  
(store in dark at room temp for a maximum of 2 weeks) 
 
Protein transfer buffer: 
3.03g  Trizma-base 
14.4g glycine 
dissolve in 900ml H2O w/o Methanol add 1/10th volume of Methanol before use 
Add approximately 650ml of distilled H2O. Mix to dissolve. Make up to a final volume of 900ml. Store 
@ 2-8˚ C. Inclusion of methanol in the buffer minimizes swelling of the gel during blotting. 
 
PBS-Tween (PBS-T): 
Dilute required volume of Tween 20 in PBS to give a 0.1% (v/v) solution. store @ 2-8˚ C. Make a liter 
of it – you will need it. 
The choice of PBS or TBS will depend on the detection system of choice. The use of PBS is not advised 
with alkaline phosphatase based detection systems as phosphate ions are powerful inhibitors of this 
enzyme. 
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 3.7 CELL CULTURE 
 
A. gambiae cell lines maintenance and thawing/freezing. 
Maintenance 
The cell lines were established from minced neonate larvae of three A. gambiae strains: 
Suakoko 2La, 4a r/r, and L3-5 (Muller, Dimopoulos et al. 1999).  
The cells are grown in Schneider medium (used: GibcoBRL-liquid, or Sigma-powder) 
supplemented with 10% FCS and 100 U/ml Pen.+100µg/ml Strep. The cell lines can be 
grown without antibiotics if special care is devoted to sterile conditions.  
CO2 gassing is not necessary. Cells are generally grown at 27°C. However, they can be 
kept at 25°C. For reduced growth, keep them at 18°C, with more medium than usual per 
flask and decreased FCS concentration (5%). Heat-inactivate FCS for one hour at 60°C prior 
to use. Generally: the more FCS is added to the Schneider Medium (up to 30% is possible), 
the faster the cells grow and attach less to the plastic (and the easier they are to resuspend).  
For splitting, shake the bottle vigorously. This releases the majority of cells and split 
diluting the cells 1:2-1:3 (up to 1:10 is possible) when cells are approaching confluence.  
Strongly adherent cells like Sua1B can be trypsinized using standard cell culture 
protocols, though the cells should be washed with PBS several times before trypsinizing 
them.  
Some debris, especially in old cultures, may be observed – it will be phagocytosed by 
the cells!  
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 Freezing/Thawing 
Use a densely grown big flask (250ml) for 2-3 aliquots.  
Remove all medium and add 2-3ml Schneider medium with 10% FCS and 10% DMSO. 
Scrape the cells to release them from the plastic surface and aliquot 1ml in cryo tubes. 
Immediately place the tubes on ice for 30-45 minutes and then put them in a polystyrene 
box overnight at -80°C. Maximal 48 hours later, transfer the tubes into liquid nitrogen. 
For thawing, warm up the tube in your hand and liberally flame the top (all the cells are 
settled on the ground of the tube). Resuspend the tube contents 1ml of fresh medium and 
add to the medium in a 15ml Falcon tube. Repeat until all content of the cryo tube is in the 
tube. Centrifuge 5min at 1500 rpm, take away the medium and resuspend the cells in new 
medium in a flask.  
You may also thaw by just adding the cryo tube contents in the flask with medium and 
letting the cells settle for a few hours. Then take off the DMSO containing medium and 
replace it with fresh medium. You may increase FCS to 20% at the beginning to let the cells 
recover. 
 
A. gambiae cell line challenge. 
Cells were challenged commercial bacterial cell wall component extracts (LPS, PGN), 
commercial fungi cell wall component extract (Zymosan) or heat killed (60˚C for 1h) 
bacteria (S. aureus, E. coli, M. luteus) and fungal spores (B. bassiana).   
LPS and PGN were dissolved in water (10 mg/ml). 2.5µl per 5ml cell well were added 
for a 5µg/ml final concentration. Zymosan was dissolved in water for a 10 mg/ml 
concentration and 5µl of that was added per well for a 10 µg/ml final concentration. 
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 M. luteus, S. aureus, E. coli (DH5α) bacteria and B. bassiana spores (American Type 
Culture and Collection, Manassas, VA) were heat-inactivated by incubation at 60˚C for 1h in 
phosphate buffered saline (PBS), diluted to a OD600=0.2 and 175µl were added per well to 
result in a final OD600=0.007. 
 
Hybridoma cell maintenance and thawing/freezing. 
Maintenance 
Care must be taken at all times to work under sterile conditions. Cells usually need to 
be split 1:5 on Monday and Wednesday and 1:10 on Friday 
Thawing 
Thaw a vial of cells quickly at 37˚C, centrifuge in 8-10 ml of HM20-10% HCF. Discard 
the medium and resuspend the pellet in 1 ml of HM20-10% HCF. Transfer the cells into a 
well of a 24 well plate (let' s call it first well). Take 0.5mL of cells from the first well and add 
to a second well containing 1 ml of HM20-10% HCF. 
Take 0.5ml of cells from the second well and add to a third well containing 1 ml of 
HM20-10% HCF. Then take 0.5ml of cells from the third well and add to a fourth well 
containing 1 ml of HM20-10% HCF. Then take 0.5ml of cells from the fourth well and put 
it back into the first well. Culture the cells at 37˚C in a humidified incubator with 5% CO2.  
When splitting cells, at each passage the HCF must be gradually decreased in 
concentration from 10% to 5%, 2.5% and no HCF. Check every time whether cells are in 
good shape and healthy. This way you will have resuspended cells at four different dilutions. 
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 Once they have recovered you can either do the subcloning immediately or transfer 
into 6 well plate/small flask by gradually decreasing the percentage of HCF. You should end 
up with a culture with no HCF. 
Ideally cells should be subcloned upon defrosting due to chromosomal instability 
inherent in hybridomas, which can be especially exaggerated by freeze/thawing. 
  
Freezing 
Aliquots of cells should be frozen as backup as soon as possible after defrosting. For 
that the cells are pelleted by centrifugation at 100g for 5 minutes. Resuspend approximately 
107 cells/ml of 90% FCS /10% DMSO. Leave at -80˚C for at least 2 hours (not longer than 
48 hours) and transfer to liquid nitrogen. 
 
Solutions and chemicals used: 
HM20 (Hybridoma medium 20% FCS) 
FCS (Hyclone # SH30070.03)   100ml 
L-Glutamine 200 mM  (Gibco # 25030-024) 5ml 
Gentamicin   50mg/mL (Gibco #15750-037) 1ml 
 
DMEM  
without Na pyruvate, with 4500mg/ml glucose,  
with Piridoxine HCl (Gibco 41965-039) make up to 500ml 
 
Hybridoma cloning factor (HCF):  
Hybrid-MAX (Euroclone: Catlogue Number ECO 1021N)…use at 10% 
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 3.8 SOFTWARE 
Software Task 
ABI PRISM 7000 SDS qRT-PCR analysis 
Adobe Photoshop CS Image processing  
Adobe Illustrator CS Image processing 
AnoBase EST retrieval (http://www.anobase.org/) 
Artemis 7.0 Sequence analysis (http://www.sanger.ac.uk/Software/Artemis/)  
BLAST Basic Local Alignment Search Tool (http://www.ncbi.nlm.nih.gov/blast/) 
ClustalW Multiple sequence alignment (http://www.ebi.ac.uk/clustalw/) 
ConSurf Surface-mapping of phylogenetic information (http://consurf.tau.ac.il/) 
Ensembl genome browser Sequence retrieval (http://www.ensembl.org/index.html) 
FlyBase Drosophila sequence retrieval (http://www.flybase.org/) 
GeneSpring Software Platform for statistical analysis of microarray data 
GenePix Pro Image analysis software for microarrays 
GenomeRNAi RNAi primer design (http://www.dkfz.de/signaling/ernai/ernai_prime.html) 
Genscan Gene prediction (http://genes.mit.edu/GENSCAN.html) 
OpenWetWare Lab resource wiki (http://openwetware.org/wiki/Main_Page) 
Primer3 Primer design (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) 
Protein Explorer Protein structure viewer  (http://www.umass.edu/microbio/chime/pe/protexpl/frntdoor.htm) 
PubMed Literature Mining (www.pubmed.gov ) 
PyMOL Protein structure viewer (http://pymol.sourceforge.net/) 
Spotfire Visual data analysis application 
Tcoffee Multiple sequence alignment (http://igs-server.cnrs-mrs.fr/Tcoffee/tcoffee_cgi/index.cgi)  
TreeView Phylogenetic analysis (http://taxonomy.zoology.gla.ac.uk/rod/treeview.html) 
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RESULTS 
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 4.1 A. GAMBIAE ORTHOLOGS OF THE TOLL 
AND IMD PATHWAY 
 
We have identified 242 genes (Christophides, Zdobnov et al. 2002) in the A. gambiae 
genome (Holt, Subramanian et al. 2002) from 18 gene families implicated in innate immunity 
in D. melanogaster. The Toll and Imd pathways are central to the D. melanogaster innate immune 
signaling and we thus decided to concentrate on them. The A. gambiae orthologs of the Toll 
and Imd pathway signaling components are presented in Fig. 4.1.1. However, a few key 
players are missing from the picture. Orthologous groups of genes, but not clear 1:1 
orthologs could be assigned to the Toll receptor, GNBP1 and GNBP3, while Dif, PGRP-LE 
and PGRP-SD are missing. 
Seven PGRPs have been implicated in the Imd and Toll signaling pathways: PGRP-LC 
(Choe, Werner et al. 2002; Gottar, Gobert et al. 2002), PGRP-SA (Michel, Reichhart et al. 
2001), PGRP-SD (Bischoff, Vignal et al. 2004), PGRP-LE (Takehana, Katsuyama et al. 2002; 
Takehana, Yano et al. 2004), PGRP-LB (Zaidman-Remy, Herve et al. 2006), PGRP-SC1 and 
PGRP-SC2 (Bischoff, Vignal et al. 2006) (Fig. 1.6.1).  
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Fig. 4.1.1 The A. gambiae orthologs of the Toll and Imd 
immune signaling pathways in D. melanogaster (modified 
from (Meister, Koutsos et al. 2004)). Genes without a clear 
cut ortholog or missing entirely in the Anopheles genome are 
in grey and have a ‘d’ for prefix. 
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 4.2 THE PGRP GENE FAMILY IN A. 
GAMBIAE 
 
Multiple alignment & phylogenetic tree. 
   
In Drosophila there are 13 genes containing 16 PGRP domains (Werner, Liu et al. 
2000) as compared to only 7 genes with 10 PGRP domains in Anopheles (Christophides, 
Zdobnov et al. 2002). The Anopheles genes are named to correspond to their Drosophila 
orthologs. In general, PGRP genes can be classified into two classes. Among the 7 Anopheles 
genes there are three genes of the short, extracellular and secreted S-class: PGRPS1 
(ENSANGG00000014831), PGRPS2 (ENSANGG00000022240), PGRPS3 
(ENSANGG00000010490), and four genes of  the long, intracellular/transmembrane L-
class: PGRPLA (ENSANGG00000007952), PGRPLB (ENSANGG00000011459),  
PGRPLC (ENSANGG00000007834), PGRPLD (ENSANGG00000024042). 
All D. melanogaster and A. gambiae PGRP domain sequences were aligned with each 
other (Fig. 4.2.1) with Tcoffee (http://igs-server.cnrs-mrs.fr/Tcoffee/tcoffee_cgi/index.cgi) 
(Notredame, Higgins et al. 2000) and the alignment was then edited by hand. It served as the 
basis for the phylogenetic tree in Fig. 4.2.2b and to illustrate the extent of conservation 
across the PGRP domains of these two species. The secondary structure of the PGRP 
domain has been mapped above the multiple protein sequence alignment (Fig. 4.2.1). 
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Fig. 4.2.1 (previous page) Multiple alignment of all A. gambiae (red) and D. melanogaster (blue) PGRP 
domains. The secondary structure (α: alpha helix; β: beta strand; η: loop) of Drosophila PGRP-SA is shown 
above the sequences. An asterisk next to the PGRP name indicates potential or experimentally proven 
Amidase activity. Pink triangles below the sequences indicate residues that correspond to the location of 
the zinc coordination residues in T7 Lysozyme. Orange stars mark the location of catalytically important 
residues in T7 Lysozyme. Red triangles indicate residues that interact with Ligands in PGRP-LE (Lim, Kim 
et al. 2006). Green triangles mark residues that interact with the ligand in human PGRP-Iα, and blue 
triangles represent residues on the surface of the putative PGN binding pocket (Guan, Roychowdhury et al. 
2004) Green numbers connected with green lines highlight Cysteine positions that form a disulfide bridge 
when present in the sequences. 
 
The multiple alignment was restricted to the conserved PGRP domains; the varying 
lengths of the full proteins and their extremely low conservation outside of the PGRP 
domains would have only served to dilute the signal for the alignment algorithm. The 
presented alignment is thus extremely compact and has very few gaps. 
It can be clearly seen from this linear alignment, that the amino acids responsible for 
ligand interactions (highlighted with colored triangles at the bottom of the alignment) are 
distributed over the whole length of the PGRP domain. This is because the 3D structure of 
the domain is organized in such a way that the required amino acids come together – as 
discussed in chapter 4.3 in the case of PGRPLC. It is worth pointing out that the disulfide 
bridge 2 is conserved in all PGRPs except PGRP-LE and that it is disrupted by the single 
mutation in the loss-of-function semmelweiss mutant (Michel, Reichhart et al. 2001). 
The phylogenetic relationships between the Drosophila and Anopheles PGRPs are shown 
in Fig. 4.2.2. This tree highlights that PGRPLB and PGRPLD are true (1:1) orthologs of their 
Drosophila counterparts while PGRPLA1, PGRPLA2 and PGRP-LA form an orthologous 
group. For PGRPLC and PGRPS1 the phylogenetic relationships that can be derived from 
the tree are not as clear. In the case of PGRPLC the situation is confounded by the 
Drosophila PGRP-LF that seems to share a common ancestor with PGRP-LC, which was 
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 duplicated within the Drosophila lineage to produce the two genes. The orthologous 
PGRPLC genes have a very similar gene organization that clearly distinguishes them from 
PGRP-LF (see chapter 4.3 ‘The PGRPLC gene cluster’).  
 
 
Fig. 4.2.2 The phylogenetic tree of the A. gambiae (red) and D. melanogaster (blue) PGRP domains of the PGRP 
gene family. a. Unrooted, radial tree with short mammalian (Hs, Homo sapiens (Kang, Liu et al. 1998; Liu, Xu et 
al. 2001); Bota, Bos taurus (Tydell, Yount et al. 2002); Mumu, Mus musculus (Kang, Liu et al. 1998)) and short 
insect (Bomo, Bombyx mori (Yoshida, Kinoshita et al. 1996; Ochiai and Ashida 1999); Caet, Calpodes ethlius 
(Marcu and Locke 1998); Trni, Trichoplusia ni (Kang, Liu et al. 1998)) PGRP domains (green) used as out-groups. 
Labels on the branches denote the Anopheles genome chromosomal regions (cytological data from polytene 
chromosomes). Solid circles on the nodes indicate clear cut orthologs and hollow circles indicate orthologous 
groups. (adapted from: (Christophides, Zdobnov et al. 2002)) b. Phylogram version of the PGRP domain 
phylogenetic tree. PGRPs with potential or proven Amidase activity cluster together and the respective section 
of the tree is indicated. Percentages on nodes indicate branches with bootstrap support >50%.  
 
  
PGRPS1. 
The relation between PGRPS1 and PGRP-SA is too distant to firmly establish their 
orthology from the phylogenetic tree alone. However, PGRPS1 is PGRP-SA’s best reciprocal 
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 blast hit, and both genes are located on the X chromosome; for that reason they can be 
regarded as orthologs (Zdobnov, von Mering et al. 2002). 
 
PGRPS2 & -S3. 
PGRPS2 and PGRPS3 do not have clear orthologs in D. melanogaster. They are clustered 
in the Anopheles genome and are intronless. Their open reading frames are only 3712 
nucleotides apart on opposite strands, and are 95% identical at the level of amino acids (9 aa 
different out of a total of 188 aa) and nucleotides (25 nt different out of a total of 564 nt).  
We examined whether or not the two genes are haplotypes of the same gene that was 
artificially duplicated during the genome assembly process. The lack of similarity of the 
surrounding genomic regions suggested that these are two separate genes. We designed 
primers for PGRPS2 and PGRPS3 targeting regions, which specifically recognize only one of 
the genes (Exp25.1-F; Exp25.2-R; Exp25.3-R) and used them to perform PCR on the 
genomic DNA of eight individual G3 and L3-5 strain females and three females of the 69 
and the Yaoundé strain each (Fig. 4.2.3). The results showed with a high degree of 
confidence, that PGRPS2 and PGRPS3 are independent genes, as the PCR on individual 
mosquitoes always produced 2 bands, one for each gene. This was consistent for all four 
strains (Fig. 4.2.3). 
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Fig. 4.2.3 Agarose gel electrophoresis of PCR performed using primers specific to either PGRPS2 (higher 
bands) or PGRPS3 (lower bands) on genomic DNA of individual G3 (1-8), L3-5 (1-8), 69 (1-3) and Yaoundé 
(1-3) strain females.  
 
PGRPLA. 
The mosquito PGRP-LA gene has two PGRP domains, similar to the fly and mosquito 
LCs and the fly LF, although the Ensembl PGRPLA (ENSANGG00000007952) annotation 
is missing the second PGRP domain. PGRPLA is in a gene cluster with PGRPLC, similar to 
its Drosophila ortholog. However, the Drosophila PGRP-LA only has a single PGRP domain 
(Fig. 4.3.1). The splice sites within the PGRP domains of all PGRPLA/PGRP-LA is 
conserved in both Drosophila and Anopheles (Fig. 4.3.3). The gene architecture suggests that 
PGRPLA2 can produce functional mRNAs, which, however, could not be detected by PCR 
in a cDNA library. This suggests that the second domain is tightly regulated and not 
expressed under unchallenged conditions. A complete annotation of PGRPLA can be found 
in chapter 10.2 (Seq. 9.2.4 & 9.2.5) and 10.3 (Seq. 9.3.17 & Seq. 9.3.18) in the Appendix of 
this thesis. 
  note: as of June 2006, PGRPLA was not annotated correctly in the Ensembl genome browser (http://www.ensembl.org). It was
annotated as a gene with a single instead of two PGRP domain. - 73 - 
 PGRPLB. 
PGRPLB is the clear-cut ortholog of Drosophila PGRP-LB: it clusters with PGRP-LB in 
the phylogenetic tree (Fig. 4.2.2) and is also its best reciprocal blast hit (Zdobnov, von 
Mering et al. 2002). The gene produces two transcripts, one of which has a transmembrane 
domain. Interestingly, transcription of the Anopheles PGRPLB gene is strongly upregulated in 
cells and adult mosquitoes challenged with various immune elicitors (Dimopoulos, 
Christophides et al. 2002). One of these challenges is malaria parasite infection.  
 
PGRPLD. 
PGRPLD is the ortholog of the Drosophila PGRP-LD. The official Ensembl PGRPLD 
annotation (ENSANGG00000024042) only encompasses the last exon of the ORF. A better 
annotation can be found in chapter 10.2 (Seq. 9.2.13) and 10.3 (Seq. 9.3.3) in the Appendix 
of this thesis. 
 
PGRP KD and survival after bacterial infection.  
All mosquito PGRP genes and isoforms (based on the different domains) were 
knocked down in adult female mosquitoes by RNAi (Blandin, Moita et al. 2002) by injection 
of dsRNA as described in Chapter 3 “Materials & Methods”. Because of the high similarity 
of PGRPS2 and PGRPS3 on the sequence level, we could not knock down these two genes 
separately. Four days after dsRNA injection, the KD mosquitoes were injected with bacterial 
suspensions in Phosphate Buffered Saline (PBS) and their survival recorded. A significant 
reduction of mosquito survival relative to the control GFP dsRNA injected mosquitoes 
could only be observed after KD of PGRPLC, for both Gram- E. coli (Fig. 4.2.4) and 
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 Gram+ S. aureus (Fig. 4.2.5) bacterial infections. The results of the different domains of 
PGRPLC are presented separately.  
PGRP KD - E.coli survival
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Fig. 4.2.4 Survival of adult female mosquitoes after gene KD by injection with dsRNA (PGRPLC, PGRPS1, 
PGRPS2/3, PGRPLA1, PGRPLA2, PGRPLB or PGRPLD or control GFP) and infection of E. coli. Error bars 
represent the Standard Error. 
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 PGRP KD - S. aureus survival
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 Fig. 4.2.5 Survival of adult female mosquitoes after gene KD by injection with dsRNA (PGRPLC, PGRPS1, 
PGRPS2/3, PGRPLA1, PGRPLA2, PGRPLB or PGRPLD or control GFP) and infection of S. aureus. Error 
bars represent the Standard Error. 
 
 
Survival of Drosophila PGRP-LC and PGRP-SAseml mutants after bacterial infection. 
The results of the bacterial survival assay after gene KD by RNAi appeared to 
contradict the published results obtained in D. melanogaster. However, the experimental 
setups are different. Forward genetics was used to obtain the results in the fruit fly and the 
readout was mainly AMP reporter genes. In Anopheles, however, survival assays were used. 
For that reason we followed the experimental setup of Anopheles in a series of Drosophila 
experiments, to be able to compare the two species.  
Mutant lines for the PGRP-LC (Gottar, Gobert et al. 2002) and the PGRP-SAseml  
(semmelweiss) (Michel, Reichhart et al. 2001) were kindly provided by Dr. Julien Royet, IMBC 
du CNRS, Strasbourg (present address: Université de la Méditerranée, Marseille, France). 
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 The white- mutant line that was used as control was obtained from Blades Biological Ltd 
(http://www.blades-bio.co.uk/drosophila_and_equipment.htm). 
Opportunistic pathogens might conceivably overwhelm an immune compromised fruit 
fly when the cuticular barrier is breached by injection and the fly is thus further weakened. 
However, such complications were not observed: the differences between the 3 Drosophila 
strains were only minor in preliminary tests with saline solution injections (1x PBS) (Fig. 
4.2.7). 
As described in chapter 3 (Materials & Methods), two to three day old flies of the 
various strains were injected with 69 nl of E. coli (at OD600=0.1) or S. aureus (at OD600=0.01) 
and their survival monitored over five days (Figs 4.2.8 and 4.2.9, respectively). After E. coli 
injection, the PGRP-LC mutant flies were the only ones to show a significant decrease in 
survival. The white- and PGRP-SAseml mutant flies were not significantly affected by E. coli 
infection.  
However, both the PGRP-SAseml and the PGRP-LC mutant flies showed a significant 
decrease in survival after S. aureus infection (>90% dead after 5 days). Though survival of the 
white- flies was also reduced, they were not as affected as the PGRP-SAseml and the PGRP-LC 
mutant flies (Fig. 4.2.9). These results suggest that, similar to its Anopheles counterpart, the 
Drosophila PGRP-LC is essential for resistance to both bacterial infections. 
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Fig 4.2.7 Survival over time of the D. melanogaster mutant strains white-, PGRP-LC- and PGRP-SAseml after PBS 
injections. 
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Fig. 4.2.8 Survival after Gram- E. coli infections of the D. melanogaster mutant strains white-, PGRP-LC- and 
PGRP-SAseml. Error bars represent the Standard error. 
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Fig. 4.2.9 Survival after Gram+ S. aureus infections of the D. melanogaster mutant strains white-, PGRP-LC- and 
PGRP-SAseml. Error bars represent the Standard error. 
  
 
Is the Drosophila semmelweis mutation rescued by PGRPS1? 
The predicted full length ORF of PGRPS1 was amplified with the primers #9.1.54/55 
(Table 9.1.1) and cloned into the pUAST Drosophila transformation vector using the 
polylinker restriction enzyme sites EcoRI and XbaI. The construct was sent to our 
collaborators at the CNRS, IBMC in Strasbourg, France. The plan was to transform the D. 
melanogaster semmelweis mutant of PGRP-SA and examine whether the mosquito ortholog 
PGRPS1 can rescue the mutant phenotype. The semmelweis mutant is a single amino acid 
change of cysteine 80 into a tyrosine. This cysteine forms the structurally important disulfide 
bridge in Figure 4.2.1 (disulfide bridge ‘number 2’ indicated with green connector lines). At 
the time of writing this thesis, this work had not yielded conclusive results.  
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 PGRP KD and Plasmodium infection. 
As a first approach, the relevance of some PGRPs to malaria infection of the mosquito 
were tested by RNAi-based gene knockdown and subsequent infection of mosquitoes with P. 
berghei as described in chapter 3 (Materials & Methods). We used two transgenic P. berghei 
strains expressing GFP at the ookinete and early oocyst stages (Vlachou, Zimmermann et al. 
2004) and all developmental stages (Franke-Fayard, Trueman et al. 2004). The mosquitoes 
used were from the susceptible G3 strain. Five to seven days post malaria infection, the 
mosquitoes were dissected and the number of oocysts and melanized ookinetes per midgut 
was counted. The results are presented as a percentage relative to the dsGFP injected control 
group of mosquitoes in Figure 4.2.6. 
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Fig. 4.2.6 Differences in G3 parasite numbers per midgut after gene KD. Green colored fractions represent 
live oocysts and black colored fractions melanized ookinetes. PGRPS2/S3, 22 midguts (P(KS-Test)=0.014, P(t-
test)=0.096); PGRPLA1, 17 midguts (P(KS-Test)=0.19, P(t-test)=0.); PGRPLA2, 71 midguts (P(KS-Test)= 
0.01, P(t-test)= 0.022); PGRPLC, 32 midguts (P(KS-Test)= 0.003, P(t-test)= 0.0005). Error bars are standard 
errors. 
- 80 - 
  
 
The KD of PGRPLA2 and PGRPLC caused a statistically significant increased the 
parasite load per G3 midgut by ~56.6% and ~178%, respectively. In contrast, the co-
silencing of PGRPS2 and PGRPS3 resulted in a reduction of parasite load by 55.9%.  KD of 
PGRPLA1 had no effect on the parasite development. 
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 4.3 THE PGRPLC GENE CLUSTER 
 
The previous sections indicated that, among the PGRPs in A. gambiae, only PGRPLC 
has an effect on the mosquitoes defense to bacterial infection, and only PGRPLC and 
PGRPLA seemed relevant to malaria infection of the mosquito. Both genes are clustered 
together in the genome. We have analyzed the PGRPLA/LC locus in detail, focusing more 
on PGRPLC. In D. melanogaster PGRP-LC is a pattern recognition receptor implicated in 
initiation of the Imd pathway (Choe, Werner et al. 2002; Gottar, Gobert et al. 2002; Ramet, 
Manfruelli et al. 2002; Werner, Borge-Renberg et al. 2003). 
 
PGRPLC gene architecture. 
The Anopheles PGRPLC gene encodes three alternative PGRP domains (Fig. 4.3.1a & 
Fig. 4.3.4) that can be alternatively used for the production of three protein isoforms. 
Furthermore, the PGRP domains have a very modular build: the fourth exon of the gene is 
common to all three PGRP domains (Fig. 4.3.1a pink exon), and the introns 5, 7 and 9 are at 
the exact same relative location in the sequence of all three PGRP domains (Fig. 4.3.1a & Fig. 
4.3.3 grey solid triangle). This modular build suggests, that production of additional PGRP 
domains by recombination of the existing exons through splicing may be possible (Fig. 4.3.6 
dashed splicing lines). This is an advantage that the Anopheles PGRPLC gene build has over 
that of the Drosophila PGRP-LC. In Drosophila the splicing has to be more rigid as the second 
splice site within the PGRP domain is lacking (Fig. 4.3.1b). 
It is also worth mentioning that although both the fly and mosquito PGRPLC genes 
have three PGRP domains, these domains are not homologous: they are more similar within 
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 than across species (Fig 4.2.2). This suggests that the common ancestor of A. gambiae and D. 
melanogaster probably had a single-PGRP-domain LC gene that duplicated independently in 
each species. This hypothesis is also supported by the exon-intron structure of the gene (Fig. 
4.2.2, 4.2.1, 4.3.3), and the analogous introns (Fig. 4.3.2). In each case, the similarities 
between domains within a species is higher than across species. 
-
 
Fig. 4.3.1 The PGRPLC gene cluster architecture in a. A. gambiae (21.1 kb) (red) and b. its orthologous cluster 
in D. melanogaster (17.1 kb) (blue).  Drawn to scale. Each box represents an exon (dash-framed boxes indicate 
untranslated exons) and connecting lines represent spliced out introns. Colored parts of exons contribute to the 
PGRP domains. Identical triangles above the introns indicate analogous locations of splice sites (compare to 
Fig. 4.3.3). (modified from (Christophides, Zdobnov et al. 2002)) 
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Fig. 4.3.2 Alignment and phylogenetic tree of the second introns of the Anopheles PGRPLC domains and the 
first introns of the Drosophila PGRP-LC domains. Numbers at the nodes are bootstrap percentages. 
 
 
 
Fig. 4.3.3 Conservation across species of the PGRPLC and -LA gene splice sites of the PGRP domain in A. 
gambiae (red) and D. melanogaster (blue). Triangles above the introns indicate analogous locations of splice sites 
(triangles correspond to the ones in Fig. 4.3.1). The numbers connected with a green line highlight the Cysteine 
residues that form a disulfide bridge (compare to Fig. 4.2.1). The blue triangle indicates the location of a 
catalytically important residue in T7 lysozyme (modified from (Christophides, Zdobnov et al. 2002)) 
 
 
 
PGRPLC splicing. 
We performed Reverse Transcriptase PCR (RT-PCR) on a cDNA pool prepared from 
bacterial challenged and unchallenged adult mosquitoes using a variety of primers distributed 
along the PGRPLC gene to examine the hypothesis that novel PGRP domains might be 
created by recombining the existing exons through alternative splicing. The design of PCR 
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 primers  was  based  on  a  gene  structure  that  was  derived  from  alignment  of t he 
genomic sequence with all available EST sequences 
(http://web.bioinformatics.ic.ac.uk:8080/AnoEST/anoest.php) as shown in Fig. 4.3.4. 
Most PCRs resulted in multiple products, depending on how the primers were 
combined (Fig. 4.3.5). The PCR products were separated by agarose gel electrophoresis, and 
purified with the QIAquick Gel Extraction Kit (QIAGEN Ltd.) and sequenced. 
 
 
Fig. 4.3.4 Genomic organization of the Anopheles PGRPLC gene, drawn to scale. Each box represents an exon 
(dash-framed boxes indicate untranslated exons). Exons are numbered and introns are assigned letters. The 
yellow line indicates the position of the transmembrane domain. The PGRP domains LC1 (exons 4,5,6), LC2 
(exons 4,7,8) and LC3 (4,9,10) are encoded by colored exons.  
 
In none of the performed PCRs could the proposed hybrid PGRPLC PGRP domains 
be detected. In fact, the only time that the linear order of the PGRP-domain exons was 
disrupted by splicing, the resulting sequences encode for early stop codons and cannot 
produce functional multidomain proteins (Fig. 4.3.5 j & g). 
However, the alternative use of a 75 nucleotide (nt) cassette (Seq. 9.2.11 & Seq. 9.2.12) 
in exon 3 was detected (Fig. 4.3.5 d, e, h). It appears that transcripts for the LC1 and LC2 
PGRP domain are always spliced together with the short version of exon 3 (Seq. 9.2.12) 
whereas the LC3 PGRP domain can be combined with either version of exon 3. The 
significance of this is unclear, however, it is worth noting that the transmembrane domain is 
situated just before this cassette, and that the D. melanogaster PGRP-LC gene has a 
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 homologous alternative cassette at the exact same position (Fig. 4.3.1, Seq. 9.2.14, Seq. 
9.2.15). 
 
 
Fig. 4.3.5 RT-PCR with a variety of primers distributed along the PGRPLC gene revealed a pool of unspliced 
transcripts. Every subpanel (a.-j.) features a different PCR primer combination and the corresponding section 
of the PGRPLC gene model in Fig. 4.3.4. The grey bars above these sections represent the sequenced RT-PCR 
products shown on the right of each subpanel. The numbers and letters next to the gray bars spell out the 
intron & exon combination for clarity. These numbers and letters are derived from Fig. 4.3.4. A summary of 
this figure can be found in Fig. 4.3.6. 
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RT-PCR on the LC1 and LC2 PGRP domains revealed a significant amount of 
unspliced transcripts (Fig. 4.3.5 a, b). This was not due to contamination with genomic DNA 
as the samples of total RNA were treated with DNAse before reverse transcription. In 
addition, the control PCR reaction with primers targeting the ribosomal S7 gene did not 
produce a double band even though the primers (S7-A & S7-B) span an intron. These data 
suggest the presence of a pool of nuclear unspliced or partly spliced transcripts that might be 
used for the production of protein coding transcripts upon a need for specific PGRPLC 
proteins (see below). Only for the LC3 PGRP domain could no unspliced transcript be 
detected (Fig. 4.3.5 c).  
 
 
 
Fig. 4.3.6 Splicing of the Anopheles PGRPLC gene. Drawn to scale. Each box represents an exon (dotted boxes 
indicate untranslated exons) and connecting lines represent spliced out introns. The yellow line indicates the 
position of the transmembrane domain and the other colored parts of exons contribute to the PGRP domains. 
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 PGRPLC domain microarray. 
To determine if the Anopheles PGRPLC ortholog is transcriptionally activated during 
immune challenge, we constructed DNA microarrays containing probes representing the 
different domains of PGRPLC (PGRP domains of other mosquito PGRP genes were also 
included). This design allowed us to examine whether the various PGRPLC exons can 
respond to different challenges, leading to production of different protein isoforms via 
alternative splicing (Dimopoulos, Christophides et al. 2002). For the hybridization we 
challenged a hemocyte-like cell line, 4a3B (Muller, Dimopoulos et al. 1999) with 
paraformaldehyde-fixed E. coli and S. aureus (OD 0,05), PGN (10 µg/ml) and H2O2 (2 µM), 
the latter serving as control. Duplicate RNA samples were collected 12 hrs after challenge 
and hybridized to arrays as described (Dimopoulos, Christophides et al. 2002). RNA 
prepared from naïve cells was used as reference. 
The results indicated that PGRP genes are differentially regulated in response to the 
different challenges (Christophides, Zdobnov et al. 2002) (Fig. 4.3.7). Interestingly, the three 
PGRP domains of PGRPLC appeared to respond differently to the diverse challenges, 
suggesting a role for alternative splicing in the response to infection. PGRPLC2 was also 
regulated transcriptionally when exposed to oxidative stress, but PGRPLC1 and LC3 were 
not. Dissecting the role of the alternatively spliced PGRP gene products may elucidate a 
novel step of innate immunity regulation at the level of RNA splicing. 
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Fig. 4.3.7 Expression profiles of PGRP 
isoforms of female adult mosquitoes 
challenged with E. coli, S. aureus, 
peptidoglycan (PGN), and H2O2. Color 
intensities indicate fold regulation relative 
to reference (naïve) cells (see Chapter 3 
“Materials & Methods”). Regulation values 
below 1.5-fold are masked. (modified from 
(Christophides, Zdobnov et al. 2002)) 
 
PGRPLC surface modeling. 
The following results were obtained with the help of Dr. Bogos Agianian in the context of our 
collaboration on the PGRP structural models.   
 
The sequence of the PGRP domains of Anopheles and Drosophila were modeled onto 
the 3D structure of the Drosophila PGRP-LB domain (Kim, Byun et al. 2003) (Fig. 4.3.8). 
PGRP sequences were firstly aligned with Tcoffee (http://igs-server.cnrs-
mrs.fr/Tcoffee/tcoffee_cgi/index.cgi) (Notredame, Higgins et al. 2000) to allow for 
determination of  a conservation score with ConSurf (http://consurf.tau.ac.il/) and based 
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 on these scores,  to then project each sequence onto the 3D model structure of PGRP-LB. 
The .pdb models of the PGRP domains obtained in this manner were then viewed with 
protein structure viewers like PyMOL (http://pymol.sourceforge.net/) or the Protein 
Explorer (http://www.umass.edu/microbio/chime/pe/protexpl/frntdoor.htm). 
 
 
Figure 4.3.8 Ribbon diagram of structure of PGRP-LB. The PGRP-specific segment at the 
N terminus, colored in gold, is absent in T7 lysozyme. The single disulfide bond is shown as 
a ‘ball-and-stick’. The bound zinc ion is shown as sphere. a. ‘front’ face of the PGRP 
domain. The isolated strand β2 adopts the typical backbone conformation of a β-strand. b. 
‘back’ face of the PGRP domain. The PGRP-specific segment (in gold) is absent from T7 
lysozyme. The segment adopts mainly extended β-strand and loop structures. (Figure 
modified from (Kim, Byun et al. 2003)). 
 
As can be seen in Fig. 4.3.9 a, all three exons encoding the PGRP domains of 
PGRPLC isoforms contribute to the PGN binding site. The first exon is common for all 
three PGRP domains. This makes the prospect of diversification of PGRPs by potential 
exon-recombination, as suggested by the Anopheles gene architecture (Fig. 4.3.4), even more 
intriguing. In Drosophila (Fig. 4.3.9 b) each PGRP domain has their own first (red) exon and 
thus constitute three entirely distinct PGRP domains. 
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Fig. 4.3.9 Pattern of exons contributing to the binding surface of the PGRPLC domains. 
The colors represent the exons coding for the respective region of the surface. a. Surface of 
the A. gambiae PGRPLC1 domains. The first, common exon is colored pink, the second and 
third exons are colored light and dark blue, respectively (analogous to the colors in Fig. 
4.3.4). b. Surface of the D. melanogaster PGRP-LC1 domains. Pink represents the first exon 
and the second exon is colored dark blue. 
 
As mentioned previously, because of separate exon duplication events in the two 
lineages, the PGRP domains of the Anopheles and Drosophila PGRPLC protein isoforms are 
more closely related with other domains encoded by the same gene than with the analogous 
domains of the orthologous gene in the other species (Fig. 4.2.2). We attempted to visualize 
the consequences of this phenomenon by color coding sequence conservation and 
projecting it onto the surface model of the first PGRPLC domain of each species, 
PGRPLC1 and -LCx (Fig. 4.3.10).  
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 Since the ‘golden’ PGRP-specific β sheets (β1 & β2) in Fig. 4.3.8 are contributed by the 
first, common ‘pink’ exon (Fig. 4.3.4), they are colored dark blue (highly conserved) on the 
backside of A. gambiae PGRPLC, indicating 100% conservation (Fig. 4.3.10). The groove 
formed by these β sheets is highly hydrophobic and as such ideal for potential protein-
protein interactions. 
The protruding ridges of the PGN binding sites are highly variant among the three 
PGRPLC domains of either species. This might reflect the need for varying PGN binding 
properties for PGRPLC to accommodate PGN from a variety of microbial sources in the 
binding site. 
The ability of a PGRP domain to bind PGN specific to Gram- bacteria (DAP-type 
PGN) is determined by specific interactions in the pocket encoded by the first exon of 
PGRPLC. This region is invariable in Anopheles, and thus all three PGRP domains should be 
able to bind DAP-type PGN. However, it is likely that one or more of the A. gambiae 
PGRPLC domains are also able to bind Lys-type (gram+) PGN, as has been shown for 
Drosophila (Werner, Borge-Renberg et al. 2003; Kaneko, Golenbock et al. 2005).  
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Fig. 4.3.10 Surface conservation of the -LC PGRP domains in Anopheles and Drosophila. The 
outer ellipse marks the ridge of the PGN binding site and the inner ellipse marks the catalytic 
Tyrosine68. Blue signifies greater and red lesser sequence conservation. The structure models of 
the first domains (LC1 and LCx) of each species have been used as scaffolds. ‘front’ refers to the 
PGN binding site, and ‘back’ refers to the opposite side; the relative orientation in space (‘up’ 
and ‘down’) of the models is the same as in Fig. 4.3.9 and Fig. 4.3.8. 
 
 
PGRPLC1, 2 or 3 specific KD  in adult mosquitoes. 
The RNAi procedure was performed as described in chapter 3 (Materials & Methods) 
on 10 one to two day old female G3 mosquitoes. Their RNA was extracted four days later 
and used to assess the KD efficiency of specific PGRPLC domain transcripts by RT-PCR 
(Fig. 4.3.11) and quantitative realtime-PCR (qRT-PCR) (Fig. 4.3.12).  
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Fig. 4.3.11 RT-PCR on whole female G3 mosquitoes to determine PGRPLC mRNA levels 
after domain specific KD of PGRPLC. Columns:  dsRNA used to inject adult G3 female 
mosquitoes for gene silencing. Rows: primers specific to the LC1, LC2, LC2 domains and 
the ribosomal protein S7 used for monitoring expression levels. 
 
The targeted KD of PGRPLC1 or PGRPLC2 transcripts (Fig. 4.3.11 first and second 
columns) does not appear to be very effective according to the RT-PCR expression assays. 
However, KD of PGRPLC3 and the entire PGRPLC gene (columns three and four) are 
effective. Intriguingly, there always seems to be a cross effect on the other domains, when 
one of them is targeted. 
Apparent lack of effectiveness might be due in part to differences in the tissues of 
isoform origin in conjunction with differences in accessibility of injected dsRNAs to 
different tissues. To obtain more definite results, we used qRT-PCR as a better method of 
transcript quantification and also distinguished between expression levels in a specific organ, 
the midgut, the carcass (the remaining tissue after removal of head, wings, legs and gut), and 
in whole mosquitoes. The results (Fig. 4.3.12) confirmed the effectiveness and partial 
specificity of domain specific KD of PGRPLC by RNAi. The reduction in LC1 transcript 
levels after dsRNA-mediated silencing was in the range of 34% - 54% for KD based on the 
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 dsLC1 RNA. LC2 and LC3 transcripts showed a specific apparent reduction following 
treatment by corresponding dsRNAs, to a range of 71% - 75% and 69% - 76%, respectively.  
Overall, RNAi seems to function well in both midgut and carcasses, indicating that 
there, the circulating hemolymph is capable of delivering the injected dsRNA and possibly, 
the small interfering RNAs (siRNA) to the mosquito tissues. 
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Fig. 4.3.12 PGRPLC domain transcript levels 
relative to dsGFP injected control levels as 
determined by qRT-PCR. a. qRT-PCR on cDNA 
from whole female mosquitoes. b. qRT-PCR on 
cDNA from female carcasses (no head, legs, wings 
and gut). c. qRT-PCR on cDNA from female 
midguts. 
 
 
- 96 - 
 PGRPLC KD and survival after bacterial infection. 
PGRPLC KD in one to two day old female G3 mosquitoes was performed as 
described in chapter 3 (materials & methods). Ampicillin resistant E. coli bacteria were grown 
to an OD of 0.7 to 1.0 (at λ=600nm), diluted to an OD of 0.01 in PBS of which 69 nl were 
then injected into the mosquito body cavity on day 4.  
Survival of the mosquitoes was recorded over the next week (Fig. 4.3.13). Relative to 
the dsGFP injected control mosquitoes, PGRPLC KD mosquitoes showed a reduction in 
survival, with the most severe effect noted in silencing the PGRPLC3 domain KD as well as 
the entire PGRPLC gene. 
Survival to S. aureus infection was examined in the same way as survival to E. coli, 
except that a higher concentration of OD600=0.4 was injected into the female G3 mosquitoes 
(Fig. 4.3.14). While the KD of the PGRPLC2 domain did not seem to have an effect on 
survival of the mosquitoes, KD of PGRPLC3 as well as the entire PGRPLC gene did. The 
effect of PGRPLC1 KD was less prominent (Fig. 4.3.14). 
The possibility of the PGRPLC KD by itself accounting for increased mortality in the 
mosquito was explored in the experiment presented in Fig. 4.3.15. and could be refuted. 
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Fig. 4.3.13 Survival after PGRPLC KD and challenge with E. coli (69 nl of OD600=0.01 in 
PBS). Number of repetitions per KD: PGRPLC 7x; PGRPLC1 4x; PGRPLC2 3x; PGRPLC3 
4x. 
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Fig. 4.3.14 Survival after PGRPLC KD and injection with S. aureus (69 nl of OD600=0.4 in 
PBS). Number of repetitions per KD: PGRPLC 6x; PGRPLC1 3x; PGRPLC2 4x; PGRPLC3 
5x. 
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Fig. 4.3.15 Comparison of mosquito survival after PGRPLC KD and injection with either  PBS, S. aureus or E. 
coli four days later. 
 
 
PGRPLC KD and Plasmodium infection. 
The PGRPLC KD and P. berghei infection were performed as described in chapter 3 
(Materials & Methods). Two mosquito strains were used: the susceptible G3 strain and the 
refractory L3-5 strain (Collins, Sakai et al. 1986). Five to seven days post malaria infection, 
the mosquitoes where dissected and the number of oocyst and melanized ookinetes per 
midgut was counted. The results are presented as a percentage relative to the dsGFP injected 
control group of mosquitoes in Figure 4.3.16. 
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Fig. 4.3.16 PGRPLC KD and P. berghei infection in susceptible G3 mosquitoes. The number of 
dissected midguts are 32 for PGRLC, 49 for PGRPLC1, 45 for PGRPLC2 and 24 for PGRPLC3. 
 
Whereas the single domain KDs did not appear to have a significant effect, the whole 
gene KD resulted in a 2.5-fold increase of the parasite load per midgut. According to the 
Kolmogorov-Smirnov (KS-)Test and the Student's t-Test, only the increase in parasite 
numbers due to the whole PGRPLC gene KD is significantly distinct from that of the GFP 
control (p values of  0.003 and 0.0005, respectively).  
The KD of the entire PGRPLC gene also caused a small but significant increase of 
2.53% in melanized ookinetes relative to the dsGFP injected control. 
 
The results obtained in the refractory mosquito strain L3-5 (Collins, Sakai et al. 1986) 
showed that the KD of PGRPLC does not alter the capacity of these mosquitoes to kill 
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 parasites by melanizing the ookinetes and preventing them from developing into oocysts, 
although this phenotype gets partially reversed by the KD of the whole PGRPLC gene 
(3.35% increase relative to the dsGFP injected control) (Fig. 4.3.17). 
However, we observed a drastic increase in parasite numbers which was statistically 
significant only in the KD of the whole PGRPLC gene (181.07% increase relative to the 
control, with a Student's t-Test p-value of 0.031) and in the PGRPLC3 KD (211.42% 
increase relative to control, with a Student's t-Test p-value of 0.046). The slight decrease in 
parasite numbers after PGRPLC1 KD is not statistically significant. 
 
parasites per midgut in L3-5 
300.00 
250.00 
200.00 
live parasites % 150.00 
melanized parasites 
100.00 
50.00 
0.00 
GFP PGRPLC (47) LC1 (21) LC2 (38) LC3 (27)
Gene KD
Fig. 4.3.17 PGRPLC KD and Plasmodium infection in refractory L3-5 mosquitoes.  
The numbers of dissected midguts are given in brackets. 
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 PGRPLC and S1 antibodies. 
Transcripts encoding the PGRPLC1, 2 and 3 and PGRPS1 proteins were amplified 
from an abdominal cDNA library (Dimopoulos, Casavant et al. 2000) with the primers 
#9.1.15 to #9.1.32 (for primer sequences refer to Table 9.1.1) and directly cloned into the 
pGEM-T easy vector (for characteristics of the vectors used refer to Chapter 10.4 ‘vector 
sequences & maps’) and verified by sequencing. The inserts were then excised with NcoI 
and EcoRI to be cloned into the expression vectors pETM-11 and pETM-60, and their 
sequences were verified. 
The constructs for PGRPLC1 (pEMT-11), PGRPLC2 (pEMT-60), PGRPLC3 
(pEMT-11) and PGRPS1 (pEMT-11) were expressed in E. coli bacteria with support of Dr. 
Ario de Marco of the EMBL Protein Expression and Purification Core Facility (Fig. 4.3.18 
a.). 
Antibodies were raised against the expressed PGRP domain of PGRPS1 and unique 
sequences of the PGRPLC isoforms (see Fig. 4.3.6) at the EMBL Monoclonal Antibody 
Core Facility (MACF) in Monterotondo, Italy and the EMBL Animal House Unit for 
polyclonal antibody production in rabbits. Only PGRPLC1 and PGRPLC2 domains yielded 
monoclonal antibodies; the PGRPLC3 and PGRPS1 produced proteins that proved to be 
insoluble in 1M Urea, which is the highest possible concentration for antigen injection. 
Western blots of whole protein extracts of three day old adult female mosquitoes 
hybridized with the PGRPLC antibodies, revealed several bands at a variety of molecular 
weights (Fig. 4.3.18 d.). Interestingly, these bands were mostly of the same molecular weight 
between monoclonal and polyclonal PGRPLC1 and PGRPLC2 antibodies.  
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 Whole PGRPLC domain proteins were produced to examine whether these antibodies 
were able to distinguish between PGRPLC isoforms and not binding to other proteins in an 
unspecific manner. The chosen sequences were amplified from the abdominal cDNA library 
with the primers #9.1.37 - #9.1.40, cloned into the pGEM-T easy vector, excised with the 
NcoI and EcoRI restriction enzymes and subcloned into the pEMT-13 expression vector. 
The pEMT-13 vector has the advantage that the expressed proteins lack His-Tags, fusion 
proteins and protease cleavage sites that might interfere with their folding. The molecular 
weights for all three expressed PGRPLC protein fragments were ~ 17 kD, as expected (Fig. 
4.3.18 b.). 
When these whole PGRPLC domain proteins were used to test the antibodies, it was 
revealed that the monoclonal mouse αPGRPLC1 antibody was highly specific, but the 
monoclonal mouse αPGRPLC2 did not recognize the PGRPLC2 domain fragment – or any 
of the other PGRPLC (Fig. 4.3.18 c.). The rabbit polyclonal versions obtained with the same 
antigens produced a high background noise that quenched any signal that might have been 
detectable. Fig. 4.3.18 e. is representative for all three polyclonal αPGRPLC domain 
antibodies. In addition, the monoclonal mouse αPGRPLC2 hybridoma lines were tested with 
a dot blot to quickly determine the specificity and sensitivity of the antibodies produced by 
different lines. Table 4.3.1 shows that while 5 out of the 7 lines showed strong reactivity to 
the antigen, none of them was specific only for PGRPLC2. 
The characterization of the PGRPLC proteins using the produced antibodies is still 
ongoing. 
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Fig. 4.3.18 a. Expressed antigens of PGRPLC1, PGRPLC2, PGRPLC3 and PGRPS1. 1 µl per lane. The 
molecular weight rainbow marker was run for reference in the left lane. b. Expressed whole PGRPLC isoforms 
at 17 kDa. c. Western blot with the whole domain PGRPLC proteins probed with the monoclonal mouse 
αPGRPLC1 and αPGRPLC2 antibodies. d. Western blot with protein extract of adult female mosquitoes 
treated with monoclonal mouse (lanes 1,4) and polyclonal rabbit antibodies (lanes 2,3,5,6). lanes 1-3: 
αPGRPLC1; lanes 4-6: αPGRPLC2. e. Western blot with the whole domain PGRPLC proteins probed with the 
polyclonal rabbit αPGRPLC1 AB (left blot) and the secondary αmouse HRP only (right blot). αPGRPLC1: 
1:10,000 dilution; αmouse HRP: 1:30,000 
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Table 4.3.1: Dotblot of monoclonal αPGRPLC2 AB probing full length 
PGRPLC domain fragments. The monoclonal αPGRPLC1 and secondary 
αHRP AB served as control. 
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 4.4 THE INTRACELLULAR RELISH 
PATHWAY* 
 
REL2 gene architecture and phylogenetic analysis. 
The genomic organization of REL2 was determined by RT-PCR using RNA from 
adult female A. gambiae. The gene consists of 11 exons and encompasses 10.9 kb of genomic 
DNA (Fig. 4.4.1b). It encodes putative proteins with a Glutamine-/Histidine-rich region 
(Q/H) that is potentially implicated in protein–protein interactions, followed by a Relish 
homology domain (RHD), an IPT/TIG domain (DNA binding), a nuclear localization signal 
(NLS), Ankyrin-repeats (ANK) and a death domain (DD) (Fig. 4.4.1c). 
We detected two REL2 transcripts: the full-length, REL2-F, and a shorter form, 
REL2-S. The latter encompasses a unique exon at its 3’ end. For mRNA splicing, this exon 
uses a splice acceptor that is 4 bp upstream to that used in REL2-F and results in a 
downstream early termination codon. Thus, REL2-F encodes a protein with all the domains 
encoded by the gene, whereas REL2-S is missing the ANK and DD. Additional alternative 
splicing at the 5’ end of REL2 may also produce two transcript variants for each form (Fig. 
4.4.1c).  
REL2-F shows significant similarity to the A. aegypti (55%) and D. melanogaster (29%) 
Relish, as well as the mouse NF-κB factors p100 (19%) and p105 (22%) (Table 4.4.1). 
Phylogenetic analysis shows that REL2-F clusters with the related Relish proteins in A. 
aegypti and D. melanogaster and not with the other NF-κB proteins like the Drosophila Dif and 
Dorsal (Fig. 4.4.2). 
 
* Some parts of this work were conducted by people in the laboratory of Dr. Liangbiao Zheng at the Yale 
University School of Medicine, New Haven, CT, USA in the context of collaboration and is presented here 
for completeness.  These parts are indicated with an asterisk. 
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Fig. 4.4.1 Genomic organization and alternative splicing of the Anopheles REL2 gene. Introns (lines) and exons 
(open boxes) are based on a. Ensembl gene prediction and b. cDNA sequencing data. Numbers below and 
above the introns and exons show the length (bp). Circles indicate putative NF-κB elements. c. REL2 has two 
alternative 5’ exons. The 5’ end of REL2-S has not been confirmed and is indicated by dashed intron lines. 
Alternative splicing occurs at the 3’ end with a REL2-S-specific exon. Protein domains are depicted by shades 
of gray inside the exons. Q/H, glutamine and histidine-rich region; RHD, Relish homology domain; IPT/TIG, 
DNA-binding domain; NLS, nuclear localization signal; ANK, Ankyrin-repeats domain; DD, death domain. 
Putative start- and stop-codons and target regions of dsRNA constructs (RHD dsRNA and ANK dsRNA) are 
indicated. (from (Meister, Kanzok et al. 2005)) 
 
 
 
 
 
 
 
Table 4.4.1 Protein sequence similarities for some selected NF-κB factors. Aa A. aegypti; Ag A. gambiae; Dm D. 
melanogaster (fruit fly); Mm Mus musculus (mouse). (sequences used: Seq. 9.3.15; 9.3.12; 9.3.9; 9.3.7; 9.3.8). 
 AgREL-2-F     
AaREL2 55% AaREL2    
DmRelish 29% 28% DmRelish   
Mmp105 22% 22% 19% Mmp105  
Mmp100 19% 22% 18% 39% Mmp100 
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Fig. 4.4.2 Phylogenetic analysis of NF-κB proteins. The N-J tree was calculated from a 
ClustalW (program version 1.82) protein alignment with default settings. Bootstrap values 
(1000 iterations) at nodes of the tree provide an estimate of the statistical significance of 
particular branching points. Aa A. aegypti; Am Apis melifera (honey bee); Ag A. gambiae; Cg 
Crassostrea gigas (portuguese oyster); Dm D. melanogaster (fruit fly); Mm Mus musculus (mouse); 
Sp Strongylocentrotus purpuratus (purple sea urchin); Tc Tribolium castaneum (red flour beetle). 
(sequences used: Seq. 9.3.4 through 16) (modified from (Meister, Kanzok et al. 2005)). 
 
  
 
REL2 KD expression profile*. 
REL2-F and -S transcripts are expressed constitutively throughout A. gambiae 
development, albeit at different levels: REL2-F is expressed more strongly (Fig. 4.4.3a). Both 
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 transcripts are also expressed in cultured cell lines, Sua1B (Fig. 4.4.3b) and 4a3A (data not 
shown).  
Cells challenged with heat-killed E. coli (Gram-) or purified E. coli lipopolysaccharides 
(LPS) up-regulate REL2-F significantly and REL2-S to a lesser degree; however, we cannot 
exclude the possibility that induction after LPS challenge was due to peptidoglycan 
contaminants that are frequently found in commercial LPS preparations (Leulier, Parquet et 
al. 2003). Challenge with the fungus B. bassiana or the Gram+ bacterium Micrococcus luteus did 
not result in a significant transcriptional up-regulation of REL2 (Fig 4.4.3b). 
 
 
Fig 4.4.3 Expression profile of REL2 in mosquito cultured cells and developmental 
stages. a. Relative abundance of REL2-F and REL2-S transcripts at different stages of 
mosquito development. b. Transcriptional regulation of REL2 transcripts in immune 
challenged cultured Sua1B cells. REL2-F was detected using primer pairs targeting the ANK 
domain (#9.1.84/85). REL2-S was detected with primers #9.1.86/87. The asterisk indicates a 
band which includes the intron sequence of REL2-S. It is unclear whether this transcript is part 
of an additional splice variant of REL2. The identity of REL2-S bands was confirmed by 
sequencing. Control RT-PCR with rpS7 showed no genomic DNA contamination. ♂, males; ♀, 
females; CTRL, Control; B.b., B. bassiana; M.l., Micrococcus luteus; E.c., Escherichia coli. 
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 REL2 KD efficiency in adult mosquitoes. 
RNAi was performed as described in chapter 3 (Materials & Methods). In brief, 
dsRNA was injected into one to two day old adult female mosquitoes that were allowed to 
recover for four days before the KD efficiency was tested by real-time quantitative RT-PCR 
(qRT-PCR). For qRT-PCR we used oligonucleotide primers spanning the alternative introns 
after the 7th REL2 exon (Fig. 4.4.1). This way both REL2-S (primers #9.1.80/81) and 
REL2-F (primers #9.1.82/83) could be targeted. Because A. gambiae shows no transitive 
RNAi effects, i.e., dsRNAs are effective only against mRNAs bearing the corresponding 
sequences (Hoa, Keene et al. 2003), and thus targeting the RHD should silence both REL2 
forms, whereas ANK-domain KD should affect only REL2-F. The results confirmed that 
RHD dsRNA injection silences both REL2-S and REL2-F transcripts equally (~50%), 
whereas ANK dsRNA decreases the levels of only REL2-F (Fig. 4.4.4). Interestingly, REL2-
S transcript levels were up-regulated by 1.5-fold in dsANK-injected mosquitoes. 
 
 
Fig. 4.4.4 Efficacy of RNAi-mediated REL2 gene silencing in adult mosquitoes after injections with either 
RHD or ANK dsRNA. Relative REL2-S and REL2-F transcript levels in KD compared with control GFP 
dsRNA-treated mosquitoes were determined in the carcass, midgut, and whole mosquitoes 4 days after 
injections by using qRT-PCR (modified from (Meister, Kanzok et al. 2005)). 
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 REL2/IMD immunity pathway and defense to bacterial infection. 
We investigated, by RNAi analysis, the possible role of REL2 and other components 
of the Imd pathway in the defense against bacterial infections in adult mosquitoes. As 
described above and in chapter 3 (Materials & Methods), dsRNA was injected into one to 
two days old adult female mosquitoes that were allowed to recover for four days and then 
challenged with bacteria representative of the Gram+ (S. aureus) or the Gram- (E. coli) types.  
Mosquito survival was assessed daily for 7 days after bacterial infection (Fig. 4.4.5). 
The results revealed that simultaneous KD of REL2-F and REL2-S transcripts (RHD 
dsRNA) significantly compromised mosquito defense against both S. aureus and E. coli. In 
contrast, KD of REL2-F alone (ANK dsRNA) reduced the survival of S. aureus – but not of 
E. coli – infected mosquitoes.  
KD of CASPL1 (the ortholog of the Drosophila Dredd) did not have a significant effect 
on the mosquito anti-bacterial and anti-parasitic immunity and thus it is not discussed 
further or shown in the figures. For the KD we used the primers #9.1.50/51 (Table 9.1.1). 
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Fig. 4.4.5 Mosquito survival after gene KD and bacterial infection. 
Survival of adult mosquitoes to a. Gram-positive S. aureus and b. Gram-
negative E. coli infections after KD of IMD, REL2-RHD, and REL2-
ANK. GFP dsRNA-treated mosquitoes were used as control. The survival 
assay was repeated at least 3 and up to 10 times per gene. Error bars 
represent the standard error (from (Meister, Kanzok et al. 2005)). 
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 REL2/IMD KD and Plasmodium infection. 
It has been reported previously that CEC1 and other AMP genes are up-regulated 
when Plasmodium crosses the Anopheles midgut (Dimopoulos, Richman et al. 1997; Vizioli, 
Bulet et al. 2000; Christophides, Zdobnov et al. 2002). Furthermore, microarray results 
(Meister, Kanzok et al. 2005) indicated that REL2 regulates expression of the major 
Plasmodium antagonist LRIM1 (Osta, Christophides et al. 2004). We tested the effect of 
REL2 and IMD KD on P. berghei survival at the oocyst stage in the mosquito midgut. We 
also tested the effect of the REL2/IMD pathway silencing on P. berghei development in the 
refractory L3-5 mosquitoes. These mosquitoes melanize all the parasites at the ookinete 
stage during midgut invasion. In the previous chapter, we showed that KD of PGRPLC, the 
putative receptor of the IMD/REL2 pathway, leads to a drastic increase of parasite numbers, 
which however are all killed by melanization. In this next set of experiments, LRIM1 was 
used as a control. KD of LRIM1 leads to an increase in parasite numbers and prevents 
parasite melanization. The REL2 and IMD KD revealed the same phenotype as that of the 
PGRPLC KD: an increase in number of melanized parasites (especially in REL2 KD 
mosquitoes; Fig. 4.4.14). This suggests that PGRPLC might be indeed the receptor of the 
IMD pathway, and that, similar to the susceptible G3 mosquitoes, L3-5 mosquitoes kill and 
lyse a large number of P. berghei parasites before melanization of the remaining ones. It also 
indicates that although the LRIM1 gene is one of the targets of the IMD/REL2 pathway, 
the effect of the pathway on P. berghei survival is much more complex. 
Silencing of REL2 (RHD dsRNA) or IMD in G3 mosquitoes resulted in a statistically 
significant twofold increase of oocyst numbers, suggesting that the pathway is, indeed, 
implicated in parasite killing before or during midgut invasion (Fig. 4.4.6, Table 4.4.2). 
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 Quantitatively similar results were obtained when silencing REL2-F alone (ANK dsRNA), 
indicating that REL2-F, rather than REL2-S, is implicated in this reaction. KDs of both 
REL2-RHD and REL2-ANK, but not of IMD, led to melanization of some parasites (~5% 
of the ookinetes). This finding would suggest that REL2-F is involved in the control of the 
melanization reaction, in a manner independent of the IMD.  
 
 
 
 
Table 4.4.2 Effect of REL2 pathway gene silencing on parasite development. 
Gene KD midguts par/midgut Prev (%) Mel (%) P (KS) P (t) 
CONTROL (5) 79 86 87.34 0.07   
IMD (5) 79 153 96.20 0.13 0.044 0.017 
CONTROL (4) 49 51 87.76 0.63   
REL2-RHD (4) 49 104 91.84 4.37 0.147 0.035 
CONTROL (3) 42 82 97.62 0.00   
REL2-ANK (3) 42 166 95.24 4.87 0.093 0.008 
Numbers of oocysts and melanized parasites are reported as three experimental 
datasets for knocked down genes or REL2 domains and control dsRNA-treated 
mosquitoes (GFP). The number of replicates is indicated in parenthesis in the first 
column. Each replicate used different batches of mosquitoes, which were fed on 
the same infected mouse. Identical numbers of midguts from control and KD 
mosquitoes were assessed for each replicate (see also Supporting Table 5). The 
probabilities (P) indicate whether the distributions of parasites in KD and control 
midguts in each dataset are similar, and were determined by KS and Student’s t 
test. Prev, prevalence; mel, melanized parasites (ookinetes); par, parasite number 
(oocysts and melanized ookinetes). 
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Fig. 4.4.6 REL2- and IMD-mediated Plasmodium killing and 
melanization in the mosquito vector. a. Averaged P. berghei oocyst load per 
midgut after KD of IMD, REL2-ANK, and REL2-RHD. The oocyst load 
after individual gene KD was normalized to the oocyst load of parallel 
dsGFP treatment and presented as a percentage. Every gene KD was 
repeated three times or more. Black sections of columns represent 
melanized ookinete fraction. Error bars represent the standard error. b. 
Representative sections of infected A. gambiae midguts infected with GFP-
tagged P. berghei. Arrows point to melanized ookinetes (from (Meister, 
Kanzok et al. 2005)). 
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 CEC1 is under REL2 transcriptional control*. 
A putative AMP target gene of Anopheles immune signaling pathways is CEC1 
(previously designated as Cecropin A) (Vizioli, Bulet et al. 2000; Zheng and Zheng 2002). 
Compared with Drosophila Cecropins, which are mostly active against Gram-negative bacteria, 
CEC1 has a wide spectrum of antibacterial activities and is induced by Plasmodium and both 
Gram types of bacteria (Vizioli, Bulet et al. 2000). Sua1B and 4a3A cells have high levels of 
constitutive CEC1 expression that are further enhanced by treatment with heat-killed E. coli 
or M. luteus (data not shown). We examined the effect of REL proteins on CEC1 gene 
expression in Sua1B cells after transfection with a CEC1-promoter luciferase-reporter 
construct (Zheng and Zheng 2002), silencing of REL1 or REL2 genes by RNAi, and 
subsequent monitoring of luciferase activity. Targeting either the RHD or ANK domains of 
REL2 resulted in substantial reduction of luciferase activity, typically 5- to 10-fold. In 
contrast, REL1 knockdown had no significant effect (Fig. 4.4.7). 
We observed that KD using the ANK dsRNA results in a major (~91%) reduction in 
CEC1-promoter expression, essentially indistinguishable from that observed with RHD 
dsRNA. Thus, it appears that REL2-F largely controls the constitutive CEC1-promoter 
expression that is detected in the Sua1B cells, whereas REL2-S has no major effect (Fig. 
4.4.7). Similar results were obtained for 4a3A cells (data not shown). Proteolytic cleavage is 
necessary to remove the inhibitory ANK domain of Drosophila Relish, and this processing 
would also be expected for REL2-F activation. By extension, these results suggest that 
REL2-F is constitutively activated in these mosquito cells. 
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Fig. 4.4.7 CEC1 promoter activity in cultured 
Anopheles cells. REL2, but not REL1, is 
required for expression of CEC1 promoter in 
Sua1B cells, which is equally affected by 
dsRNAs encompassing the RHD and the 
ANK-repeats domain. CTRL, control 
(modified from (Meister, Kanzok et al. 2005)). 
 
Other Anopheles orthologs of Drosophila Imd-pathway components, the Imd adaptor 
(IMD) and caspase Dredd (CASPL1), were previously identified (Christophides, Zdobnov et 
al. 2002); orthologs of IKKβ (IKK1 or ENSANGG00000014263) and IKKγ (IKK2 or 
ENSANGG00000018475) were identified herein: (Meister, Kanzok et al. 2005). To examine 
the degree of functional Imd-pathway conservation between Anopheles and Drosophila, we 
silenced these genes in Sua1B and 4a3A cells by using RNAi and observed significant down-
regulation (Fig. 4.4.8). In both cell lines, IMD KD reduced CEC1-promoter expression 
(~60% and 68%, respectively), although not as efficiently as REL2 KD. This is consistent 
with evidence from Drosophila imd mutants, in which Cecropin A expression is reduced but not 
abolished (Onfelt Tingvall, Roos et al. 2001). 
Surprisingly but consistently, silencing of CASPL1 and IKK1 or IKK2 had opposite 
effects in the two cell lines. In Sua1B cells, KD of CASPL1 but not of IKK1 or IKK2, 
substantially reduced CEC1 promoter expression, whereas, in 4a3A cells, KD of IKK1 or 
IKK2, but not of CASPL1, reduced CEC1 promoter expression.  
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Fig. 4.4.8 CEC1 promoter activity in cultured Anopheles cells. a. REL2, IMD, and CASPL1, but 
not IKK1 or IKK2, are required for CEC1 expression in Sua1B cells. b. REL2, IMD, IKK1, and 
IKK2, but not CASPL1, are required for CEC1 expression in 4a3A cells. CTRL, control; CAS, 
CASPL1 (modified from (Meister, Kanzok et al. 2005)). 
 
We determined the level of gene silencing for IKK1, IKK2 and CASPL1 (Fig. 4.4.9). 
Importantly, KD of IKK1 and IKK2 in Sua1B was highly effective, suggesting that these 
genes are not implicated in the regulation of CEC1 in Sua1B cells. KD of CASPL1 in the 
same cells was less effective (~40%), and yet associated with substantial reduction in CEC1 
activity (Fig. 4.4.8a). A plausible explanation that requires further investigation is that 
IKK1/IKK2 and CASPL1 are implicated in alternative branches of the CEC1-activation 
pathway that are differentially active in these two cell types. 
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Fig. 4.4.9   Efficacy of RNAi-mediated gene silencing of IKK1, IKK2, and CASPL1 genes in 
Sua1B cultured cells. RNAi effectiveness was determined a. qualitatively by RT-PCR and b. 
quantitatively by qRT-PCR. Ribosomal protein S7 rpS7 served as internal reference and 
untreated cells served as calibrator (modified from (Meister, Kanzok et al. 2005)). 
 
Other genes under REL2 transcriptional control*. 
A DNA microarray analysis (Dimopoulos, Christophides et al. 2002) was performed to 
identify genes regulated by REL2 in Anopheles 4a3A cells by comparing the expression 
profiles of cells treated with either REL2 (RHD) or control lacZ dsRNAs. Cells were 
challenged 24 h after dsRNA addition, by a 12-h exposure to heat-killed E. coli, and 
expression profiles were assessed at 0, 2, 6, and 12 h. From the 3,840 EST clones present on 
the microarray, nine were consistently down-regulated in REL2 KD cells by at least 1.7-fold 
and one by 1.2-fold (Table 4.4.4). Six of these genes have been categorized previously as 
defense/immunity-related (Dimopoulos, Casavant et al. 2000). They encode the AMPs 
CEC3 and GAM1 (previously CecB and Gambicin, respectively), the serine protease 
CLIPB14, another two CLIP-domain serine proteases, a fibrinogen-domain lectin, a Brix-
domain protein implicated in ribosome biogenesis, a protein disulfide isomerase, KIN1, a 
kininogen-domain protein (see below), and LRIM1, a leucine-rich repeat immune protein 
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 with strong anti-parasitic activity (Osta, Christophides et al. 2004). The CEC3 gene is tightly 
clustered with CEC1 and CEC2 and its promoter region includes two NF-κB binding sites 
(Zheng and Zheng 2002), suggesting regulatory similarities to CEC1. At least 1, and as many 
as 10, κB elements were detected in adjacent genomic regions of all regulated genes (Table 
4.4.4).  
 
Table 4.4.4 REL2 regulated genes as determined by microarray (Meister, Kanzok et al. 
2005). 
Ensembl gene ID Folds # κB Gene description 
ENSANGG00000010552 -2.85 2 LRIM1 
ENSANGG00000013355 -2.6 4 CLIP domain SP 
ENSANGG00000009506 -2.3 2 CEC3 
ENSANGG00000015633 
-2.28 8-10 CLIPB14 (SP) 
ENSANGG00000018623 -2.2 1 Brix domain 
ENSANGG00000013381 -2.19 1 CLIP domain SP 
ENSANGG00000015896 -2.1 2 Disulfide isomerase 
ENSANGG00000015703 -2.01 4 Fibrinogen lectin 
ENSANGG00000010776 -1.7 2 GAM1 
ENSANGG00000011642 -1.2 2 KIN1 
The number (#) of putative NF-κB sites in the vicinity of each gene is listed; SP, serine 
protease. 
 
 
KIN1 encodes a short mature cationic polypeptide with a kininogen domain, which is 
enriched in histidine (26 residues, 36%), plus an amino-terminal signal peptide. KIN1 is 
strongly up-regulated by immune challenges (Dimopoulos, Christophides et al. 2002) and 
Plasmodium infection (Vlachou, Schlegelmilch et al. 2005). Examination of a KIN1-promoter 
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 luciferase construct in Sua1B cells showed that REL2 is, indeed, required for KIN1 
expression. RHD and ANK dsRNA resulted in more than 50% reduction of KIN1 
promoter activity (Fig. 4.4.10). 
 
 
Fig. 4.4.10 KIN1 gene is transcriptionally regulated by REL2. The KIN1 
promoter was amplified from genomic DNA with KIN1-promoter 
primers (#9.1.88/89) and cloned into pGL3 (Promega, Madison WI). 
KIN1 KD and the luciferase assay in Sua1B cell lines was carried out as 
described in chapter 3 (Materials & Methods). CTRL, control (modified 
from (Meister, Kanzok et al. 2005)). 
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 The Anopheles TOLL/REL1 pathway in anti-bacterial defense. 
The importance of the IMD/REL2 pathway in resistance to infection with both 
Gram+ and Gram- bacteria prompted us to expand our analysis to the other NF-κB factor 
in the Anopheles genome, REL1 (the ortholog of Dorsal), that we had used as control thus far 
(Fig. 4.4.7 & 4.4.10). REL1 lacks an IκB inhibitory domain, similar to its fly ortholog. Thus, 
Dorsal (and Dif) in Drosophila is inhibited from constitutive translocation to the nucleus by the 
IκB-domain protein Cactus, which also has an Anopheles clear-cut ortholog, CACT. We used 
dsRNA injection in adult mosquitoes, as described in the Materials & Methods (Chapter 3), 
to KD REL1 (primers #9.1.68/69), CACT (primers #9.1.66/67)or both genes 
simultaneously. The mosquitoes which were then infected with E. coli and S. aureus bacteria 
and their resistance to infection, expressed by their survival rates, was monitored. 
However, none of the KDs led to reduced mosquito survival after infection with E. coli   
(Fig 4.4.11) or S. aureus (Fig 4.4.12) bacteria. The fact that KD of REL1 had no measurable 
effect on mosquito survival after bacterial challenge, suggests that REL2 is sufficient to 
confer resistance to bacterial infections. 
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Fig. 4.4.11 Survival of adult female mosquitoes after gene KD by injection with dsRNA (IMD (5 repetitions), 
REL1 (3 repetitions), CASPL1 (3 repetitions), CACT (1 repetition), CACT/REL1-doubleKD (1 repetition) or control 
GFP) and injection of E. coli.  
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Fig. 4.4.12 Survival of adult female mosquitoes after gene KD by injection with dsRNA; REL1 (3 repetitions), 
CASPL1 (3 repetitions), CACT (1 repetition), CACT/REL1-doubleKD (1 repetition) or control GFP) and injection of 
S. aureus.  
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 The role of the Toll/REL1 pathway in Plasmodium infection. 
We assessed the role of REL1 in mosquito infection with the rodent malaria parasite P. 
berghei as described previously. KD of REL1 did not have any effect on the number of 
oocysts developing in the mosquito midgut, suggesting that only REL2, and its associated 
IMD pathway is involved in the P. berghei killing that is documented before or during midgut 
invasion (Fig 4.4.13). However, the evidence from a massive screen that was conducted in 
the laboratory suggested that KD of the IκB protein CACT leads to extensive parasite killing 
and melanization. Indeed, our results, presented in Fig 4.4.13 showed that CACT KD results 
in extensive parasite killing and elimination, possibly by lysis, that reaches 80% of the 
parasites compared to the control dsGFP treated mosquitoes, while the remaining 20% of 
the parasites are melanized. 
To further explore the role of CACT in inhibition of the mosquito NF-κB pathways, 
we simultaneously silenced CACT and either of the two NF-κB factors, REL1 and REL2. 
As REL2-S is lacking an inhibitory IκB domain (compared to REL2-F), this 
experiment was critical to examine whether its nuclear translocation is inhibited by CACT. 
However, the results showed that only silencing of REL1 was able to rescue the wt 
phenotype of CACT KD mosquitoes. Double KD of CACT and REL2 resulted in a 
phenotype similar to that of CACT, namely extensive parasite lysis and some ookinete 
melanization. 
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Fig 4.4.13 Differences in G3 parasite numbers per midgut after gene KD. KD of the P. berghei antagonist 
LRIM1 was used as control. Green colored fractions represent live oocysts and grey colored fractions 
melanized ookinetes. Sample sizes: CACT, 43 midguts; REL1, 52 midguts; CACT/REL1, 30 midguts; 
CACT/ANK, 21 midguts; CACT/RHD, 12 midguts; LRIM1, 67 midguts. Error bars represent standard errors. 
 
parasites per midgut in L35
0
100
200
300
400
500
600
GFP IMD LRIM1 REL2 RHD
gene KD
%
melanized parasites
live parasites
 
Fig 4.4.14 Differences in L3-5 parasite numbers per midgut after gene KD. Green colored bars represent live 
oocyst fractions and grey colored bars melanized ookinetes. Sample sizes: IMD, 79 midguts; LRIM1, 7 midguts; 
REL2, 31 midguts. Error bars represent standard errors. 
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 A. gambiae immunity to fungal infection. 
Innate immune defense to fungi in D. melanogaster is mediated by the Toll pathway and 
the NF-κB transcription factor Dif (Lemaitre, Nicolas et al. 1996). Similarly, the A. aegypti 
REL1 transcription factor, which is orthologous to the A. gambiae REL1 and believed to be a 
component of the Toll pathway, mediates immunity to the filamentous entomopathogenic 
fungus B. bassiana (Bian, Shin et al. 2005; Shin, Kokoza et al. 2005). 
 We examined the role of the A. gambiae REL1 and REL2 in defense to B. bassiana. 
The mosquitoes were exposed to fungi spores using the protocols described in the Materials 
& Methods (chapter 3). As shown in Fig. 4.7.1, the effect of a mosquito infection with 
spores of B. bassiana proved to be dramatic and the fungi overwhelm the mosquito innate 
immune system and all mosquitoes die within the following four days (Fig. 4.7.2).  
 
Fig 4.7.1 a. A. gambiae overcome by B. bassiana 6 days after infection. b. Close-up of head region 
 
 
 The effect was so drastic, that any additional effect from a gene KD was masked by 
the rate of natural death from the infection (Fig. 4.7.3).  We also examined whether KD of 
CACT can lead to an increase in mosquito survival. However, the rate of infection again did 
not allow to observe any possible effect (data not shown).  
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 These results indicated that the A. gambiae infection with B. bassiana needed further 
optimization in order for it to be used as a diagnostic tool to examine the role of immune 
pathways during fungal infections. 
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 Fig 4.7.2 A. gambiae survival to infection with B. bassiana. The infection was repeated 11 times – the uninfected 
mosquitoes (kept in the same location) were sampled twice. 
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Fig 4.7.3 A. gambiae survival to infection with B. bassiana after KD of REL1, REL2 or treatment with dsGFP. 
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DISCUSSION 
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 5.1 THE A. GAMBIAE PGRP GENE FAMILY 
 
The first step on the way to activation of the immune signaling pathways is the 
recognition of PAMPs (pathogen associated molecular patterns) by specific receptor proteins 
(Janeway and Medzhitov 2002). In insects, the PGRP and GNBP protein families of 
receptors seem to have the main responsibility of pathogen recognition and pathway 
activation (Royet, Reichhart et al. 2005).  
The strong upregulation of the PGRPLB gene in cells challenged with immune elicitors 
and in the mosquito upon malaria infection (Dimopoulos, Christophides et al. 2002) drew 
our attention to the PGRP family, even though the gene KD by RNAi proved not to have a 
significant effect on mosquito survival after subsequent bacterial challenge. 
Members of the family of PGRPs have one or more PGRP domains and are important 
components of insect immune reactions. The first PGRP was characterized in Bombyx mori as 
a hemolymph protein that binds PGN and activates the PPO cascade (Yoshida, Kinoshita et 
al. 1996). In Drosophila, secreted PGRP-SA is essential for activating the Toll signaling 
pathway mediated response to Gram+ bacteria, but not to fungi (Michel, Reichhart et al. 
2001), while PGRP-LC activates an alternative immune signaling pathway (imd) that 
responds to Gram- bacteria to induce certain AMPs (Choe, Werner et al. 2002; Gottar, 
Gobert et al. 2002).  
Of the 13 Drosophila genes that encode PGRP domains (Werner, Liu et al. 2000), seven 
are classified as short (S) and encode secreted proteins, while six genes of the long (L) 
subfamily encode transmembrane or intracellular products. The Anopheles genome includes 
three members of the short subfamily (PGRPS1, PGRPS2 and PGRPS3) and four of the long 
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 subfamily (PGRPLA, PGRPLB, PGRPLC and PGRPLD). The latter are clear orthologs of 
correspondingly named D. melanogaster genes.  
Among the short PGRPs, PGRPS1 was identified as the ortholog of the Drosophila 
PGRP-SA gene, but our results, using reverse genetics and bacterial challenge, could not 
implicate it in bacterial defense in Anopheles. It remains to be seen if PGRPS1 is able to 
rescue the Drosophila PGRP-SA mutant semmelweis. These experiments are currently ongoing.  
The sequence of the other two short PGRPs (PGRPS2 and S3) differ only in 9 amino 
acids which reveals an amazing subtlety in specificity and prompts us to speculate that these 
genes may have an important role in the mosquito defenses. The recognition of their 
putative ligands has to be critical enough, so as to justify the maintenance of these two 
almost identical genes in a gene cluster. An alternative explanation would a gene regulatory 
mechanism involving RNAi, as these genes are on opposing DNA strands. Preliminary 
evidence obtained from the first version of the A. aegypti genome suggests that there, too, 
exist two very closely related, clustered short PGRPs. 
Relatively little is known about PGRPLA and PGRPLD. They could not be implicated 
in bacterial defense, and the PGRPLA1 isoform does not appear to have a role in defense 
against the malaria parasite. However, KD of PGRPLA2 increases the parasite load per 
infected midgut in the G3 mosquito strain by 56.6%. Interestingly, we couldn’t detect this 
gene by PCR in freshly prepared adult mosquito cDNA or various cDNA libraries (larval, 
thoracical, abdominal). This might indicate that the gene is only expressed at very low levels 
or that its expression is restricted to specific tissue or cell types. 
5 PGRPs in Drosophila (PGRP-SB1, PGRP-SB2, PGRP-SC1, PGRP-SC2, PGRP-LB)  
and 3 PGRPs in Anopheles (PGRPS2, PGRPS3, PGRPLB) have all the required attributes 
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 and features (disulfide bridges and catalytically important residues) of a catalytically active 
Amidase. Importantly, the PGRPs with putative Amidase activity cluster together on the 
phylogenetic tree which leads to the intriguing conclusion, that the PGRPs not 
phylogenetically clustering with these catalytically active PGRPs are likely to be involved in 
signaling instead. 
PGRPS2, PGRPS3, PGRPLD, PGRPLB, PGRPLA1 and PGRPLA2 genes all have 
either no assigned ortholog or their ortholog has not been implicated in signaling. A recent 
report suggested that human PGRPs kill bacteria by interacting with the PGN of their cell 
wall (Lu, Wang et al. 2005) – unlike AMPs which permeabilize their membranes (Zasloff 
2002; Ganz 2003; Brogden 2005). The authors postulated, that PGRPs represent a new class 
of bactericidal and bacteriostatic proteins with a structure and mechanism of action different 
from that of classical AMPs (Lu, Wang et al. 2005). It is possible that some of the 
aforementioned Anopheles PGRPs fulfill a similar bactericidal role in insects. 
 
The PGRPLC gene. 
PGRPLC was the only gene having an effect on mosquito survival after bacterial 
challenge when knocked down. It also had an effect on parasite development in the 
mosquito. This prompted us to investigate the PGRPLC gene cluster in A. gambiae, which is 
21.1 kb long and encompasses the PGRPLA and PGRPLC genes. PGRPLA has two PGRP 
domains and PGRPLC has three domains. Compared to the analogous gene cluster in D. 
melanogaster, it is slightly bigger by 4 kb because of longer intronic and intergenic sequences, 
and has lost the PGRP-LF gene and gained a PGRP domain in PGRPLA. It is very likely 
that the common ancestor of flies and mosquitoes had just one single domain PGRPLC 
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 gene, because a phylogenetic analysis showed that the PGRP domains are more similar 
within each species than across species and because the second splice site of all the Anopheles 
PGRPLC domains are unique to A. gambiae. 
The PGRP domains of both PGRPLC and PGRPLA are encoded by three exons per 
domain which are of exactly the same length between the domains, and within a gene and 
can thus in theory be rearranged by alternative splicing and still yield functional PGRP 
domains. In an attempt to detect potential hybrid PGRPLC domains, RT-PCR with a variety 
of primers distributed along the length of the gene was performed. However, only one 
novel, though not functional (frameshift) PGRP domain could be detected. We could also 
detect a pool of unspliced transcripts for the PGRPLC1 and PGRPLC2 domains. Only 
PGRPLC3 appeared to always be spliced. These transcripts were not due to genomic DNA 
contamination and although the presence of nuclear unspliced mRNA cannot be ruled out, it 
is an insufficient explanation as the ribosomal control gene S7 appeared to be completely 
spliced. We hypothesize that this unspliced pool of transcripts may act as a immature 
transcript reservoir to decrease reaction timing in case of infection and to direct the splicing 
to the PGRPLC isoform that is best suited to deal with the specific invader. Indeed we were 
able to detect by microarray analysis that the PGRPLC domains are differentially regulated in 
response to various pathogens. 
The apparent efficiency and specificity of KDs by RNAi was limited and may be 
complicated both by questions of PGRP turnover rates and by what appears to be a reserve 
of unspliced transcripts. Knocked down transcripts could be replenished from this pool and 
other mRNA isoform transcript levels could be affected. Even more worryingly, the other 
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 PGRPLC domains appeared to compensate for the reduction of the targeted domain by 
increasing their transcript levels. 
Nevertheless, both by RT-PCR and by qRT-PCR we observed significant reduction of 
transcript levels. The clearest results were obtained by qRT-PCR in dissected midguts and 
carcass, where the apparent reduction in transcript levels after dsRNA-mediated silencing 
was in the range of 34 to 76 percent. 
 
Structural modeling of the PGRP domains. 
The rational of splice isoforms was best investigated by exploring the 3D structure of 
the PGRPLC domain. Also, we aimed to detect structural difference between the three 
domains of PGRPLC that might reflect different recognition specificities. As PGRP domains 
display an exceptional level of conservation, we modeled the domains in question onto 
solved 3D structures of Drosophila PGRP domains. To this date, crystal structures of 
Drosophila PGRP-LB and PGRP-SA and human PGRP-IαC and -S have been reported (Kim, 
Byun et al. 2003; Chang, Pili-Floury et al. 2004; Guan, Malchiodi et al. 2004; Guan, Wang et 
al. 2005). Importantly, all these structures adopt a conserved surface groove that has been 
demonstrated to be the PGN-docking groove by mutational and structural analysis (Chang, 
Pili-Floury et al. 2004; Guan, Roychowdhury et al. 2004). We finally used the structural 
model of the Drosophila PGRPLB (Kim, Byun et al. 2003) as a template to model the 
individual domains of PGRPLC onto.  
The bottom of the PGN binding site is conserved between the three domains as it is 
encoded mainly by the first common exon. However, the ridges of the pocket encoded by 
the unique exons of each domain are rather divergent and are thought to confer different 
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 binding specificities. When the PGN recognition sites between isoforms within each insect 
species were compared, diversity at the edges of the binding pocket was intensified by small 
loop insertions or deletions (Fig. 4.3.10), suggesting isoform-specific topological changes.  
Most probably, these changes of isoforms are “tailored” to be specific to PGN ligands.  
When mutating amino acids on both edges of this groove region of PGRP-SA in Drosophila, 
almost every position tested led to impaired PGN binding and Toll signaling activity (Chang, 
Pili-Floury et al. 2004). Thus, further structural studies of the Anopheles PGRPs could 
provide the basic understanding of ligand recognition.   
The postulated rearrangement of exons in the mRNA transcript would thus form new 
hybrid domains that are indeed likely to produce new recognition surfaces. As all three exons 
contribute equally to the binding site, we could speculate that a possible hybrid domain may 
increase the binding spectrum and specificity of PGRPLC pattern recognition capacity. 
Indeed, Drosophila PGRP-LC domain homo- and heterodimers have since been shown to 
distinguish between both polymeric and monomeric forms of Gram- DAP-type PGN 
(Kaneko, Goldman et al. 2004; Stenbak, Ryu et al. 2004) and even to mount a response to 
Lys-type PGN (Kaneko, Golenbock et al. 2005; Kaneko and Silverman 2005). 
Just like the PGN docking pocket, the ‘back face’ groove displays a conserved 
hydrophobic surface with extremely variable edges.  This was also observed when the 
Drosophila PGRPs were compared (Fig. 4.3.10). This hints at the fact that the ‘back face’ of 
PGRP domains might serve an equally important role to pattern recognition as the front, as 
growing evidence suggests that they might interact with immunity effector proteins (Pili-
Floury, Leulier et al. 2004), or other PAMPs such as LPS (Werner, Borge-Renberg et al. 
2003; Tydell, Yuan et al. 2006) or 1,3-β-Glucan (Lee, Osaki et al. 2004). 
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 The whole of the PGRP domain is extremely rigid and no conformational changes can 
be invoked to explain a signal cascade initiation upon ligand binding (Kim, Byun et al. 2003). 
There has since been evidence accumulating that PGRPs dimerize when brought in physical 
proximity (Werner, Borge-Renberg et al. 2003; Mellroth, Karlsson et al. 2005) through 
binding to the same surface and thus initiate signaling with their hydrophobic ‘back face’.  
In the case of the Anopheles PGRPLC, the two beta strands representing the putative 
protein interaction region on the ‘back face’ of each domain are encoded by the common 
exon, and are thus likely to interact with the same downstream signaling partners. This 
means that the signals originating form the various PGRPLC domains most likely are 
integrated to amplify their combined signal. This is in agreement with the fact that we 
showed PGRPLC to be important to the immune response to both E. coli and S. aureus 
bacteria.  
 
The mosquito PGRPLC is implicated in defense to bacteria. 
We confirmed the relevance of the PGRPLC gene to the A. gambiae innate immune 
system by gene knockdown (KD) and subsequent infection with Gram+ (S. aureus) and 
Gram- (E. coli) bacteria. In both cases, KD of the gene severely impairs mosquito resistance 
the bacteria. As far as individual PGRPLC domains in these assays are concerned, 
PGRPLC3 appears to be the most important one as its KD reduces survival after bacterial 
challenge to a similar extent as the whole gene KD does. This is interesting in the context 
that the PGRPLC3 transcript is the one that is always readily spliced. PGRPLC2, on the 
other hand, does not seem to play an important role in defense to the Gram+ S. aureus. 
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 Thus we speculate that PGRPLC could act as a PRR for both Gram types of bacteria 
unlike its Drosophila counterpart which is believed to be only necessary to defend against 
Gram- bacteria. However, this result prompted us to reinvestigate PGRP-LC’s role in 
Drosophila by subjecting a PGRP-LC mutant fly strain (Gottar, Gobert et al. 2002) to the 
same assays with the same bacterial strains that we had used on the mosquito. We also tested 
the PGRP-SAseml  (semmelweiss) mutant strain (Michel, Reichhart et al. 2001) for further 
comparison. The results showed that, as expected, the semmelweis mutant had increased 
mortality after Gram+ (S. aureus) but not after Gram- (E. coli) challenge.  However, the 
mutant PGRP-LC fly stain displayed a reduction in survival after challenge with either type 
of bacteria. This latter result was surprising, but exactly analogous to the results obtained in 
the mosquito.  
From this data, we conclude that there has not necessarily been a switch in pathways in 
Anopheles as we initially believed after the mosquito survival experiments. An alternative 
explanation for the reduced survival after Gram+ bacteria infection in the PGRP-LC mutant 
could be the fact that PGRP-LC has multiple modes of action. It can activate AMP 
expression (Choe, Werner et al. 2002; Gottar, Gobert et al. 2002) and/or initiated 
phagocytosis (Ramet, Manfruelli et al. 2002) and thus different functions of the gene might 
result in reduction in survival for different bacteria, i.e. failure of AMP expression in the case 
of E. coli, but lack of phagocytosis in the case of S. aureus. However, RNAi screens in 
Drosophila and Anopheles cultured cells point to PGRP-LC as a key player for phagocytosis of 
only Gram- (E. coli) but not Gram+ (S. aureus) bacteria (Ramet, Manfruelli et al. 2002; Moita, 
Wang-Sattler et al. 2005). 
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 Another hypothesis was that the constitutive activation of PGRP-LC keeps commensal 
bacteria in check and thus its KD would leave the immune system exposed to such bacteria. 
The insect would thus be very fragile as a result and the subsequent experimental infection is 
not the cause of the observed phenotype. However, we tested this hypothesis by comparing 
the survival rates of  PGRP KD mosquitoes that were infected with bacteria or injected with 
just saline solution. The results falsified this hypothesis as no increase of the death rate was 
observed in the non-infected mosquitoes. 
 
A role for PGRPLC in malaria parasite killing. 
 As the immune system is known to be activated by the malaria parasite, we 
investigated the involvement of PGRPLC in the defense against P. berghei. KD of the whole 
PGRPLC gene in susceptible G3 mosquitoes results in a 2.5-fold increase of parasites in 
infected mosquito midguts. In addition, a residual number (2.5%) of parasites gets 
melanized. However, the specific KDs of individual PGRPLC domains do not seem to have 
an effect on the malaria parasite, suggesting that it is the concerted action of the different 
isoforms that mediates parasite killing. 
The numbers of malaria parasites per midgut obtained when infecting the refractory 
mosquito strain L3-5 after PGRPLC KD (Fig. 4.3.17), are slightly different from those 
obtained in G3. The increase in parasites in L3-5 is not as high after PGRPLC gene KD - 
though the melanization reaction at large is unperturbed (3.35% percent of the parasites are 
now alive as compared to none in the GFP control). However, the domain specific KD of 
PGRPLC3 alone increases parasite numbers in the L3-5 strain, unlike in the G3 strain. In 
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 fact, PGRPLC3 can probably be held accountable for the increase in parasite numbers we 
see in the whole gene KD. 
This slight discrepancy between the two strains is not without precedent – the two 
strains have displayed this kind of inconsistent behavior after KD of the same gene in the 
past ((Volz, Osta et al. 2005) and (Fig. 4.4.14)). Nevertheless, the PGRPLC KD results are in 
good accordance with the results obtained in G3 Plasmodium infected midguts after KD of 
IMD and REL2 (Fig. 4.4.6). Parasite numbers roughly double after KD of this pathway and 
the balance of melanization gets disturbed which results in a low but consistent number of 
melanized parasites per midgut. 
Three other PGRP genes also show an effect on parasite numbers in susceptible 
mosquitoes. PGRPLA2 shows a similar phenotype to that of PGRPLC although the 
numbers are not as much increased. Notably, PGRPLA2 is not detectably expressed in the 
various mosquito tissues tested. It is most likely expressed at very low levels in specific 
tissues or cells (e.g. hemocytes). In contrast, the simultaneous KD of the – very similar – 
PGRPS2 and S3 genes leads to lower parasite numbers (approximately 44%). Both genes 
encode proteins with a predicted amidase activity and thus, based on evidence from 
Drosophila, may function as clearing and inactivating PGN. If this is true, the proposed model 
of action of PGRPLC during Plasmodium infection is the following: commensal bacteria that 
reside in the mosquito gut (and/or propagate during a blood meal) constitutively activate the 
PGRPLC-triggered pathway that consequently keeps their numbers under control. A side 
effect of this pathway activation is killing of a large number of parasites that attempt to 
invade the mosquito gut. This may be achieved through parasite agonists such as LRIM1 
(Osta, Christophides et al. 2004) and CLIPB14/B15 (Volz, Osta et al. 2005), all of which are 
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 targets of the PGRPLC-activated IMD/REL2 pathway (Meister, Kanzok et al. 2005). At the 
same time, catalytic PGRPs, such as PGRPS2 and S3, negatively regulate the pathway via 
scavenging of the bacterially shed PGN. Silencing of these PGRPs constitutively activates 
the pathway, resulting in increased killing of Plasmodium parasites. 
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 5.2 THE A. GAMBIAE IMD PATHWAY  
 
We showed that PGRPLC, and thus its downstream immune signaling pathway, the 
Imd pathway (Choe, Werner et al. 2002; Gottar, Gobert et al. 2002), is very important for the 
mosquito defense against bacteria as well as the malaria parasite. Two PGN recognition 
proteins have thus far been shown in Drosophila to mediate activation of the Imd pathway in 
Drosophila: the transmembrane PGRP-LC (Choe, Werner et al. 2002; Gottar, Gobert et al. 
2002) and the extracellular PGRP-LE (Takehana, Katsuyama et al. 2002). After an initial 
recognition event, the signal is passed on directly to Imd (Choe, Lee et al. 2005), an adaptor 
protein carrying a Death domain, which is commonly associated with proteins controlling 
apoptosis (Lemaitre, Kromer-Metzger et al. 1995). Interestingly, the second Imd-pathway-
associated receptor, PGRP-LE, has no Anopheles orthologue (preliminary data suggests that it 
might be present in A. aegypti). In contrast, intracellular components of the Imd pathway are 
highly conserved in Anopheles (Christophides, Zdobnov et al. 2002). 
Downstream of Imd, the pathway appears to fork into two parallel branches (Fig. 
1.6.1). One path involves the Drosophila homolog of the MAPKK (MAP-Kinase-Kinase) 
TAK1 and the mammalian I-κB kinase complex (IKK) (Silverman, Zhou et al. 2000). The 
complex phosphorylates the inhibitory carboxyterminal I-κB domain of Relish, the third 
member of the NF-κB  family of transcription factors, which acts similarly to the Toll 
pathway inhibitor Cactus, preventing the nuclear translocation of the transcription factor 
domain when the pathway is inactive (Dushay, Asling et al. 1996). This I-κB domain is thus 
marked for cleavage and subsequently degraded by the proteasome.  
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 The other path signals through the death domain carrying FADD to the caspase 
Dredd which proteolytically cleaves the I-κB domain of Relish, freeing the transcription 
factor to enters the nucleus. Whether phosphorylation of the I-κB domain precedes cleavage 
by Dredd is unclear (Stoven, Ando et al. 2000). Once inside the nucleus, Relish induces 
transcription of downstream effector genes such as AMPs.  
Orthologs in Anopheles have been identified in the genome for all the aforementioned 
genes (PGRPLC, IMD, IKK1, IKK2, REL2, CASPL1, TAK1, FADD) except for PGRP-LE, 
(Christophides, Zdobnov et al. 2002; Christophides, Vlachou et al. 2004) (Fig. 4.1.1). 
 
The intracellular components of the Anopheles IMD pathway. 
We examined the intracellular part of the IMD pathway in A. gambiae by RNAi. 
Silencing the receptor adaptor protein IMD resulted in reduction of survival after S. aureus 
(Gram+) infection, similar to the putative receptor PGRPLC. However, IMD KD appeared 
to have no effect when the mosquitoes were exposed to E. coli infection. These results could 
indicate that although PGRPLC may recognize both S. aureus and E. coli (or both Gram+ 
and Gram- bacteria), it only passes the signal through IMD in the case of Gram+ S. aureus, 
and that in the case of E. coli it either triggers a different signaling cascade or promotes 
bacterial phagocytosis which is independent of IMD. The fact that resistance to E. coli is 
mediated by a form of Relish (REL2-S; see below) that lacks the inhibitory I-κB domain 
supports the former hypothesis, although the latter hypothesis cannot be excluded. 
CASPL1, IKK1 and IKK2 are likely to also be part of the IMD pathway in Anopheles, as 
their KD resulted in reduced activation of a CEC1 reporter construct in cell lines, similar to 
that of IMD and REL2-F, although  silencing of CASPL1 and IKK1 or IKK2 surprisingly but 
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 consistently had opposite effects in the two cell lines. In Sua1B cells, KD of CASPL1 but 
not of IKK1 or IKK2 substantially reduced CEC1 promoter expression. In 4a3A cells, 
however, KD of IKK1 or IKK2 but not of CASPL1 reduced CEC1 promoter expression 
(Fig. 4.4.8).  
We used semiquantitative and quantitative RT-PCR to confirm silencing of the genes. 
Importantly, KD of IKK1 and IKK2 in Sua1B was highly effective, suggesting that these 
genes are not implicated in the regulation of CEC1 in Sua1B cells. KD of CASPL1 in the 
same cells was less effective (~40%) and, yet, associated with substantial reduction in CEC1 
activity. A plausible explanation that requires further investigation is that the pathway 
branches of IKK1/IKK2 and CASPL1 are alternative branches of the CEC1-activation 
pathway that are differentially active in these two cell types. Recent, preliminary results show 
that CEC1 activation following S. aureus infection is indeed mediated by PGRPLC.  
Thus, one would expect CASPL1 and IKK1/IKK2 to be situated downstream of IMD 
in the pathway, and only responsive to S. aureus. However, KD of CASPL1 in adult 
mosquitoes did not show any effect following S. aureus (or E. coli) infection. This result could 
suggest that either both branches of the pathway are needed or that CASPL1 is not 
important for resistance to S. aureus (IKK1 and IKK2 have not been tested). 
  
REL2 mediated defense against bacteria and malaria parasites. 
The transcription factor of the Drosophila Imd pathway is the NF-κB factor Relish 
(Dushay, Asling et al. 1996), and its ortholog in Anopheles is REL2 (Christophides, Zdobnov 
et al. 2002). However, there is a major difference between the two genes. REL2 produces 
two isoforms, a full length form, REL2-F, and a short form, REL2-S, which lacks the I-κB 
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 inhibitory domain. The REL2-F situation is a similar setup as with two (p52/p100; 
p50/p105) of the five mammalian NF-κB factors (Rel-A (p65), NF-kappaB1 (p50/p105), 
NF-kappaB2 (p52/p100), c-Rel and Rel-B (Ghosh, May et al. 1998)) that also produce 
proteins that carry their own Ankyrin (I-κB) domains. Furthermore, REL2-F and the 
mammalian p100/p52 and p105/p50, but not the Drosophila Relish, contain a death domain 
at their carboxy terminal, after the I-κB domain. This could imply a drastic difference in the 
transcription factor activation and thus the signaling events between the mosquito and the 
fly NF-κB pathways. It is noteworthy that the ortholog of REL2 in the mosquito A. aegypti 
has similar structural characteristics and is also able to produce two isoforms of the 
transcriptional activator, one with the I-κB and death domains and one without (Shin, 
Kokoza et al. 2002). 
 Indeed, our results reveal that the two forms of REL2 are differentially involved in 
defense against Gram+ and Gram- bacteria: REL2-F confers resistance to S. aureus 
infections and REL2-S to E. coli. In this way, the single mosquito gene REL2 mediates 
alternative immune responses, which, in the fruit fly require two genes: Relish and Dif. 
Interestingly, Dif is not present in the mosquitoes (Meister, Kanzok et al. 2005; Shin, 
Kokoza et al. 2005). Thus, in addition to the use of REL1, posttranscriptional processing of 
REL2 could be another strategy applied by Anopheles (and possibly Aedes) to compensate for 
the absence of Dif. 
In addition to compensating for the absence of Dif, this data could imply a major 
difference in the evolution of the NF-κB signaling pathways during the ~250 million years 
from the last common ancestor of Drosophila and Anopheles (Yeates and Wiegmann 1999; 
Gaunt and Miles 2002). On the one hand, the Anopheles PGRPLC, IMD and REL2-F are 
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 used for defense against the Gram+ bacterium S. aureus, whereas the orthologous and 
structurally similar cascade in the fruit fly is required for defense against Gram- bacteria. On 
the other hand, PGRPLC and REL2-S are responsible for defense against the Gram- 
bacterium E. coli, possibly through a different signaling cascade, as IMD is not involved in 
this reaction. REL2-S is structurally analogous to Dif and Dorsal which deal with fruit fly 
responses against Gram+ bacteria as none of them has an inhibitory I-κB domain. Together 
with our data about the mosquito REL1, the ortholog of Dorsal, which is discussed further 
below, these results may suggest that the function that the Toll pathway has in the Drosophila 
anti bacterial defense is likely to have been assumed by a different pathway of the mosquito, 
which derived from the original IMD pathway and involves PGRPLC and REL2-S, but not 
IMD.  
As discussed above, REL2-F, unlike its fly counterpart Relish but similar to 
orthologous genes in other higher eukaryotes, encodes a death domain located at the 
carboxyl terminus of the deduced protein. This domain might be used for oligomerization 
with the respective domain of IMD or other death domain-encoding proteins (such as 
CASPL1). Pertinent information is available from studies on the Relish gene of A. aegypti, the 
vector of yellow and dengue fever, which belongs to a different mosquito subfamily 
(Culicinae rather than Anophelinae). In addition to the two isoforms that are orthologous to the 
Anopheles REL2-F and REL2-S, the Aedes REL2 produces a third transcript that encodes a 
protein encompassing only the ANK and Death domain (Shin, Kokoza et al. 2002). It is 
pertinent to speculate that a similar REL2 protein form having is expressed in Anopheles, 
which we have missed in our analysis. In such a case, this protein could function as the 
inhibitor of the REL2-S nuclear translocation. As discussed also in the next chapter, we have 
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 shown that this role is not served by CACT, as one would expect since Cactus is the 
inhibitor of Dif and Dorsal in Drosophila.  
In Aedes, transgenic overexpression of a truncated version of the REL2-S homologue 
(C8), which lacks the putative glutamine- and histidine-rich transactivator domain, results in 
susceptibility to Gram- but not to Gram+ bacteria (Shin, Kokoza et al. 2003), similar to the 
results we obtained in Anopheles. However, additional studies are required to determine 
whether C8 indeed acts as a dominant negative allele of REL2-S, as suggested. In this case, 
our postulated change in pathway function between Anopheles and Drosophila would probably 
have occurred in the common ancestor of anopheline and culicine mosquitoes. In strong 
support of our hypothesis about the difference in immune pathways between mosquitoes 
and flies, more recent studies have shown that the Aedes orthologue of REL1 is not involved 
in defense against bacteria but only against fungal infections (Shin, Kokoza et al. 2005). 
Likewise, our results that are discussed below, indicate that the Anopheles REL2 may be the 
only NF-κB factor implicated in the antibacterial defense against E. coli and S. aureus and that 
REL1 has no role in these reactions. Our preliminary data implicates REL1 in anti fungal 
response. Thus, it is likely that the two mosquitoes use similar strategies to deal with 
infections. 
An important finding of our work is that the PGRPLC/IMD/REL2-F signaling 
cascade is involved in limiting the number of P. berghei oocysts that develop in the mosquito 
midgut. As discussed previously, this reaction could be due to activation of the pathway by 
bacteria residing in the mosquito gut. However, it is believed that the malaria parasite itself is 
able to elicit immune responses in the mosquito, since challenge of mosquito cell lines with 
P. berghei ookinetes under otherwise septic conditions leads to transcriptional activation of 
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 immunity genes (G.K. Christophides, personal communication), some of which are targets 
of the IMD pathway. Whether P. berghei is recognized by receptors of the IMD pathway (or 
PGRPLC itself) remains to be investigated. 
Nevertheless, the observed parasite killing through the PGRPLC/IMD/REL2-F 
pathway is thought to be the result of the transcriptional activation of effector genes that are 
targets of this pathway.  
A recent study has shown that ectopic overexpression of CEC1 drastically reduces 
susceptibility of mosquitoes to Plasmodium (Kim, Koo et al. 2004). Other REL2-regulated 
proteins (Table 4.4.4) that might explain the observed phenotype are Gambicin (GAM1), 
another AMP with anti-parasitic activity in vitro (Vizioli, Bulet et al. 2001), LRIM1, a key 
antagonist of ookinete-to-oocyst development (Osta, Christophides et al. 2004), and 
CLIPB14/B15, of which the KD also leads to an increase in parasite numbers (Volz, Osta et 
al. 2005). 
The silencing of PGRPLC and REL2-F also leads to melanization of some ookinetes 
during their passage through the Anopheles midgut epithelium. This melanization reaction is 
independent of IMD (melanization is not observed after IMD KD), pointing to an 
alternative signaling cascade. In Drosophila, the Imd pathway seems to regulate melanization 
upstream of Serpin27A (Takehana, Yano et al. 2004), which is an inhibitor of the final steps 
of prophenoloxidase activation and is controlled by the Toll pathway (Ligoxygakis, Pelte et 
al. 2002). 
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 5.3 THE A. GAMBIAE TOLL/ REL1 
PATHWAY 
 
Our results that far had shown that the IMD/REL2 pathway, but not the Toll/REL1, 
is involved in the mosquito defense to bacterial infections. The same pathway is used to 
control the numbers of P. berghei parasites that develop to oocysts on the mosquito midgut. 
In contrast, the REL1 pathway remains inactive during P. berghei infection and we had used 
REL1 as control in our experiments in cell lines and when we tried to determine whether 
CACT was the I-κB factor for REL2-S. The results made it apparent that REL1 played an 
important role in defense against Plasmodium and that we needed to conduct further 
experiments to examine the role of REL1 and the Toll pathway.  
Upstream of the Drosophila Toll pathway, the soluble PGN recognition protein PGRP-
SA (Michel, Reichhart et al. 2001) and GNBP1 (a β-1,3 glucan binding protein) (Pili-Floury, 
Leulier et al. 2004) act in concert to  recognize Gram+ bacteria and mediate activation of the 
pathway (Gottar, Gobert et al. 2002). Furthermore, another member of the GNBP family, 
GNBP3, was implicated in the recognition of fungi which also active the Toll pathway 
(Leclerc and Reichhart 2004). Upon bacterial and fungal recognition, the signal is conveyed 
to a proteolytic cascade, ultimately leading to cleavage of the cytokine-like polypeptide 
Spaetzle (Spz), which in turn binds to and activates the receptor activity of Toll (Lemaitre, 
Nicolas et al. 1996). Subsequent conformational changes of Toll result in the intracellular 
recruitment of at least three cytoplasmic proteins, MyD88, Tube and Pelle. The latter is a 
serine-threonine kinase believed to play an indirect role in the phosphorylation and 
subsequent proteolytic degradation of Cactus, a member of the I-κB family of proteins, that 
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 normally bind to and prevents nuclear translocation of the NF-κB  transcription factors, 
Dorsal and Dif. Whereas Dorsal is essential for developmental processes, Dif is mostly 
implicated in the transcription of AMPs through specific binding to cis-acting elements (κB) 
found in the promoter sequences of these genes.  
Orthologs of PGRP-SA (PGRPS1) and the intracellular signaling molecules (MYD, 
TUBE, PLL1) were found in Anopheles; however, no orthologs of Dif and GNBP1 were 
detected, and Toll forms an orthologous group together with four mosquito genes 
(TOLL1A, TOLL5A, TOLL1B, TOLL5B) (Christophides, Zdobnov et al. 2002; Luna, 
Wang et al. 2002).  
Our results suggest, that unlike in Drosophila, where the Toll pathway appears to be 
important for bacterial and fungal infections, the pathway might have a secondary role in 
defense against bacterial infections in Anopheles. Preliminary results suggest that the Anopheles 
Toll pathway may have a role in the antifungal defense, similar to the Drosophila Toll. 
Interestingly, Drosomycin, the prime anti-fungal peptide in Drosophila has no ortholog in 
Anopheles. 
The mosquito Toll pathway also appears to play an important role during infection 
with the malaria parasite Plasmodium. Our results suggest that the pathway either fails to be 
activated or is actively evaded by the parasite. The consequences of Toll pathway activation 
are lethal for the parasite as REL1 mediates effective killing of all P. berghei parasites by both 
lysis and melanization. This can be achieved by elimination of CACT, the suppressor of 
REL1 nuclear migration (see below). The implication of the Toll pathway in parasite 
melanization is not surprising, given that there is a direct link between the Toll pathway and 
melanization in Drosophila (Ligoxygakis, Pelte et al. 2002). 
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 We cannot comment at this point on the conservation of the intracellular signaling 
events between the Anopheles and the Drosophila Toll pathways, however, the transcriptional 
NF-κB activator appears to be conserved as REL1 is the ortholog of Dorsal.  
 
CACT is the I-κB inhibitor of REL1. 
The absence of an ortholog of the NF-κB-like transcription factor Dif in Anopheles may 
imply that in a putative Toll pathway, one of the other two Anopheles NF-κB-like proteins, 
REL1 (the Dorsal orthologue) or REL2 (the Relish orthologue), may substitute for the role of 
Dif. The Drosophila Dorsal has been mainly implicated in developmental processes (reviewed 
in (Belvin and Anderson 1996)), but recent reports suggested additional roles for Dorsal in 
immunity (Bettencourt, Asha et al. 2004). A third NF-κB gene with an RHD (Rel homology 
domain) and IPT/TIG transcriptional activation domain is present in the Anopheles genome 
(ENSANGG00000014870) and would certainly be another potential candidate. However, 
this gene has an ortholog (CG11172) in D. melanogaster that not much is known about other 
than that its structural characteristics. 
The inhibitor of nuclear migration of Dorsal and Dif is the I-κB protein Cactus which 
has a clear-cut ortholog in Anopheles, CACT. Thus it was expected that CACT would be the 
I-κB inhibitor of REL1. In addition, the fact that REL2-S is lacking the inhibitory Ankyrin 
repeats domain and serves some for the roles of the missing Dif makes it a likely candidate 
to also be inhibited by CACT.  
To detect the genetic relationship between CACT and REL1 or REL2-S, we used a 
powerful genetic tool that was revealed by silencing of CACT and subsequent infection with 
P. berghei. CACT KD mosquitoes are fully refractory to P. berghei infections: more than 80% 
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 of ookinete staged parasites are lysed, and the remaining 20% of parasites are melanized (Fig 
4.4.13). The effect of the CACT KD on P. berghei ookinetes suggests that a previously 
repressed antagonistic module of the malaria parasite was activated by the KD. It was thus 
expected that the double KD of CACT and this antagonist should rescue the wild-type (wt) 
phenotype, susceptibility to P. berghei parasite development.  
However, the double KD of CACT and REL2 produced the same refractory 
phenotype as the CACT KD did. In fact, the phenotype appeared aggravated as the parasite 
numbers were even more reduced (Fig 4.4.13). This suggested that nuclear translocation of 
REL2-S is not inhibited by CACT, but by a different I-κB protein, e.g. a third form of 
REL2, that has only the ANK domain as discussed in a previous section. In contrast, the 
double KD of CACT and REL1 was able to completely rescue the wt phenotype. Also, KD 
of REL1 alone had no significant effect on the malaria infection load of the midgut (Fig 
4.4.13). It thus appears likely that REL1 is the partner of CACT in A. gambiae; however, this 
signaling pathway remains silent during Plasmodium infection and REL1 is retained in the 
cytosol. As mentioned above, this latter circumstance may have its origin either in failure of 
pathway activation (absence or evasion of recognition by the parasite) or in active pathway 
suppression by the malaria parasite. 
Regulation of the melanization reaction is thought to be achieved through serpins 
(serine protease inhibitors), which act as suicide substrates of the PPO activating serine 
proteases (PPAEs) (De Gregorio, Han et al. 2002; Ligoxygakis, Pelte et al. 2002; Ligoxygakis, 
Pelte et al. 2002; Zhu, Wang et al. 2003). A proposed model in Drosophila is founded on a 
preactivation balance between the inhibitory serpin and the PPAE, which changes in favor 
of the PPAE upon Toll pathway activation (Ligoxygakis, Pelte et al. 2002; Ligoxygakis, Pelte 
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 et al. 2002). This model would explain why some parasites are melanized upon activation of 
the Toll pathway by KD of CACT and subsequent nuclear translocation of REL1. 
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 5.4 THE CURRENT WORKING MODEL OF 
ANOPHELES INNATE IMMUNE SIGNALLING. 
 
An updated view of the innate immune pathways in A. gambiae. 
The conclusions about signaling pathways from the work reported in this thesis are 
summarized in Figure 5.3.1. PGRPLC is the only PRR we know of at this time that signals to 
the innate immune pathways in A. gambiae. It mediates defense to both Gram- and Gram+ 
bacteria as the KD of PGRPLC results in reduced survival after bacterial challenge with 
either Gram-type.  
The intracellular signaling after infection with Gram+ (S. aureus) bacteria is likely to 
proceed through IMD. Essentially, the Imd pathway of Drosophila, which mediates defense 
against Gram- bacteria, seems to be intact and to have changed its recognition properties in 
Anopheles.. CASPL1, IKK1 and IKK2 appear to also be situated downstream of IMD in the 
mosquito, just like in the fruit fly. The signaling cascade going through IMD results in the 
activation of the NF-κB factor REL2-F whose KD leaves the mosquito defenseless to 
Gram+ (S. aureus) bacterial infections (Fig. 4.4.5a).  
At this time, it is unclear what the intracellular signaling events are in the case of a 
Gram- (E. coli) bacterial infection; however, the signal seems to activate the short form of 
REL2 (REL2-S). The I-κB factor that retains REL2-S in the cytosol also remains unknown 
unclear at this point (CACT is not involved in this reaction). It could be speculated that 
another isoform of REL2, carrying only the ANK domain may function as the inhibitor of 
REL2-S or that REL2-S in the cytosol exists as a dimer with REL2-F. Preliminary data 
- 153 - 
 reveals that the Toll/REL1 pathway is also involved in defense to fungal infections with B. 
bassiana.  
 
 
Fig 5.3.1 An updated view of the A. gambiae REL1 and REL2 innate immune pathways, 
based on the results reported in this thesis. Solid arrows signify direct interactions; 
dashed arrows represent unknown intermediate steps. 
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 The pathway of the PGRPLC/IMD/REL2-F genes appears to also be capable of 
conferring some resistance to Plasmodium infections as their KD can double the parasite load 
in a mosquito midgut. PGRPLC and REL2 also influence the expression of genes inhibiting 
the ookinete melanization reaction. Whether the signaling in response to Plasmodium involves 
CASPL1, IKK1 and IKK2 like in the case of Gram+ bacteria, was not tested, but seems 
likely.  
 
A working model for the defense of Anopheles against Plasmodium. 
Infection of A. gambiae with the rodent malaria parasite P. berghei can be responded to 
by both the Toll/REL1 and the IMD/REL2 pathway, which are capable of driving lysis of 
parasites before or during invasion of the mosquito midgut. Melanization of the Plasmodium 
ookinetes appears to be also positively controlled by the TOLL/REL1 pathway (Fig. 4.4.13), 
whereas the IMD/REL2 seems to negatively affect ookinete melanization. Although the 
REL2 pathway is a factor affecting the final number of parasites developing in the mosquito, 
the REL1 pathway either fails to be activated during infection is actively inhibited by the 
parasite. When integrating these results, we can construct a working model of the Anopheles 
defense against Plasmodium that is shown in Fig. 5.3.2. 
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Fig 5.3.2 A working model for the defense of A. gambiae against P. berghei. The green colored 
parasites represent live parasites, black parasites symbolized melanized parasites. The 7 green 
parasites in the center are the ones that will develop to the oocyst stage in naïve infected 
mosquitoes. The 15 parasites on the right are what we see after KD of PGRPLC/IMD/REL2 
and the one on the left is the picture presented to us after CACT KD.  
 
According to this working model, the PGRPLC/IMD/REL2 pathway kills and lyses 
about half of the initial parasite population and through an unknown mechanism inhibits 
parasite melanization. As discussed in previous sections, this lysis reaction could be a side-
effect of the pathway activation in response to the bacterial proliferation in the mosquito 
midgut after the blood meal. We do not know if the mosquito immune system is capable of 
directly recognizing the Plasmodium parasite, and if so, what receptor would mediate this 
recognition. 
The next step in Fig. 5.3.2 is generally suppressed in the mosquito, possibly by means 
of immune evasion by Plasmodium. This would not be unprecedented, e.g. another 
apicomplexan parasitic protozoa, Toxoplasma, inhibits the phosphorylation and thus the 
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 activation of NF-κB factors (Shapira, Harb et al. 2005). However, when the TOLL/REL1 
pathway is activated by KD of CACT all parasites are killed, about 80% of parasites are lysed 
and the remaining 20% are melanized. It may not be possible or desirable for the parasite to 
shut down/evade the IMD/REL2 pathway as well, as it may be needed to contain the strong 
bacterial growth in the mosquito midgut following a blood meal. Some of the AMPs 
secreted in response to these bacteria have however indeed been shown to harm the parasite 
(GAM1 (Vizioli, Bulet et al. 2001); CEC (Kim, Koo et al. 2004)). 
 
Microarray expression analysis of REL2 KD in cell lines revealed several target genes 
of this pathway.  Among these, was the major parasite antagonist LRIM1 and the AMP 
GAM1, which has been shown to have in vitro activity against Plasmodium (Vizioli, Bulet et 
al. 2001; Osta, Christophides et al. 2004).  
We have also done a whole mosquito REL2 KD microarray hybridization (Data not 
shown) and preliminary results indicate that among the genes down regulated after REL2 
KD are: GAM1 (Vizioli, Bulet et al. 2001), KIN1, CEC1, CEC3, CLIPB14 (Volz, Osta et al. 
2005), CLIPB15 (Volz, Osta et al. 2005), DEF1, LRIM1 (Osta, Christophides et al. 2004) – 
all of which have either been shown or are likely to reduce the ability of the parasite to 
survive in the mosquito. 
A similar preliminary microarray analysis of the KD of CACT in combination with 
KD of REL1 in the whole mosquito revealed numerous targets of the REL1 pathway: 
DEF1, CEC1, GAM1, Serine Proteases, KIN1, CLIPB15, TEP15, a GNBP, SOD, CLIPA3 
and a Lysozyme (Data not shown). These results, albeit preliminary, clearly show that there is 
extensive overlap in the regulated target genes of REL1 and REL2. The only genes specific 
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 to REL1 appear to be SOD and CLIPA3, while the only gene truly specific to REL2 
transcriptional activation seems to be LRIM1. 
Among the experiments to be done in the future would thus be the double KD of 
CACT and LRIM1. It will be interesting to see if LRIM1 is able to reverse the CACT KD 
phenotype, suggesting a fine interplay between the two pathways. Another would be the 
double KD of CTL4 and CACT or REL2, as it would be interesting to know if CTL4 is 
activated by the REL1 pathway and if the parasite killing following these KDs is cumulative 
and the mechanisms by which it is achieved is the same or distinct.  
Finally, another interesting experimental setup would be to co-infect malaria and a 
fungus. Assuming that the fungus is activating the TOLL/REL1 pathway and that the 
malaria parasite is evading or modulating the pathway activation, we would predict that 
mosquitoes infected with fungi became partially or completely refractory to malaria. 
 
In conclusion, our data suggests significant divergence of immune signaling between 
the A. gambiae mosquito and the fruit fly D. melanogaster. The documented differences most 
likely reflect their different lifestyles and, consequently, different infectious agents that the 
two insects encounter during their lifetimes. In mosquitoes, one of these agents is the 
malaria parasite Plasmodium. 
 
Perspectives. 
Our knowledge about the innate immune pathways to date almost exclusively derives 
from studies in D. melanogaster (reviewed in: (Hoffmann 2003)). The genetic tools available 
for Drosophila are by far superior to that of most other model organisms. However, this 
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 means that pathway information was for the most part obtained by creation of or screening 
for mutant flies and using a few genes as pathway readout: Diptericin for the Imd pathway and 
the antifungal gene Drosomycin for the Toll pathway. This relatively simple reductionist 
approach has revealed the hierarchy of genes in the pathways and is the origin of the 
convenient assignment of Gram- bacteria to the Imd pathway and Gram+ bacteria to the Toll 
pathway. Only slowly are studies published suggesting that these assignments might be an 
oversimplification and the situation is in fact more complicated. Rather than the Gram type 
of bacteria, the PGN type (Dap or Lys) seems to be the distinguishing factor for the two 
immune pathways and the upregulation of AMPs seems to be far less selective than was 
initially thought (Hedengren-Olcott, Olcott et al. 2004). It is noteworthy, that while the 
Gram+ genera Bacillus and Clostridium have the DAP type PGN (found in Gram- bacteria), 
the Lys type PGN is exclusively found in the rest of Gram+ bacteria. 
In order not to loose sight of the big picture, survival assays, like the ones used in this 
work, could prove to be very useful. Rather than sampling a single reporter gene, survival 
probability of the whole organism is recorded. We are aware that this approach might well 
lead to results different to the ones obtained in Drosophila; especially genes further 
downstream in the pathway might not prove to be as relevant for survival as crosstalk 
between the pathways might be able to compensate for the knock down. 
On the other hand – the effect of a knock down might be especially dramatic, the 
further up in the signaling chain it happens. This may explain why PGRPLC has a drastic 
effect on survival for both Gram types of bacteria, yet it was always only associated with the 
Imd pathway in Drosophila.  
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 It has been proposed that the function of the Toll pathway is mainly to deal with fungal 
infections. In fact, in Drosophila only the anti-fungal gene Drosomycin is exclusively activated 
by the Toll pathway – all other AMPs appear to be activated independently of the Gram type 
of the infecting bacteria (Hedengren-Olcott, Olcott et al. 2004). We were not able to record 
any effect on survival for the NF-κB transcriptional activator REL1 – the supposed 
functionally equivalent gene of Dif in Anopheles. This result reinforces the hypothesis that the 
Toll pathway’s main function is to deal with fungal infections, a hypothesis that is supported 
by a study conducted in the mosquito A. aegypti (Bian, Shin et al. 2005). 
A better and more sensitive indicator of the importance of a knocked down gene for 
innate immunity would probably have been bacterial survival and/or propagation in the 
mosquito instead of survival of the mosquito itself. Bacterial numbers in the mosquito could 
be recorded using bacterial strains with antibiotic resistances and smearing mosquitoes onto 
antibiotics treated agar plates after a certain time, or by performing RT-PCR on whole 
mosquitoes with primers targeting strain specific bacterial genes. 
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SUMMARY 
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 6.1 SUMMARY. 
 
Innate immunity is the first line of defense against invading microorganisms and 
provides clues to adaptive immunity for the development of memory for subsequent 
infections. Insects, similar to other invertebrates, do not have adaptive immunity and thus 
rely on their innate immune system to combat infections. We have analyzed the role of the 
peptidoglycan (PGN) receptor protein (PGRP) family and other components of innate 
immune signaling pathways in the immune defense of the mosquito Anopheles gambiae, the 
main vector of human malaria in sub-Saharan Africa. The PGRP gene family consists of 
seven genes with ten PGRP domains. We have shown that from all PGRP genes only 
PGRPLC has a role in the resistance to bacterial infections of both Gram types. In our 
experiments we have used the Gram-positive bacterium Staphylococcus aureus and the Gram-
negative bacterium Escherichia coli. The PGRPLC gene encodes at least three isoforms that 
derive from infection-driven alternative splicing of a pool of immature transcripts. Each 
isoform contains a different PGRP domain, encoded by three exons that all contribute 
equally to the PGN binding pocket. Structural modeling of the PGRPLC isoforms revealed a 
potential for all isoforms to bind both types of PGN, the Lys-type, which is mostly found in 
Gram-positive bacteria and the DAP-type, mostly found in Gram-negative bacteria. The 
isoform PGRPLC3 seems to be the most important in the defense against both bacteria 
species, although PGRPLC1 also has a crucial role in the defense against S. aureus. 
Bacterial defense is mediated by the NF-κB transcription factor REL2, which is the 
ortholog of the Drosophila Relish. The REL2 gene also encodes two protein isoforms: REL2-
S, which only has the NF-κB domain, and REL2-F, which carries an I-κB inhibitory domain 
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 and a death domain in addition. REL2-F functions together with the receptor adaptor 
protein IMD to deal with S. aureus infections, whereas REL2-S has a role in the defense 
against E. coli. The PGRPLC/IMD/REL2-F pathway (IMD) is also partly responsible for the 
losses of Plasmodium berghei, which can be observed during the first stages of malaria infection 
of A. gambiae. P. berghei is a rodent malaria parasite, which has been used as a model in our 
studies. Whether the pathway is able to recognize the malaria parasite through PGRPLC or 
another associated receptor is still unclear. Another possibility is that the pathway is activated 
by the proliferation of commensal bacteria in the mosquito gut following a blood meal. 
However, we have shown that more than one of the three main isoforms of PGRPLC are 
required for the reaction to P. berghei. Other PGRP genes, which  have been proven to play a 
role during infection with P. berghei,  are PGRPLA2, which also mediates parasite killing, and 
the almost identical and thus hardly indistinguishable PGRPS2 and S3, which appear to 
inhibit parasite killing. This is possibly achieved by negative regulation of the IMD pathway 
through sequestration of PGN, which derives from the commensal bacteria and 
constitutively activates the pathway.  
We have shown that REL1, the second NF-κB transcription factor of A. gambiae, 
which is orthologous to the Drosophila Dorsal (Dif does not exist in Anopheles), is not 
involved in the mosquito resistance to bacterial infections. This fact provides additional 
evidence that the REL2-associated pathways are of utmost importance in the A. gambiae 
defense to bacteria. In addition, REL1 has no role in the documented P. berghei killing. 
However, silencing of the REL1 inhibitor CACT (the ortholog of the Drosophila Cactus) 
during a parasite infection leads to a very strong refractoriness phenotype: most of the 
midgut-invading ookinetes are eliminated (presumably by lysis) and the remaining of the 
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 ookinetes are melanized. We thus assume that under wild-type infection conditions the 
parasite is either evading recognition by the REL1-associated receptors or actively 
modulating activation of REL1.  
In conclusion, the data reported in this PhD thesis suggest significant divergence of 
immune signaling between the mosquito A. gambiae and the fruit fly D. melanogaster. The 
observed differences most likely reflect their different lifestyles and, consequently, different 
infectious agents, which the two insects encountered during their evolutionary lifetimes. In 
mosquitoes one of these agents is the malaria parasite.  
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 6.2 ZUSAMMENFASSUNG. 
Angeborene Immunität ist die primäre Verteidigungsstrategie gegen eindringende 
Mikroorganismen und liefert dem adaptiven Immunsystem Signale für die Entwicklung von  
Gedächniszellen für  nachfolgende Infektionen. Ähnlich wie andere Invertebraten, verfügen 
Insekten nicht über eine adaptive Immunreaktion und verlassen sich deshalb voll auf ihr 
angeborenes Immunsystem, um Infektionen zu bekämpfen. Wir haben analysiert, welche  
Rolle die Familie der Peptidoglycan (PGN) Rezeptor Proteine (PGRP) und andere 
Komponenten der angeborenen Immunsignalkaskaden bei der Immunantwort des Moskitos 
Anopheles gambiae spielen. A. gambiae ist der Hauptüberträger  der  menschlichen Malaria im  
südlich der Sahara gelegenen Teil Afrikas. Die Genfamilie der PGRPs besteht aus sieben 
Genen mit zehn PGRP Domänen. Wir konnten zeigen, dass von allen PGRP Genen nur 
PGRPLC eine Rolle in der Verteidigung gegen bakterielle Infektionen, egal welchen 
Gramtyps, spielt. In unseren Experimenten haben wir das grampositive Bakterium 
Staphylococcus aureus und das gramnegative Bakterium Escherichia coli benutzt. Das PGRPLC 
Gen kodiert mindestens 3 Isoformen, die – je nach Infektion – aus einem Pool von unreifen 
Transkripten durch alternatives Splicing gebildet werden. Jede Isoform hat eine andere 
PGRP Domäne, welche jeweils von drei Exons kodiert wird, die alle gleich viel zur PGN 
Erkennungstasche beitragen. Strukturelle Modelle von PGRPLC zeigten, dass alle Isoformen 
dazu in der Lage sind, beide Arten von PGN zu binden, wobei die Lys-Form hauptsächlich 
in grampositiven Bakterien und die DAP-Form hauptsächlich in gramnegativen Bakterien 
vorkommt. Die PGRPLC3 Isoform scheint die wichtigste Rolle bei  der Verteidigung gegen 
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 die beiden bakteriellen Formen zu haben, obwohl PGRPLC1 auch eine wichtige Rolle bei  
der Verteidigung gegen S. aureus zu spielen scheint. 
Die Verteidigung gegen Bakterien wird von dem NF-κB Transkriptionsfaktor REL2 
bewerkstelligt, welcher das Ortholog des Drosophila Relish Gens ist. Das REL2 Gen kodiert 
zwei Protein Isoformen: REL2-S, das lediglich  die NF-κB Domäne hat, und REL2-F, das 
zusätzlich noch eine inhibierende I-κB und eine Death Domäne hat. REL2-F arbeitet mit 
dem Rezeptor-Adaptor Protein IMD zusammen, um S. aureus Infektionen zu bekämpfen, 
wogegen REL2-S eine Rolle in der Verteidigung gegen E. coli spielt. Die 
PGRPLC/IMD/REL2-F Signalkaskade (IMD) ist auch teilweise verantwortlich für die 
Verluste, die Plasmodium berghei,  ein Nager Malariaparasit, während der ersten Stadien der 
Malaria Infektion in A.gambiae erleidet. Dieser Malariaparasit ist  als Modelsystem für unsere 
Studien verwendet  worden. Ob die IMD Signalkaskade auch fähig ist, den Malariaparasiten 
direkt durch PGRPLC oder einen anderen beteiligten Rezeptor  zu erkennen, ist immer noch 
unklar. Nach einer Blutmahlzeit vermehren sich die residenten Bakterien im Moskitodarm. 
Es ist durchaus möglich, dass die Signalkaskade dadurch aktiviert wird. Unabhängig davon, 
konnten wir zeigen, dass mehr als eine der drei PGRPLC Isoformen benötigt werden, um 
eine Reaktion auf P. berghei hervorzurufen. Weitere PGRP Gene, die nachweislich eine Rolle 
während der Infektion mit P. berghei spielen, sind PGRPLA2 und PGRPS2 und S3. 
PGRPLA2 begünstigt den Kampf gegen den Parasiten, während PGRPS2 und S3, die 
nahezu identisch und deshalb kaum zu unterscheiden sind, den Kampf gegen den Parasiten 
zu behindern scheinen. Letzteres könnte durch Sequestration des PGN der residenten 
Bakterien erreicht werden, welches zu  einer Inhibierung der IMD Signalkaskade führen 
würde.  
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 Wir haben gezeigt, dass der zweite NF-κB Transkriptionsfaktor in A. gambiae, REL1, 
der ein Ortholog des Drosophila Dorsal ist (Dif existiert nicht in Anopheles), nicht in der 
Moskito Verteidigung gegen bakterielle Infektionen involviert ist. Dieser Umstand beweist 
noch einmal mehr, welche große Bedeutung den REL2 Signalkaskaden in A. gambiae im 
Kampf gegen die Bakterien zukommt. Zudem scheint REL1 keine Rolle in der Verteidigung 
gegen P. berghei zu spielen. Setzt man jedoch den REL1 Inhibitor  CACT (das Ortholog des 
Drosophila Cactus) während einer Malaria Infektion außer Kraft, so kommt es zu einem sehr 
stark refraktorischen Phenotypus: Die meisten der Ookineten, die versuchen in den Moskito 
Mitteldarm einzudringen, werden eliminiert (vermutlich lysiert) und die restlichen Ookineten 
werden melanisiert. Wir vermuten, dass unter den Bedingungen einer natürlich 
hervorgerufenen Infektion der Parasit entweder die Erkennung durch die Rezeptoren der 
REL1 Signalkaskade vermeidet oder aber gezielt  die Aktivierung von REL1 verhindert. 
Zusammenfassend lässt sich sagen, dass die Daten, die in dieser Doktorarbeit 
angeführt  werden, eine signifikante Abweichung der Signalkaskaden des Moskito A. gambiae 
von denen der Fruchtfliege D. melanogaster beschreiben. Die beobachteten Unterschiede  
lassen sich wahrscheinlich auf die unterschiedlichen Lebensumstände und infektiösen 
Organismen zurückführen, denen diese zwei Insekten während ihrer Evolution ausgesetzt 
waren. Für den Moskito war einer dieser Organismen der Malaria Parasit. 
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 4a r/r susceptible Anopheles gambiae strain 
aa amino acid 
AB antibody 
ANK Ankyrin-repeat domain 
bp base pair 
BSA bovine serum albumin 
CACT Anopheles gambiae Cactus ortholog 
CASPL1 Anopheles gambiae Caspase8/Dredd ortholog 
CDS coding sequence 
CLIPA clip domain serine protease A 
CNRS Centre National de la Recherche Scientifique 
CTL C-type Lectin 
CTLMA Mannose binding CTL 
Dap diaminopimelic acid 
DD Death Domain 
DNA deoxyribonucleic acid 
Dnr1 Drosophila melanogaster inhibitor of Dredd 
Dredd Drosophila melanogaster gene 
dsRNA double stranded ribonucleic acid 
EMBL European Molecular Biology Laboratory 
FADD Fas-associated death domain protein 
FCS fetal calf serum 
G3 wild type Anopheles gambiae strain 
GFP green fluorescent protein 
GNBP Gram-negative binding protein 
Gram+  Gram-positive bacteria 
Gram-  Gram-negative bacteria 
IMBC l’Institut de Biologie Moléculaire et Cellulaire 
Imd immune deficiency gene 
L3-5 refractory Anopheles gambiae strain 
LB medium Lysogeny Broth (not: Luria broth, Lennox broth, or Luria-Bertani 
medium) for bacterial growth 
LPS Lipopolysaccharide 
LRIM1 Anopheles gambiae gene leucine rich immune molecule 1 
Lys Lysine 
MACF EMBL Monoclonal Antibody Core Facility  
MDP  Muramyl Dipeptide 
ml milliliter  
µl  microliter 
NAG  β-1,4-linked N-Acetylglucosamine 
NAM N-Acetyl Muramic Acid  
NAMLAA N-acetylmuramoyl-L-alanine amidase 
Nec blood serpin Necrotic 
nl nanoliter 
NLS nuclear localization signal 
nt nucleotide 
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 ORF open reading frame 
ON over night 
PAMP pathogen associated molecular pattern 
PBS Phosphate buffered saline 
PCR polymerase chain reaction 
PGN Peptidoglycan 
PGRP Peptidoglycan Recognition Protein 
PO Phenoloxidase 
PPO Prophenoloxidase 
PPAE PPO activating enzyme 
PRR pattern recognition receptor 
Psh Persephone protease 
REL1 Anopheles gambiae dorsal ortholog 
REL2 Anopheles gambiae relish ortholog 
RHD Relish homology domain 
RNA ribonucleic acid 
RNAi RNA interference 
RT room temperature 
seml semmelweis mutation of PGRP-SA 
serpin serine protease inhibitor 
siRNA small interfering RNA 
SOB  Super Optimal Broth (bacterial growth medium) 
SOC Super Optimal Catobolite Repression (SOB medium with added glucose) 
SOD Superoxide Dismutase 
Spz Spaetzle gene 
TAK1 Anopheles gambiae TAK1 ortholog 
TEP Thioester-containing protein 
wt wild-type 
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 9.1 PRIMER SEQUENCES 
 
Table 9.1.1. Sequences of primers used. 
# Gene Primer Name Primer Sequence (5’-3’) 
Amplicon 
Size 
Remarks 
9.1.1 AgS7 qRT-PCR F GTGCGCGAGTTGGAGAAGA 300nM for qRT-PCR 
9.1.2 
S7 
AgS7 qRT-PCR R ATCGGTTTGGGCAGAATGC 
78 bp 
900nM for qRT-PCR 
9.1.3 N/A T7-d(T)24 GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG(T)24   
9.1.4 S7-A GGCGATCATCATCTACGTGC 
9.1.5 S7 S7-B GTAGCTGCTGCAAACTTCGG 460 bp 
semiquantitative 
RT-PCR primers 
9.1.6 PGRPS2&3 Exp25.1-F 
GAATTAATACGACTCACTATAGGG AGA 
ACAACTTCCTGGTCGGTGAG  w/ T7 overhang 
9.1.7 PGRPS2 Exp25.2-R GAATTAATACGACTCACTATAGGG AGA TCACCTGTCACAATGGTCGT 533 bp w/ T7 overhang 
9.1.8 PGRPS3 Exp25.3-R GAATTAATACGACTCACTATAGGG AGA CCCCACATTAAGCTACGTTTC 423 bp w/ T7 overhang 
9.1.9 PGRPLC1-Forw AAACCACACCAACTACGGTGA 
9.1.10 PGRPLC1 PGRPLC1-Rev AATGTGGCAAAAGCCTCAG 
323 bp (+89 
bp intron) 
semiquantitative 
RT-PCR primers 
9.1.11 PGRPLC2-Forw ATGGATGGCAAAAACTACGAC 
9.1.12 PGRPLC2 PGRPLC2-Rev CAGTGCTTCGATTAGCCACTT 
309 bp (+100 
bp intron) 
semiquantitative 
RT-PCR primers 
9.1.13 PGRPLC3-Forw TTTAGCGACATTGCGTATCA 
9.1.14 PGRPLC3 PGRPLC3-Rev GGAAGTCATCAAGGACACTTGG 
431 bp(+63 
bp intron) 
semiquantitative 
RT-PCR primers 
9.1.15 PGRP-LC1-AB-F AAAGTTGGAGCCCACACCAAA 
9.1.16 PGRPLC1 PGRP-LC1-AB-R CAAAAGCCTCAGCTGTTC 
234 bp, 
78 aa for AB production 
9.1.17 PGRP-LC2-AB-F ACCATTCCCGGTTACAATTC 
9.1.18 PGRPLC2 PGRP-LC2-AB-R CAAGCTGTGCAGTGCTTCGAT 
222 bp, 
74 aa for AB production 
9.1.19 PGRP-LC3-AB-F AAAGGGTTCAACGTGGACAGC 
9.1.20 PGRPLC3 PGRP-LC3-AB-R TCGTCGGTTTGTGGTGTCGTT 
282 bp, 
94 aa for AB production 
9.1.21 PGRP-S1-AB-F GCCCAGGACGAGCCGGCCCAG 
9.1.22 PGRPS1 PGRP-S1-AB-R GTCAAGCTCTTGCAGCTTCG 510 bp, 170aa for AB production 
9.1.23 PGRP-LA1-AB-F CTCGGCAACAGCCACATGATC 
9.1.24 PGRPLA1 PGRP-LA1-AB-R TCTAACCTGTCTTCGTGCCACAAGC 438 bp, 146aa for AB production 
9.1.25 PGRP-LA2-AB-F CTCGGCAACGGGCACATGGTC 
9.1.26 PGRPLA2 PGRP-LA2-AB-R TCGATGTGCGACGATTTTGTAG 
429 bp, 
143aa for AB production 
9.1.27 PGRP-LB-AB-F CCGGTGCCCTACGTGACGCGA 
9.1.28 PGRPLB PGRP-LB-AB-R TTTGATCTCCTCGAACAGCCG 477 bp, 159aa for AB production 
9.1.29 PGRP-LD-AB-F CCGTTCTTTTTGGTCGAGCG 
9.1.30 PGRPLD PGRP-LD-AB-R ATCGCTCCAGCTGACTGTAC 487 bp, 162aa for AB production 
9.1.31 PGRP-2-AB forward CGCATCGTGACCCGCGCCCAG 
9.1.32 
PGRPS2 
& 
PGRPS3 PGRP-2-AB reverse GCGCGGCCAGGTGCGGATCTC 
480 bp, 
160 aa 
for AB production of 
both S2 & S3 
9.1.33 PGRPLC-RTPCR-Forward CCGGTTAATAACGTCATCATTGC  900nM for qRT-PCR 
9.1.34 Exp48.50 TCACCGTAGTTGGTGTGGTT 119 bp 900nM for qRT-PCR (LC1 Reverse) 
9.1.35 Exp48.51 CGTCGTAGTTTTTGCCATCC 118 bp 900nM for qRT-PCR (LC2 Reverse) 
9.1.36 
PGRPLC; 
qRT-PCR 
primers 
Exp48.52 TCGGGACTCGAATGAAACTC 107 bp 900nM for qRT-PCR (LC3 Reverse) 
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 9.1.37 PGRPLC-dom-F CCCATGGGT CCAGATCCGAGACCGTTACGG  whole PGRP domain, with 5’NcoI overhang
9.1.38 PGRPLC1-dom-R GGAATTCCC AAAATGTGGCAAAAGCCTCA 507bp, 169aa 5’ EcoRI overhang 
9.1.39 PGRPLC2-dom-R GGAATTCCC AAACTGGGGCAAGCTGTGCAG 508bp, 169aa 5’ EcoRI overhang 
9.1.40 
PGRPLC; 
whole 
PGRP 
domains 
PGRPLC3-dom-R GGAATTCCC CCAGTGGGGCCAAGTTTTGATG 510bp, 170aa 5’ EcoRI overhang 
9.1.41 M13/pUC-Forward CGCCAGGGTTTTCCCAGTCACGAC 
9.1.42 M13/pUC-Reverse AGCGGATAACAATTTCACACAGGA 
9.1.43 SP6 Promoter CATACGATTTAGGTGACACTATAG 
9.1.44 T7 Promoter 20mer TAATACGACTCACTATAGGG 
9.1.45 
N/A 
T3 Promoter 23mer GCAATTAACCCTCACTAAAGGGA 
N/A plasmid sequencing (pLL10 etc) 
9.1.46 GFP-T7-Forward TAATACGACTCACTATAGGG CAAGACACGTGCTGAAGTCAA 
9.1.47 
GFP 
GFP-T7-Reverse TAATACGACTCACTATAGGG GCCTGAATTTAACCAGGAACC 
~450 bp w/ T7 overhang, for RNAi 
9.1.48 LacZ-T7-Forward TAATACGACTCACTATAGGG AGAATCCGACGGGTTGTTACT 
9.1.49 
LacZ 
LacZ-T7-Reverse TAATACGACTCACTATAGGG CACCACGCTCATCGATAATTT 
~550 bp w/ T7 overhang, for RNAi 
9.1.50 CASPL1-T7-F TAATACGACTCACTATAGGG TATGCGCTGCAAATTCTCAC 
9.1.51 
CASPL1 
CASPL1-T7-R TAATACGACTCACTATAGGG CGGACTGTTTCAAACCCAAC 
~400 bp w/ T7 overhang, for RNAi 
9.1.52 Exp9-F TAATACGACTCACTATAGGG TACCCTTCTGGACGAACTGC 
9.1.53 
DEF1 
Exp9-R TAATACGACTCACTATAGGG CTTCCCAGGATGCTAAGCTG 
240 bp w/ T7 overhang, for RNAi 
9.1.54 Exp1-F AACCGGAATTC AAGCAAACGTCATTCTGAGAGTC 5’ EcoRI overhang 
9.1.55 PGRPS1 Exp1-R ACTAGTCTAGA GCCTTTTGCAAGTAGAGAGCA 689 bp 5’ XbaI overhang 
9.1.56 Exp13-F GAATTAATACGACTCACTATAGGG AGA AATCCGACGCAACGATACG 
9.1.57 
REL2 
Exp13-R GAATTAATACGACTCACTATAGGG AGA GACCGCAATGTGAAGGATG 
427 bp 
REL2-ANK domain, 
w/ T7 overhang for 
RNAi 
9.1.58 Exp 18-F GAATTAATACGACTCACTATAGGG AGA CGAACCTCAGCAATGGAGTAG 
9.1.59 
REL2-B-
Form Exp 18-R GAATTAATACGACTCACTATAGGG AGA CTCTGCAAGTGTTAAAAACAGTGA 
90 bp 
targeting exon of 
REL2-B form, w/ 
T7 overhang for 
RNAi 
9.1.60 PGRPLC RTPCR F CACGCACCTGGCAATCTAGTCT 
9.1.61 PGRPLC PGRPLC RTPCR R TGGCACACAGGACAATCATCA 96 bp qRT-PCR primers 
9.1.62 Exp20-For GAATTAATACGACTCACTATAGGG TTTACCAGCTGATTGCTCAGG 
9.1.63 
Dnr1, 
Dredd 
inhibitor Exp20-Rev GAATTAATACGACTCACTATAGGG CTTCAGCTCCACGTACGTCTC 
314 bp 
w/ T7 overhang, 
for RNAi; 
ENSANGG000000
15649 
9.1.64 2nd IMD RT-PCR F TCGCAAATGATGCAGAGCC 900nM for qRT-PCR 
9.1.65 IMD 2nd IMD RT-PCR R AAATGGCGCGACACCGTAT 65 bp 900nM for qRT-PCR 
9.1.66 Exp31-CACT-F GAATTAATACGACTCACTATAGGG AGA GTCCGCTCTACACATCAGCA 
9.1.67 
CACT 
Exp31-CACT-R GAATTAATACGACTCACTATAGGG AGA CCGTTCGGGTTAATGATGAC 
318 bp w/ T7 overhang, for RNAi 
9.1.68 Exp31-REL1-F GAATTAATACGACTCACTATAGGG AGA ATCAACAGCACGACGATGAG 
9.1.69 
REL1 
Exp31-REL1-R GAATTAATACGACTCACTATAGGG AGA TCGAAAAAGCGCACCTTAAT 
386 bp w/ T7 overhang, for RNAi 
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 9.1.70 Exp46-PGRPS1-F GAATTAATACGACTCACTATAGGG AGA GGACGAGCCGGCCCAGGAATC 
9.1.71 
PGRPS1 
Exp46-PGRPS1-R GAATTAATACGACTCACTATAGGG AGA CAGCTTCGCGTACAGATAC 
493 bp 
w/ T7 overhang, 
for RNAi ; same as 
MMC2 primers 
9.1.72 Exp45-PGRPLD-F GAATTAATACGACTCACTATAGGG AGA GACTCGGAGGATTGTCTGGA 
9.1.73 
PGRPLD 
Exp45-PGRPLD-R GAATTAATACGACTCACTATAGGG AGA CGGATCGACTCGGTGATAAA 
281 bp w/ T7 overhang, for RNAi 
9.1.74 Exp45-PGRPLB-F GAATTAATACGACTCACTATAGGG AGA CCATCCCGTACGTCATCATA 
9.1.75 
PGRPLB 
Exp45-PGRPLB-R GAATTAATACGACTCACTATAGGG AGA ATGTTCTTCGGTGGCAAATC 
274 bp w/ T7 overhang, for RNAi 
9.1.76 Exp45-PGRPLA1-F GAATTAATACGACTCACTATAGGG AGA CCGACATTCCAAGCAACTTT 
9.1.77 
PGRPLA1 
Exp45-PGRPLA1-R GAATTAATACGACTCACTATAGGG AGA ACCAGCCTAGCGTACAGCAT 
280 bp w/ T7 overhang, for RNAi 
9.1.78 Exp45-PGRPLA2-F GAATTAATACGACTCACTATAGGG AGA TGCTGATAACGCACATAGGC 
9.1.79 
PGRPLA2 
Exp45-PGRPLA2-R GAATTAATACGACTCACTATAGGG AGA TTGCTCGGTATGTCTTGCAG 
124 bp w/ T7 overhang, for RNAi 
9.1.80 Exp34-RT-REL2-For ACCGATACGGAAAGTGTGCT 300nM for qRT-PCR 
9.1.81 REL2-S Exp34-REL2-S-Rev CGGTGCTCCTCGTAATGACT 228 bp 300nM for qRT-PCR 
9.1.82 Exp34-RT-REL2-For as above 900nM for qRT-PCR 
9.1.83 REL2-F Exp34-REL2-F-Rev GTATCGTTGCGTCGGATTG 215 bp 300nM for qRT-PCR 
9.1.84 Dev-REL2-F-For AATCCGACGCAACGATACG 
9.1.85 REL2-F Dev-REL2-F-Rev CATCCTTCACATTGCGG  
9.1.86 Dev-REL2-S-For ACCGATACGGAAAGTGTGCTGGGACGGGC 
9.1.87 REL2-S Dev-REL2-S-Rev CAATGGAGTAGTCATTACGAGGAG  
primers for 
developmental 
profile(Meister, 
Kanzok et al. 2005) 
9.1.88 KIN1-Promoter-F CGAGCTCG GCAAAGGAATTATCCGGTGA 5’ SacI overhang 
9.1.89 KIN1 KIN1-Promoter-R GAAGATCTTC GTTCAGCTCTGGATCGCACT  5’ BglII overhang 
9.1.90 IMD-KD-F GAATTAATACGACTCACTATAGGG AGA GGGAATTTCCCAAATGGTGTG 
9.1.91 
IMD 
IMD-KD-R GAATTAATACGACTCACTATAGGG AGA TGTGTAGATTGCTCGCGTTC 
229 bp w/ T7 overhang, for RNAi; (reorder)
9.1.92 ENSANGT00000020234R6920 AGCCCCAACAATATG AGCGAGCCGCATCTGG 
9.1.93 
REL2 ENSANGT000000202
34S6920 CTACTCAGTCAACGG TACGGCCGCCTCCTTCT 
 
MMC2-Primer, 
Plate 4, Row 1, 
Column 3 
9.1.94 ENSANGT00000013041R6542 
AGCCCCAACAATATG 
AATATCTATCTCGCGAACAATAA 
9.1.95 
LRIM1 ENSANGT000000130
41S6542 TCAGATTAGCTCAGT TGGCACGGTACACTCTTCC 
 
MMC2-Primer, 
Plate 2, Row 4, 
Column 11 
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 9.2 NUCLEOTIDE SEQUENCES  
 
>Seq. 9.2.1 PGRPS1 
ATGATGCTGTTCGGAGGCATTTTACCGTATCTGCTTGTGCTATGGCAGCTACTGGCTTCGGTCGATGATTT
GTTGCATATTCTAGTCGCCCGGGCCCAGGACGAGCCGGCCCAGGAATCCGCCTGCCCAGCCATCGTGAAGC
GGGCGGCCTGGGGTGCAGCCAAGTCGAAGAACGTCACCTACCAGCTGAAACCGGTCGCGAACGTGATCGTG
CACCATACGACCGGGGAGCGGTGCGCGACAGTGGCCACCTGCAAGGAGATGGTGGCAAACATACAGACCTA
CCACCAGACCGACAACCGGTGGAGTGACATCGGCTACAACTTCCTAATCAGCGGGCAGAATGTGTACGAGG
GCATCGGCTGGCACCGGATGGGGGCGCATCTGCGCGGCTACAACGACAAATCGATCGGCGTCGCCTTCCTG
GGCAACTTTGACCAAGAGCGGCCGACCCCCCGCAGCCTCAACCTGCTTGCCCGGCTACTCCAGTGCGGTGT
CGAGCTGGGCGAGCTAGCCGACGACTACCGGCTGTACGGTGCCCGCCAGCTCCAGAGCACCAACAGCCCGG
GCCGGTATCTGTACGCGAAGCTGCAAGAGCTTGACCACTGGCAGGCGCAA 
 
>Seq. 9.2.2 PGRPS2 (ENSANGP00000012978/agCP5898) 
ATGAACAAGTTCGCGACCGTTCTGGTGCTGGCCAGCATCTGTCTGGCGGGCGTTTCGGCCCAGTGCCCGCG
CATCGTGACCCGCGCCCAGTGGGGAGCCCGTGCCGCCAGCACCTCGCAGCTGCCGATCCGTCCGGCCCCGT
GGGTCGTGATGCACCATACGGCCGGTGCGTCCTGCACGACCGATGCGGCCTGCGCCCAGCAGATGCGCAAC
ATCCAGTCCTTCCACATGGACGGCAACGGCTGGGCTGACATTGGCTACAACTTCCTGGTCGGTGAGAACGG
TGCGGCCTACGAGGGACGCGGCTGGGGCCGCCAGGGCGCTCACGCTCCCGGCTACAACGATCGCTCGGTCG
GCATGGGCGTGATCGGCACGTTCACCAACGCCATCCCGAATGCGGCCGCCCGTACCGCAGCCCGTAACCTG
ATCACCTGCGGTGTGTCGCTCGGCCACATTGCCTCGAACTACTGGCTGATTGGACATCGTCAGGCCGTCGC
CACCGCCTGCCCGGGCAATGCGTTCTTCAACGAGATCCGCACCTGGCCGCGCTTCAACCCGAACGTG 
 
>Seq. 9.2.3 PGRPS3 (ENSANGP00000012979/agCP5906) 
ATGAACAAGTTCGCGACCGTTCTGGTGCTGGCCAGCATCTGCCTGGCGGGCGTTTCGGCCCAGTGCCCGCG
CATCGTGACCCGCGCCCAGTGGGGAGCCCGTGCCGCCAACACCGCCCAGCTGCCGATCCGTCCGGCCCCGT
GGGTCGTGATGCACCATACGGCCGGTGCGGCCTGCACGACCGATGCGGCCTGCGCCCAGCAGATGCGCAAC
ATCCAGTCCTTCCACATGGACGGCAACGGCTGGGCTGACATTGGCTACAACTTCCTGGTCGGTGAGAACGG
TGCGGCGTACGAGGGACGCGGCTGGGGCCGCCAGGGCGCTCACGCTCCCGGCTACAACGATCGCTCGGTCG
GCATGGGCGTGATTGGCACGTTCACCAACGGCATCCCGAATGCGGCCGCCCGCAACGCTGCCCAGCAGCTG
ATCAGCTGTGGTGTGTCGCTCGGCCACATTGCCTCGAACTACTGGCTGATCGGACATCGTCAGGCCGTTGC
CACTGCCTGCCCCGGAAATGCCTTCTTCAACGAGATCCGAAACTGGCCGCGCTTCAACCCGAACGTG 
 
>Seq. 9.2.4 PGRPLA1 partial CDS 
ATGGCCACGAACCATCAGAATGGGCTCAGCACTGGCAATGGCGGAAATACGACCGTGCAACCGGCGGCCAC
AAGCGTCATCAATCTGTCGAACTCCAGCGACGTCGTCATTGGCCCGATGACACAGTACCAAGGTTCCGTTA
CTATCTACCAGTACATGGATGCGACCGTCGAAGCTAGCCGAATTGCAAGTAAGTTTCCGCTTCCTATGCGT
AGCAGGAGCTTGACTGAATTTTATGACCTCGTCTTCCCATCGCACCTTTCCTTTCCTACAGCCGGCCGCAA
CAATCAGAACCGCGGACTACCTTCAGCGGAACCATCGACCCTGCGTCAGGAGCGCTACTTCATTTACGGAG
CGCTGATATTTTTCGCGATCGTCGGATTCTCAACCGCCATCTACTTCATCGTGAACCAGGTGCGCGGTCCA
GCTGACATTGACCGGGAGATACTGTTCGACACCAACTACCACCGGCGGACGATGCCCAATCTCGGCAACAG
CCACATGATCATCGAACGGCGTAACTGGGGTTCGCAGCTAGATGCGCACGCATCGATCCAATTGGAGCATC
CGGTTCAGTACGTGATCGTTACGCACATCGGCCTGCGCTCCAAAAATTGCACCGGCATGCACGAATGTGCG
AACAGGATGCGCATGCTACAGGATGCAGCCATCGGTGAGCGGAATCTGCCCGACATTCCAAGCAACTTTTA
TCTTGGTGGAGATGGCAACGTGTACGTGGGCCGTGGTTGGGATATTGCAAATTCGTATCACAATCGAACAC
TGTCCGTCTGCTTCATAGGAGACTTCCAAACCTACGAACCGAAAGAATCTCAATTCTCCGCCTTGCACCAT
CTCCTGACGTACGGTGTGATACAGCGAAAGCTTGCCAGCGACTATAAGCTTGTGGCACGAAGACAGACCAA
ACCTACCACAGCCAGCCCTGGCGACATGCTGTACGCTAGGCTGGTTAGACTATCCCGGTGGAATCCTTGTG
GAACGCAAGCATACGCACACTGTGGGGCCGAATTGGGCTTTCCGAGCGTTTGGGACGATGAGCACGATTTC
AATGAGCGGAACGGAATTCATAACCCATTGTTAATTCATCGGAAAAGCACAGAAGAAGAA 
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 >Seq. 9.2.5 PGRPLA2 (ENSANGG00000007842/agCP15114) 
ATGGCCACGAACCATCAGAATGGGCTCAGCACTGGCAATGGCGGAAATACGACCGTGCAACCGGCGGCCAC
AAGCGTCATCAATCTGTCGAACTCCAGCGACGTCGTCATTGGCCCGATGACACAGTACCAAGGTTCCGTTA
CTATCTACCAGTACATGGATGCGACCGTCGAAGCTAGCCGAATTGCAATTCCCAATCTCGGCAACGGGCAC
ATGGTCATCGATCGCCACAACTGGGGTGCACAGCAGGGTGTACATGGACCGTACAAGCTGCCACATCCCAT
TCCGTACGTGCTGATAACGCACATAGGCGTCCACTCGGAAATCTGCTCCGATGTGCACGTTTGCTCCATCA
AGATGCGCACGCTGCAAGATGCAGCAATTGCCGAGAAAAGTCTGCAAGACATACCGAGCAATTTTTATGTC
GGTGGGGACGGAAACGTTTACGTTGGTCGTGGATGGGATACGGCCAATGCGTACGCTAATATGTCACTGGC
CGTGTGCTTCATGGGCGATTACGGGCGGTATGAACCGAACGATCTTCAGCTTTCAGCACTGGACCATCTAT
TGACGTTCGGCGAGAAACACCGCCTTTTAACGGAAGACTACAAAATCGTCGCACATCGACAGGCACGAACT
ACACGCAGTCCTGGGATAAAACTGTACGAGAAAATAACGAAACTCACGCGATGGTACCCGTGCGGACTACC
AGGTTACGCAAAGTGTGGCGTCGAAATAGGCCTACCAACAGTCTGGGATCAAGAATACCCAAAATCGATCC
CTACAATAGTTCCGAATGCTAGTGCTAATAGTACTCAAACCAAT 
 
>Seq. 9.2.6 PGRPLB transcript 1 (ENSANGT00000013948) 
CGTCCGCCACAGTATCATTTCAACCTGCGCCGGAGCCATCCGCGATAATAAGTGCGCGTACTTGAGTGCGT
ACCACCGACCAGTTGTGCGCCATCCCGTGCCGAACAAAAACAATACGTTTCGCGTTTCCACGCTATCAACA
ATCGCGTCGAGACCACGCGCGACACTGCTCTCTGTACGCAAATAATTCGATCGAGTGGGGCTGCTCTTTGG
GTTGCGTTGTCAAGCTCACGCGCAGGCTACTAGATACCGCACCTGCAGACAGACATGAAAGTGCAATCGGT
AACCTTCCCGTGGTTCTTATCCCGACAGTAGTGACAGTGATTTATTTGCTGAACGCACCAACGCACACAAC
ACCGTACAACAAATTCCTCACGAAAATACTGCTTATAAAAAAACTCCAGTGGCGGTGAGGAGAAAGATTGT
CCAAGAAGCGATTTCGGAACGGTTTAACGCAGAAGTTAGTGCACTAAATTATTGCAACAAAATGGACTTTG
TGAAAGACTTTTGTTACTACTTCGGCGTCATAGCATTTACCCTATTTTACGTTGCGGTTGATAGTAAAGCA
TGTGACCCGGTGCCCTACGTGACGCGAGACTTTTGGAGTGCTCTGCCACCGAAACGGATCGAACACTTCGC
CGGTCCCATCCCGTACGTCATCATACATCATTCGTACCGGCCGGCGGCATGCTACAACGGGCTGCAGTGCA
TCGCGGCAATGCAATCGATGCAGAAGATGCACCAGGACGAGCGCCAGTGGAACGACATCGGGTACAGCTTT
GCGGTCGGTGGCGACGGGCACGTGTACCAGGGCCGGGGATTCAATGTGATTGGCGCTCATGCGCCCCGATA
CAACAACCGCAGCGTTGGGATCTGTCTGATCGGTGATTGGGTTGCGGATTTGCCACCGAAGAACATGCTCA
CGGCCGCCCAAAACCTCATCGAGTATGGTGTCCGGAATGGGCTGATTGCACAGAACTACACCTTGCTGGGG
CATCGGCAGGTACGCACGACCGAATGTCCGGGCGATCGGCTGTTCGAGGAGATCAAAACCTGGCCCCATTT
CGATCCGATGACGGACATTGTCGATCAGAACAGTGTTTGACAGTGGCGAACGGAACCGGCCCCTACATGCT
ACAAGTATTGAAGAAACTCTTAAATAGCTTATTAACGTGCGCTACCTCTCCTTTGCATACGGTAACCATCA
TGTTCCTAAAGTGTGTGTTTTTTTTTTTTGGAATAAAACCATTCAAAACA 
 
>Seq. 9.2.7 PGRPLB transcript 2 (ENSANGT00000024009) 
ATGAATTTCTTATCACTGAAATACCATTTACGTTGGCAAACAGCTGACCAAACATTAGATTACAAATTGGC
AGTACGTTGTTGTGTTTACTTCCAGCTACTGCCCCCGGTAGTTTACTCAAATGCCCGCATATTAAGAGCCT
ACTGCCAGTTGGACAGTTTAATCATGATCGTGTACGTGATCGTGATCATTGCTTCCGTCATTCAGCTGCAT
GCTGCAGTCATTCGTGATGCGGTAATGGAACTTTTCCCCTTTTCCGACGATTCCGATACTACTACTGCACC
AACAATGACGTACGGTGCAAACCCGGTGCCCTACGTGACGCGAGACTTTTGGAGTGCTCTGCCACCGAAAC
GGATCGAACACTTCGCCGGTCCCATCCCGTACGTCATCATACATCATTCGTACCGGCCGGCGGCATGCTAC
AACGGGCTGCAGTGCATCGCGGCAATGCAATCGATGCAGAAGATGCACCAGGACGAGCGCCAGTGGAACGA
CATCGGGTACAGCTTTGCGGTCGGTGGCGACGGGCACGTGTACCAGGGCCGGGGATTCAATGTGATTGGCG
CTCATGCGCCCCGATACAACAACCGCAGCGTTGGGATCTGTCTGATCGGTGATTGGGTTGCGGATTTGCCA
CCGAAGAACATGCTCACGGCCGCCCAAAACCTCATCGAGTATGGTGTCCGGAATGGGCTGATTGCACAGAA
CTACACCTTGCTGGGGCATCGGCAGGTACGCACGACCGAATGTCCGGGCGATCGGCTGTTCGAGGAGATCA
AAACCTGGCCCCATTTCGATCCGATGACGGACATTGTCGATCAGAACAGTGTTT 
 
>Seq. 9.2.8 PGRPLC1 partial CDS 
GTGAACGCATACGCAACGATTCGGTCATCGCCTCACCGTCATCGGGCCCATCCAGTACGCGCCCATCAAAA
CGGGAAGTCCGTGTTCAGGAATTATACAAGAAAAAAACTTCTTTTCTTGCTAGACAAAGCGTGTTACCACA
GCAACACACTTCCAAGAACGAGAATCTGTAATCTGTGTATTCCTGTTGGTGGAGGAAAAGCAGAGACTGGA
GCTACTGCGAGGCTAAGATGTCTCTCAACACTTCCGTGAGATAAAGAATAGCCACACTACAAACACAAACA
AACGGAAGCTTTCGGAGATACTTGCAAGTCGTGTGACTGTGACAGTGCCCGTTGCAGCAGTAAACGAAACC
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 CGAACGATGGCACTGGCAAGGAACCTACAGCTAGAAAATGATACCTCAGTCAACACCGGATACCACACTAA
GGCACAGTCGATGTCGGCGAGCGGCGGTGATACGATCGCTGGCCTAAACAACTCGGGCACCGGGACCGGCA
AGTCAGATAGCGCTAAGGGCAGCAGTCTTTCCAATATCTCGGCGTCATCCATCAAACGAACAGACAACGGT
GGCGATGATGACGACTCGAGTGTCTTCGATAGCAGTAGTAGCGATACCGAGTGTGACGATGATTCTATCAA
GCGAGCGATTGATCGTATCCCGGGTACACTGGCACCGGGGGAGGCACGCGTGCTCCCGAACGCGAACGTTA
AGGTTGCCGTGGAAGCCATCGCTCCCGGGGTACGGCCAAGCCCGGCTGCATCCACGATCGGGGCGATCGCG
GTCCACAACTCGTCGGACATCACGTTCGGCAACAAAACGTACATCAAGGGGCAGGTTGTGATAAAGAACAT
TTACCAGGATCTACCATCCGCAACCAAACCTCCCGAGCCACGCACCTGGCAATCTAGTCTTAAGACAATCA
TAAAGGATAAACCCTTGATCAGCTTTATCGTAATGGTATCGCTGATGATTGTCCTGTGTGCCATTGTAGCG
GTCATATCGATCCTCACCGCGTCAGAGGATGATCTATTCCCAGATCCGAGACCGTTACGGTTAGTGACGAG
AACGGAATGGCTGGCGCAACCGCCCAGAGAGGAATTGACCGATCTGAAACTGCCGGTTAATAACGTCATCA
TTGCTCACACTGCCACCGAAGGTTGCACTACTCAGCAAGCATGCAAAGCACTAGTGCAATCAATTCAAAGG
TATCACGTAAACCACACCAACTACGGTGATATCGGTTACAACTTTTTGATCGGTGGTGACGAATTTGTGTA
CGAGGGCCGCGGATGGCTTAAAGTTGGAGCCCACACCAAAAATTACAACACGATCAGCTACGGGATAGCAT
TCATCGGTAACTACGAGACTATCAATCGACCAACGGAACAGCAGATGGAACAGTTGGTACTGCTGCTTCGC
AACGGTACCGACGGCGGATGGCTTGCCAAGGAGTACAAGCTGTGCGGTGCCAGCCAGCTGAAGGGCACCAT
CAGCCCGGGCAAATATCTAATGGAACAGCTGAGGCTTTTGCCACATTTTAGTGAACGTTTGTAATTATGAT
ACGCATAGGTGATTGAACGTACGTAGTGTAGGTGCATGTGCCATTGAAGCGAAAGTGATGAATGCAGAATC
GAGTAAGACTGAGTGGCACCCTCTAAGATGAAGAACAACTCGTTAACCACGTTAACCCTGTCACTGGCAAC
CAAAAAAAACATCATATACCAGGCAACCGGGCTGCGCGGTTGGAAGCTACGTTCGAGGCTTGTAACTTTTG
AATACGTAATCCAATATCAATGCAATACTGTGATGAAAATTGAATAAACTAATGTAGTTTCTTTAACTGTG
CATAGATTGGTTCAACTCGCTACCGTTTTTATGTTATAGCTTTTTAAAGTTGACAGGATTTTATTGAAAAA
AAAAAACAAAATGAAA 
 
>Seq. 9.2.9 PGRPLC2 partial CDS 
GTGAACGCATACGCAACGATTCGGTCATCGCCTCACCGTCATCGGGCCCATCCAGTACGCGCCCATCAAAA
CGGGAAGTCCGTGTTCAGGAATTATACAAGAAAAAAACTTCTTTTCTTGCTAGACAAAGCGTGTTACCACA
GCAACACACTTCCAAGAACGAGAATCTGTAATCTGTGTATTCCTGTTGGTGGAGGAAAAGCAGAGACTGGA
GCTACTGCGAGGCTAAGATGTCTCTCAACACTTCCGTGAGATAAAGAATAGCCACACTACAAACACAAACA
AACGGAAGCTTTCGGAGATACTTGCAAGTCGTGTGACTGTGACAGTGCCCGTTGCAGCAGTAAACGAAACC
CGAACGATGGCACTGGCAAGGAACCTACAGCTAGAAAATGATACCTCAGTCAACACCGGATACCACACTAA
GGCACAGTCGATGTCGGCGAGCGGCGGTGATACGATCGCTGGCCTAAACAACTCGGGCACCGGGACCGGCA
AGTCAGATAGCGCTAAGGGCAGCAGTCTTTCCAATATCTCGGCGTCATCCATCAAACGAACAGACAACGGT
GGCGATGATGACGACTCGAGTGTCTTCGATAGCAGTAGTAGCGATACCGAGTGTGACGATGATTCTATCAA
GCGAGCGATTGATCGTATCCCGGGTACACTGGCACCGGGGGAGGCACGCGTGCTCCCGAACGCGAACGTTA
AGGTTGCCGTGGAAGCCATCGCTCCCGGGGTACGGCCAAGCCCGGCTGCATCCACGATCGGGGCGATCGCG
GTCCACAACTCGTCGGACATCACGTTCGGCAACAAAACGTACATCAAGGGGCAGGTTGTGATAAAGAACAT
TTACCAGGATCTACCATCCGCAACCAAACCTCCCGAGCCACGCACCTGGCAATCTAGTCTTAAGACAATCA
TAAAGGATAAACCCTTGATCAGCTTTATCGTAATGGTATCGCTGATGATTGTCCTGTGTGCCATTGTAGCG
GTCATATCGATCCTCACCGCGTCAGAGGATGATCTATTCCCAGATCCGAGACCGTTACGGTTAGTGACGAG
AACGGAATGGCTGGCGCAACCGCCCAGAGAGGAATTGACCGATCTGAAACTGCCGGTTAATAACGTCATCA
TTGCTCACACTGCCACCGAAGGTTGCACTACTCAGGCCGCATGCCGTTTGCGGGTGCGCTTAATTCAGGAG
TTTCATATGGATGGCAAAAACTACGACGATATAACGTACAACTTTCTAATCGGTGGAGATGGACATATCTA
CGAGGGTCGAAATTGGCACAAAATTGGTGCCACCATTCCCGGTTACAATTCCCGCAGCATAACGGTGGCCT
TTGTGGGAGAGTACAATTACGGTGGCAAACCTACTAAAAAGCAAATCGAGCTGTTGAAATATCTACTGCAC
TTTGGTGCAAAGGAGCGGCACCTAAAGGAAGGTTACCGAATATATGCCTCGGAGCAGCTGGATCCAACGGT
TGGGACGGGCAAGTGGCTAATCGAAGCACTGCACAGCTTGCCCCAGTTTGTCGATAAGGAGCAAAATAAGG
ACGAGCGCCCCGATCACGAG 
 
>Seq. 9.2.10 PGRPLC3 partial CDS 
GTGAACGCATACGCAACGATTCGGTCATCGCCTCACCGTCATCGGGCCCATCCAGTACGCGCCCATCAAAA
CGGGAAGTCCGTGTTCAGGAATTATACAAGAAAAAAACTTCTTTTCTTGCTAGACAAAGCGTGTTACCACA
GCAACACACTTCCAAGAACGAGAATCTGTAATCTGTGTATTCCTGTTGGTGGAGGAAAAGCAGAGACTGGA
GCTACTGCGAGGCTAAGATGTCTCTCAACACTTCCGTGAGATAAAGAATAGCCACACTACAAACACAAACA
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 AACGGAAGCTTTCGGAGATACTTGCAAGTCGTGTGACTGTGACAGTGCCCGTTGCAGCAGTAAACGAAACC
CGAACGATGGCACTGGCAAGGAACCTACAGCTAGAAAATGATACCTCAGTCAACACCGGATACCACACTAA
GGCACAGTCGATGTCGGCGAGCGGCGGTGATACGATCGCTGGCCTAAACAACTCGGGCACCGGGACCGGCA
AGTCAGATAGCGCTAAGGGCAGCAGTCTTTCCAATATCTCGGCGTCATCCATCAAACGAACAGACAACGGT
GGCGATGATGACGACTCGAGTGTCTTCGATAGCAGTAGTAGCGATACCGAGTGTGACGATGATTCTATCAA
GCGAGCGATTGATCGTATCCCGGGTACACTGGCACCGGGGGAGGCACGCGTGCTCCCGAACGCGAACGTTA
AGGTTGCCGTGGAAGCCATCGCTCCCGGGGTACGGCCAAGCCCGGCTGCATCCACGATCGGGGCGATCGCG
GTCCACAACTCGTCGGACATCACGTTCGGCAACAAAACGTACATCAAGGGGCAGGTTGTGATAAAGAACAT
TTACCAGGATCTACCATCCGCAACCAAACCTCCCGAGCCACGCACCTGGCAATCTAGTCTTAAGACAATCA
TAAAGGATAAACCCTTGATCAGCTTTATCGTAATGGTATCGCTGATGATTGTCCTGTGTGCCATTGTAGCG
GTCATATCGATCCTCACCGCGTCAGAGGATGATCTATTCCCAGATCCGAGACCGTTACGGTTAGTGACGAG
AACGGAATGGCTGGCGCAACCGCCCAGAGAGGAATTGACCGATCTGAAACTGCCGGTTAATAACGTCATCA
TTGCTCACACTGCCACCGAAGGTTGCACTACTCAGACGAAATGCATGTATCAGGTAAAGTTGATCCAGGAG
TTTCATTCGAGTCCCGACTCGAGGAACTTTAGCGACATTGCGTATCAATTTCTGGTGGGTGGTGATGGCAA
CGCGTACGAGGGTAGAGGATGGACAAAGCAAGGAGCGCACACGAAAGGGTTCAACGTGGACAGCATCTGCA
TCGCGTTCATTGGAACATTCATCGCGGATCCGCCACCGATCGCTCAGCTCAGTGCTGCGCAGCAGCTCATA
CTGCTAGGTATGAAGGAAAACTATCTTGCCTCCAACTACAGCCTGTACGGCCACCGACAGCTGGCACCGTT
CGAGAGTCCGGGCAAGGCACTGTTCGATATCATCAAAACTTGGCCCCACTGGTCGAACAAGCTGGGGTCCA
ATCACTGGGTCGAACCGGCGAACGACACCACAAACCGACGATGACGCAGGAAACGACTTGCCCCCATCACC
ATTCCTCCCCCCAAGTGTCCTTGATGACTTCCTCTCTCCTTCTCTCTCTCTTGAACCGGAAAAAGAGAACC
AAAAAGACTGTGATGATGAAAATAATCGAATAAACATTTTAAATATGGTGTAATTTAGCTCATACGATAAA
A 
 
>Seq. 9.2.11 PGRPLC 3rd exon with alternative spliced extension cassette 
TACCATCCGCAACCAAACCTCCCGAGCCACGCACCTGGCAATCTAGTCTTAAGACAATCATAAAGGATAAA
CCCTTGATCAGCTTTATCGTAATGGTATCGCTGATGATTGTCCTGTGTGCCATTGTAGCGGTCATATCGAT
CCTCACCGCGTCAGGTAAAGCTAGATTTAGGCTCCCCGTAGGCGACGGCGACGACAATCGTCCCAATATTC
CGCAGGACAAGGATATAG 
 
>Seq. 9.2.12 PGRPLC 3rd exon without alternative spliced extension 
cassette 
TACCATCCGCAACCAAACCTCCCGAGCCACGCACCTGGCAATCTAGTCTTAAGACAATCATAAAGGATAAA
CCCTTGATCAGCTTTATCGTAATGGTATCGCTGATGATTGTCCTGTGTGCCATTGTAGCGGTCATATCGAT
CCTCACCGCGTCAG 
 
>Seq. 9.2.13 PGRPLD partial CDS 
ACCAACGCAAGAGTGTCAATCCATCTCGAACCGAATCGACGCTGCTTTCCCGAATACAATCTTCAATTCCT
CCGCCTCCTCTATGGGCTAAGGGTTTGCGGGCCAGCGAAGGCACCGCTGCAGGCTCCCGACATCCTTATAT
TGTTGCCAACCTTCCATCCCTCCCAGCCAGCAATGTATCAGGCCGCGCGCACCGTTGCGGCGTCGAGCTCG
AGCCGGCTGCACTCCCCCGTTGCCTGGAGCCGCAAGTCCGTGCAGGAGGGCTACTACGATCTCGAGGCGGG
CGAAACGGAACGAACGCCCCTGCTGTACGTGCGCGACAATGGACGCTACCGGGCGAAGAGCCTGCACCGTG
CCAACGATCCGAACCGGGTGCATCCGGTCGCGCTGGGGCTGATGGTGGCGCTGCTCGTCTTCCTGCTGATC
GGTGTCGTGATCGGCGTCTATCTGCTGCTGCTGACGGTTCAACGGCCCTGGCCCGTATCGCATCCGTTCTT
TTTGGTCGAGCGACCCGCCTGGTGGCAGTATCCGGTGGCGCTCGAGGCGGCCACCCTCGACCGGCTCGCCG
TTACTAACGTGATCGTGCTGCACACCGACTCGGAGGATTGTCTGGATCAGGAGCGCTGTGTGCGCTACCTG
CAAAATACCGAGCGGAGCTGCTGGGCGGCACGGCGTGACCACATCCCGTACAACTTCTTGATCGGCGGGGA
CGGTGTGACGTACGAGGCGCGCGGCTGGAAGAGTCAGCACGGGTTCGTCGATCTGCCCGGCCGCAACACAA
CGCTCGTGGTGGGCATGATCGGCAACTTCACCGACCGTCAACCGGCGGAAGTACAGTACGCCGAGCTGAAG
GCATTTATCACCGAGTCGATCCGGCGGCTTAGCCTCTCGCCCCAGTACCGCCTGCACGGAGCGGTCAATGC
AACGCGTCCCTCGCGAGACGGTACAATCGCGCTGTACAGTCAGCTGGAGCGATGGCCACACTGGAAGGGGT
TCGTCGCTCGCGACCAACCC 
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 >Seq. 9.2.14 Drosophila PGRP-LC 3rd exon with alternative spliced 
extension cassette 
GCTCCAAACACGAAGATCCGGCGCAAACCCCACCAATTTGTCCTTTTCTGCCCAACACTGTCGGACGCAAG
GCCGTCACAGTTACAGTGGTTTTTGTAACTTTAACCTTCCTGCTGGGTATCGTACTGGCCACCACCACAAA
TCTCTTCGGAAAGACGTTGAACCAAAGTAAGATCAGAGATGACGACGATTACAGACAAAATATTCCAATCA
ATTCAACAATAG 
 
>Seq. 9.2.15 Drosophila PGRP-LC 3rd exon without alternative spliced 
extension cassette 
GCTCCAAACACGAAGATCCGGCGCAAACCCCACCAATTTGTCCTTTTCTGCCCAACACTGTCGGACGCAAG
GCCGTCACAGTTACAGTGGTTTTTGTAACTTTAACCTTCCTGCTGGGTATCGTACTGGCCACCACCACAAA
TCTCTTCGGAAAGACGTTGAACCAAA 
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 9.3 PROTEIN SEQUENCES 
 
>Seq. 9.3.1 PGRPLB transcript 1 (ENSANGP00000013948) 
PSRGSYPDSSDSDLFAERTNAHNTVQQIPHENTAYKKTPVAVRRKIVQEAISERFNAEVSALNYCNKMDFV
KDFCYYFGVIAFTLFYVAVDSKACDPVPYVTRDFWSALPPKRIEHFAGPIPYVIIHHSYRPAACYNGLQCI
AAMQSMQKMHQDERQWNDIGYSFAVGGDGHVYQGRGFNVIGAHAPRYNNRSVGICLIGDWVADLPPKNMLT
AAQNLIEYGVRNGLIAQNYTLLGHRQVRTTECPGDRLFEEIKTWPHFDPMTDIVDQNSV 
 
>Seq. 9.3.2 PGRPLB transcript 2 (ENSANGP00000022756) 
MNFLSLKYHLRWQTADQTLDYKLAVRCCVYFQLLPPVVYSNARILRAYCQLDSLIMIVYVIVIIASVIQLH
AAVIRDAVMELFPFSDDSDTTTAPTMTYGANPVPYVTRDFWSALPPKRIEHFAGPIPYVIIHHSYRPAACY
NGLQCIAAMQSMQKMHQDERQWNDIGYSFAVGGDGHVYQGRGFNVIGAHAPRYNNRSVGICLIGDWVADLP
PKNMLTAAQNLIEYGVRNGLIAQNYTLLGHRQVRTTECPGDRLFEEIKTWPHFDPMTDIVDQNSV 
 
>Seq. 9.3.3 PGRPLD partial CDS 
TNARVSIHLEPNRRCFPEYNLQFLRLLYGLRVCGPAKAPLQAPDILILLPTFHPSQPAMYQAARTVAASSS
SRLHSPVAWSRKSVQEGYYDLEAGETERTPLLYVRDNGRYRAKSLHRANDPNRVHPVALGLMVALLVFLLI
GVVIGVYLLLLTVQRPWPVSHPFFLVERPAWWQYPVALEAATLDRLAVTNVIVLHTDSEDCLDQERCVRYL
QNTERSCWAARRDHIPYNFLIGGDGVTYEARGWKSQHGFVDLPGRNTTLVVGMIGNFTDRQPAEVQYAELK
AFITESIRRLSLSPQYRLHGAVNATRPSRDGTIALYSQLERWPHWKGFVARDQP 
 
>Seq. 9.3.4 AaREL1 Aedes agypti REL1 
MGPNDNNVMEDDPSLPDLPNNLIVTDDILDLIIDIIDQEMPPTAQERPHVVITEQPQSKALRFRYECEGRS
AGSIPGVHSTPEQKTFPGIEIRGYKGRAVVVVSCVTKDPPYRPHPHNLVGKEGCKKGVCTVEINSSTMSYT
FSNLGIQCVKKKDIEEALRLREEIRVDPFKTGYGHARQPATIDLNAIRLCFQVFLEGQQRGRFTEPLQPVV
SDVIYDKKAMSDLVICKLSDVTAPVAGGREIILLCEKVAKEDIAVRFYEEQHGNIVWEEYGEFQHTNVHKQ
VAICFRTPRYRTLEVEHPVMVNIQLKRPSDGATSEPLPFELTPLDSAKRKKRKPNTWGDTPEHMPEAARHP
YYATLGNVPGEAIKTEPRDSPTHPFNFIGNYRQPNESPSPIERSPLYGNTTPVGQTSPYNAGRTSVTPTPG
GYQPNVMNPDFLLGGTQQFQNQYAFPTLPPTNGQPMYLQQPQQQQQQQQFQPPANMNNQQQFNVSNLIDPQ
DQLPQPGPSGVQAVPSFQPSGSIGEINISSPWLTMDSSELKSLMVHTLSDMKQEQQRIQQEAETLSDSFDR
LSTNLNNLNKP 
 
>Seq. 9.3.5 CgRel2 Crassostrea gigas Rel2 (Pacific oyster) (Acc# 
AAK72691) 
MAELNFGYDNPMGLGSNDLRLLMDGNHELLTNFDTADNDLVQLITQNQESFMTPQIPVTQPQPPKPQKQTT
HRGTPHKTQDGIYVEIVEQPKQRGLRFRYECEGRSAGSIPGEGSTSEKKTFPTIKIHNYTGTAVIVVSCVT
KDQPYEPHPHNLVGRDCKRGVCTLKVKDTNVISFPHLGIQCAKKKDVENNLKQRKEINVDPFQSGFKHLNK
INSIDLNVVRLCFQVFLPDENGKITRIVPPVVSHCIHDKKSLNELVICRVDRHSGKAKGGDEVFLLCEKIN
RDDIVVRFYEETECGECLWEDFADFSTNDIHRQYAIVFRTPPYKDTMITRPKEVKMQLKRNNEPETSDSIP
FIYMPEDPDPDRIMEKRKRKADQLKNWGFDMNVSGEDIKQRLKIKATKSRIKQEVPEVPPYTVENLLGGAH
QMPPVSNVTTTHTKDGTSLNVRTLDNTTMGNVTITPTESVRQQLANLPDDVQIKLLQNLAVRKLQEEATSR
INQPGQQLEKDHSTFLQSLLGGGMGMPQNSNPAQPLNQNLMMGGQAMGQCSGMDQENVDLMLQAYLGDQDQ
NMSFDSFGSNIGNMNFDPSVGANLNVTNDQGGLDETKTAVQSLGQS 
 
>Seq. 9.3.6 SpNF-kappaB Strongylocentrotus purpuratus (sea urchin) NF-
kappaB (Acc# T14892) 
MEEKSDSVQSVEIPEDMLQQLIHQNGQVGLPMSGAENDFDSNDLMHLPVMKGLQEEVSKPHLKILEQPRQR
GFRFRYGCEGPSHGGLPGQNSQRGKRSFPSVEICNYKGSARIVVSLVTNEETPRPHAHSLVGKHCKDGLCT
VQVGPKDMTASFPNLGILHVTRKDVVPTLKTRILAQHRLYKDLINNSTPGESHWTEPSDAEIEKKAKEMAK
DMDLSVVRLCFQTYLPDISGHFTRPLDPVISVPVFDSKAPNATTLKICRMDKSAGCCTGGEEVYLLCDKVQ
KEDIQVKFFEISADGQMVWQSLAEFGPTDVHRQYAIVFKTPAYKDINIDKPVYVHVQLKRKSDNETSDPKP
FTFHPQVPDREGILRKRKKHLAHFNEYSSTYQQGGLGGSNGMGGGGGSTSFNFNNPNMGYGANTYNFSGNQ
MTSSTSQPQSVPQQIPSHQSGVVATGNSSQQMVYTTSTGAQNHQPLPSIATLARKPQEQLQQQQFQLQQQL
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 QQQQQQQQQQQQQQQRQQQQQQPMQMDFQMPPIQGSAMGGQAGGDRVKMESESKYCGNMDTAEGFQLDSNT
LRDCGPLPDLKELQDTGVLDLIPKGISRPKDMVEKNIQTDDITIDSDSMAWHVAQVTANALHDYAATGDIK
TILTVQRHLIAVEDDNGDTALHAAIINKKYDVTHALLSAVIKIPDQIIVNQTNHLKQTPLHLAVITNQSKM
VEVLLRCGANPNLCDHEGNTPLHLATMMGMTEGVNFLVRGPKAKAAIKPIKTDINPTNYEGLAPVHLAVIA
KNLDILKALVSSGADVNVADGKTGRTALHYAVEVESFPILGYLLIEAKVDINAVTFCGDSALHLASSLDLR
AVATLLIAAGADPKLENADLGDDSDSDVDGEDDDGEKDGEKKEEGVEEEEKEKHGKTPYQLATSAKMKEVL
SGHSTRRVEEEDFDYIETGSAISSVGSIQSEDHMKVNSWDQGYFSGKSSSSVSNLELKRTWPRVKSRMLGS
SLVTSKGDIGLLSETTTEKLGSMLDDNYPTTQSWFTLANRLGLSNMLNFLKLVPSPTAVILKQFEAMDGTI
KELRDVLSSMNHIEAVALLDQAVSWRKEKADEAHMYSSMHQSLGKMNLSDAHMHQHQFVY 
 
>Seq. 9.3.7 Mmp105 Mus musculus NF-kappa-B p105 subunit (Acc# P25799) 
MADDDPYGTGQMFHLNTALTHSIFNAELYSPEIPLSTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGAS
SEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGVCTVTAGPKDMVVGFANLGILHV
TKKKVFETLEARMTEACIRGYNPGLLVHSDLAYLQAEGGGDRQLTDREKEIIRQAAVQQTKEMDLSVVRLM
FTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYE
EEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDVNITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKE
EVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGSTGSPGPGYGYSNYGFPPYGGITFHPGVTKSNA
GVTHGTINTKFKNGPKDCAKSDDEESLTLPEKETEGEGPSLPMACTKTEPIALASTMEDKEQDMGFQDNLF
LEKALQLARRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHAQLVRDLLEVTSGLISD
DIINMRNDLYQTPLHLAVITKQEDVVEDLLRVGADLSLLDRWGNSVLHLAAKEGHDRILSILLKSRKAAPL
IDHPNGEGLNAIHIAVMSNSLPCLLLLVAAGAEVNAQEQKSGRTPLHLAVEYDNISLAGCLLLEGDAHVDS
TTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWEKAGEDEGVVPGTTPLDMAANWQVF
DILNGKPYEPVFTSDDILPQGDMKQLTEDTRLQLCKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSK
TLMDNYEVSGGTIKELMEALQQMGYTEAIEVIQAAFRTPATTASSPVTTAQVHCLPLSSSSTRQHIDELRD
SDSVCDSGVETSFRKLSFTESLTGDSPLLSLNKMPHGYGQEGPIEGKI 
 
>Seq. 9.3.8 Mmp100 Mus musculus NF-kappa-B p100 subunit (Acc# Q9WTK5) 
MDNCYDPGLDGIPEYDDFEFSPSIVEPKDPAPETADGPYLVIVEQPKQRGFRFRYGCEGPSHGGLPGASSE
KGRKTYPTVKICNYEGPAKIEVDLVTHSDPPRAHAHSLVGKQCSELGVCAVSVGPKDMTAQFNNLGVLHVT
KKNMMEIMIQKLQRQRLRSKPQGLTEAERRELEQEAKELKKVMDLSIVRLRFSAFLRASDGSFSLPLKPVI
SQPIHDSKSPGASNLKISRMDKTAGSVRGGDEVYLLCDKVQKDDIEVRFYEDDENGWQAFGDFSPTDVHKQ
YAIVFRTPPYHKMKIERPVTVFLQLKRKRGGDVSDSKQFTYYPLVEDKEEVQRKRRKALPTFSQPFGGGSH
MGGGSGGSAGGYGGAGGGGSLGFFSSSLAYNPYQSGAAPMGCYPGGGGGAQMAGSRRDTDAGEGAEEPRTP
PEAPQGEPQALDTLQRAREYNARLFGLAQRSARALLDYGVTADARALLAGQRHLLMAQDENGDTPLHLAII
HGQTGVIEQIAHVIYHAQYLGVINLTNHLHQTPLHLAVITGQTRVVSFLLQVGADPTLLDRHGDSALHLAL
RAGAAAPELLQALLRSGAHAVPQILHMPDFEGLYPVHLAVHARSPECLDLLVDCGAEVEAPERQGGRTALH
LATEMEELGLVTHLVTKLHANVNARTFAGNTPLHLAAGLGSPTLTRLLLKAGADIHAENEEPLCPLPSPST
SGSDSDSEGPERDTQRNFRGHTPLDLTCSTKVKTLLLNAAQNTTEPPLAPPSPAGPGLSLGDAALQNLEQL
LDGPEAQGSWAELAERLGLRSLVDTYRKTPSPSGSLLRSYKLAGGDLVGLLEALSDMGLHEGVRLLKGPET
RDKLPSTEVKEDSAYGSQSVEQEAEKLCPPPEPPGGLCHGHPQPQVH 
 
>Seq. 9.3.9 DmRel Drosophila melanogaster Relish Rel (CG11992-PA) 
MNMNQYYDLDNGKNVMFMNDASSTSGYSSSTSPNSTNRSFSPAHSPKTMELQTDFANLNLPGGNSPHQPPM
ANSPYQNQLLNNGGICQLGATNLINSTGVSFGVANVTSFGNMYMDHQYFVPAPATVPPSQNFGYHQNGLAS
DGDIKHVPQLRIVEQPVEKFRFRYKSEMHGTHGSLNGANSKRTPKTFPEVTLCNYDGPAVIRCSLFQTNLD
SPHSHQLVVRKDDRDVCDPHDLHVSKERGYVAQFINMGIIHTAKKYIFEELCKKKQDRLVFQMNRRELSHK
QLQELHQETEREAKDMNLNQVRLCFEAFKIEDNGAWVPLAPPVYSNAINNRKSAQTGELRIVRLSKPTGGV
MGNDELILLVEKVSKKNIKVRFFEEDEDGETVWEAYAKFRESDVHHQYAIVCQTPPYKDKDVDREVNVYIE
LIRPSDDERSFPALPFRYKPRSVIVSRKRRRTGSSANSSSSGTESSNNSLDLPKTLGLAQPPNGLPNLSQH
DQTISEEFGREKHLNEFIASEDFRKLIEHNSSDLEKICQLDMGELQHDGHNRAEVPSHRNRTIKCLDDLFE
IYKQDRISPIKISHHKVEKWFIEHALNNYNRDTLLHEVISHKKDKLKLAIQTIQVMNYFNLKDVVNSTLNA
DGDSALHVACQQDRAHYIRPLLGMGCNPNLKNNAGNTPLHVAVKEEHLSCVESFLNGVPTVQLDLSLTNDD
GLTPLHMAIRQNKYDVAKKLISYDRTSISVANTMDGNNALHMAVLEQSVELLVLILDAQNENLTDILQAQN
AAGHTPLELAERKANDRVVQLLKNVYPEKGELAMTWIPCKVKEE 
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 IDSSSDESSDAGQLEIKSEEMDIETKDEDSVELDLSSGPRRQKDESSRDTEMDNNKLQLLLKNKFIYDRLC
SLLNQPLGHGSDPQDRKWMQLARQTHLKQFAFIWLGAEDLLDHVKRKGASVEFSTFARALQAVDPQAYALL
VNPT 
 
>Seq. 9.3.10 DmDorsal Drosophila melanogaster Dorsal dl (CG6667-PA)  
MFPNQNNGAAPGQGPAVDGQQSLNYNGLPAQQQQQLAQSTKNVRKKPYVKITEQPAGKALRFRYECEGRSA
GSIPGVNSTPENKTYPTIEIVGYKGRAVVVVSCVTKDTPYRPHPHNLVGKEGCKKGVCTLEINSETMRAVF
SNLGIQCVKKKDIEAALKAREEIRVDPFKTGFSHRFQPSSIDLNSVRLCFQVFMESEQKGRFTSPLPPVVS
EPIFDKKAMSDLVICRLCSCSATVFGNTQIILLCEKVAKEDISVRFFEEKNGQSVWEAFGDFQHTDVHKQT
AITFKTPRYHTLDITEPAKVFIQLRRPSDGVTSEALPFEYVPMDSDPAHLRRKRQKTGGDPMHLLLQQQQK
QQLQNDHQDGRQTNMNCWNTQNIPPIKTEPRDTSPQPFGLSYRAPPELTPSPQPLSPSSNYNHNSTPSPYN
MASAVTPTNGQQQLMSPNHPQQQQQQQQYGATDLGSNYNPFAQQVLAQQQQHQQQQQQHQHQHQQQHQQQQ
QQQQQQQQQSLQFHANPFGNPGGNSWESKFSAAAVAAAAATATGAAPANGNSNNLSNLNNPFTMHNLLTSG
GGPGNANNLQWNLTTNHLHNQHTLHQQQQLQQQQQQQYDNTAPTNNNANLNNNNNNNNTAGNQADNNGPTL
SNLLSFDSGQLVHINSEDQQILRLNSEDLQISNLSIST 
 
>Seq. 9.3.11 DmDif Drosophila melanogaster Dif (CG6794-PA)  
MFEEAFGDIQEIINASMELNGGATGGGSVAGAVGGGGAAHHILSQSTSLPVMPSHIPLHLQNQNMNQNLPE
PSARSGPHLRIVEEPTSNIIRFRYKCEGRTAGSIPGMNSSSETGKTFPTIEVCNYDGPVIIVVSCVTSDEP
FRQHPHWLVSKEEADACKSGIYQKKLPPEERRLVLQKVGIQCAKKLEMRDSLVERERRNIDPFNAKFDHKD
QIDKINRYELRLCYQAFITVGNSKVPLDPIVSSPIYGKSSELTITRLCSCAATANGGDEIIMLCEKIAKDD
IEVRFYETDKDGRETWFANAEFQPTDVFKQMAIAFKTPRYRNTEITQSVNVELKLVRPSDGATSAPLPFEY
YPNPELLTKHNRRVAQKTVESLKRSLMSTNLHPSKQVKTSSQYTIFSKPQIATTTPQTQVSPGMPLMFPGG
SPNFVQDIKMENGFMDVDSQSSQCPSVERNFASPRSNCSTVDSIPPMQMGQNQTHLYLPDATNFTFNGNFA
SPSSNCSTVDSIPPFQIGQRNNHMYLPENSNFPVNGCSPTHFSGGSMTPINNNNNVLINNNNNDFLSQKMS
AISIPPQGNFGIKQVYQQTQQFLPQLQPESIPYLAQSHPEQSQYQQQQQPQEQQPPADEPTQSFSDLISSS
IGMAPIDTSELIQDIEAELNSLGIQPFK 
 
>Seq. 9.3.12 AaREL2 Aedes aegypti REL2 R6 isoform (Acc# AAM97895) 
MSTLLNLDSYRHELFEHHQHQQQHHQLQQLSSSPTYSVLSMESVSPVSSSSASPAADTSKYYASNSPSSVS
NMSPKSTASDTSSFNMQNLNISNAYPYFAETHHQTMTTGEEGQLQTFTYNDPTQPRVELSVPQLTIVEQPV
DKFRFRYQSEMHGTHGSLMGVHTEKSKKTFPTVQLHGFQGEAKIRCSLFQVDPNRRAAHSHNLVIKSGEID
LNDPHDIDVNEECNYVAMFQGMGIIHTAKKNIAEELSKKMKKQRSVEMNRELTLREEYQLQKEAAEMAKTM
NLNQVCLCFQAFQVDASTGRWAQLCEPVYSNPINNMKSALTGELKICRLSATVGNVDGGEEVFMFVEKVCK
NNIKIRFYELDEYDQEIWQDWGSFSEADVHHQYAIAFKTPAYHNKDITEPVEVLMQLYRPRDKCQSEPVPF
KFKPRFNISRKRPRVSSGLLSNEIPTVVPNEPGSSRLPSFHHPFSMMPPMQAPIAEASGSSSSHTISKEYN
KSGIIQEILDSHIPTTIAGDISFSSNDFKEFVNCNSEELRKLITEIGEAQEESKLETDAVSVGHVDEAAAQ
FERTLEQYLEHNSQAKDVEILKKILAIIRLLFRKNYDQCRELISALWMSANKLKANCLHMAIERRNITIAC
KLVELLQDHHLLDMLDLFNERNETALHLAVSANLVEVVDVLLLTGSRISYCDSRGNSALHRAVYENALDSL
NVLLGHCKRNGFRLDSTNDDGFTALHLAVMCKNLKATKVLLDRGASYVLRDLKHGNNILHIAVESDSLDMV
NFILEGVDKTLADEPNNAGYTPLQLANARHLANANNKLIVRELLRYNPSGVLEKEHLTEEEDDDQEQEENL
PPSSDSQSETVLESMNVSCNRVEVIRLLEDYSPPNDEPKLTPLENVPYNSTLEDGSVYLFDEVCLSHLCGL
LNRKNLWREVGSLLEFNSFFMIWETSVNPAGMLLNYFEMQKVKLEHLIDVLQALDQKEAIHYIDEMICRQM
K 
 
>Seq. 9.3.13 AmDorsal Apis mellifera (honey bee) dorsal protein (Acc# 
AAP23055) 
MEQFHDMSDGNIHMSDVIEVIETDTKYNGREDQIPREMNTERLLPYVEIIEQPASKALRFRYECEGRSAGS
IPGVNSTSENKTFPTIKIVGYKGRALVVVSCVTKDQPYRPHPHNLVGKEACKQGVCTVEVSSENMTVTFAN
LGIQCVKKKDIEEALKIREEIRVDPFRTGFEHKRQPTSIDLNAVRLCFQVFLEGSQKRKFNVPLQPVVSDP
IFDKKAMSDLVICKLSHSNASVAGGMEMILLCEKVAKEDIQVRFFEEKDGQVLWEGFGDFQPVHVHKQTAI
AFRTPTYRMQQVEQPVQVYIQLKRPSDGATSEPFPFLMLPLGADDPDSLRRKRQKINNSQNALVLRHVQAE
AEKHAAMLYQYNFNIIISEPTERISPYGYPIGSGGSFPSLYPMATTSPQSQSTIQTLRPQVSPDRTSPMEY
RLYNPALIQSQPSPQYPSTSSHILQQPSIRTYTQQQFPYVHDTLQIQPQEQLTLSKVTSNYHEEFQSLNNA
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 VGEMEATNVTNILSMDNTQYNLDLSLPQLDSTELADLDISLSENLSSGLSISDSTKPETSKGINAEPSNIE
ESNNMTDSFTRIANNTIQELYTLNNMYKPTREVD 
 
>Seq. 9.3.14 TcDorsal Tribolium castaneum (red flour beetle) Dorsal 
(Acc# AAG22858) 
MDENHLEQTLENAGMPDESINISDVIEVIETDPDFHESTMFNGGGEIPQNIIQQQPQQARRRAFVKIIEQP
ASKALRFRYECEGRSAGSIPGASSTPENKTFPSIQVMGYQGRAVVVVSCVTKDEPFRPHPHNLVGREGCKK
GVCTMEINSDTMCVTFSNLGIQCVKKKDIESALRLREEIKVDPFMTGFSHRNQPTSIDLNAVRLCFQVFLE
GERRGKFTVPLTPVVSEPIYDKKAMSDLMIVKLSHCNSYVDGGRNEIILLCEKVAKEDIQVRFFEEKNGKV
VWEGFGDFQPSQVHKQTAICFKAPRYHTLDITEPVKVFIQLRRPSDGATSEALPFELLPLDSEPGMLKRKR
QKYHDPSQLLRHVEESDKQRTHQPFLLNIPSEGIKVEPRDKAPSPYGGQMFEAPIPNVSPHYVTPTPPEAP
LFQNVLPPIGGMMNWNMPSTSVVGDMLNMNWNPSAQNDLSGVNLSETPSGISSLLNLDNQQLELKPIDLNS
GDLSMLETNNLSETFTQNLSLMDESEGRQEPNMTDSLTRLANSALDNICQASDMYKGAP 
 
>Seq. 9.3.15 AgREL2-F Anopheles gambiae REL2-F 
MSTLLNLDSYRHELYEQQQLLGTSPIQYTVLSMDTPSPSSSSAAAAVVSVGEFTLGPGRTYASALSPSSSS
ASPSSPSSVASPNSRASNMSPESSASDQSAAYTLQNLNLSSSAGTMNYPGMGYQQQQQQQQQQQQHHQHQQ
LQQQQHHYYTPQLLNLDQEQLQTQTFTYVTSSNEAFAAPEPNYSEPHLVILEQPVDKFRFRYQSEMHGTHG
SLMGSRTEKSKKTFPTVELRGYGGEAKVRCSLYQVDPQRRAPHSHHLVIKSGELDLIDPHDLDVGGAAGAA
EPSEGVGGDGKYVATFQGMGIIHTAKKFIAEELYKKLRKHRLCELNREPTEREEQQMQKEAAVMARTMNLN
QVCLCFRAYRVEPGTGRWVPICEPVYSNPINNMKSALTGELKICRLSTTVSGVDGGEEVFMFVEKVCKNNI
KIRFYELDEYDQEVWQEMAIFSEADVHHQYAIAFKTPPYRHKDITEPVEVLMQLFRPRDRCQSEPVLFKYK
PRPGMMVVPGAGASGASRKRLRISSGNVSSEIPTVIQNDPNGPVGPAGVGGGGGGGGGGGGGGVIGSGSTT
RLPPLHQPFPMLANHAGGGAIPEGQEPTSTTSLTTSAHHPDIMSGIGSTTTISKELTKASIIQEILNIPTT
IASDVAFDSSDFPCNSEEFNKLIQEIGNQQDLVKLETDAETAGGGATDTESVLGRAIADLVASGDDSRQGE
MLRKLLALIKLFAGDVNRSRQLLASHWTAANQQQLNCLHAAIRRNDTTIACKLIELLHEYQLAEELLDLPN
DRNETGLHLAVSCNSEPIVKALLGAGAKLHYCDYRGNTPLHRAVVENVPDMVRLLLLQGGLRLDCTNDDGL
TALQAAVYARNLKITRILLEAGASVREKDLKHGNNILHIAVDNDALDIVHYILEEVKEELGRERNNAGYTP
LQLADAKSHTGQGNNKLIVRELLRHYPDGLQKEVKKEVDAAEDDEEEEEEEQEEEEDEDEEGGEEHGQREA
SAPSSSVLDSMDLINGERASIARLLEEHEPEAEPQRKATKRSDSGPDRTEPDTLLDEQCLEELCRLLDAGS
GWRELGSLLDFHSFFTVWEQAPSPARMLLGYFEMQQLHLDRLIDMLRVLELRDPIRSIDEMICRRMK 
 
>Seq. 9.3.16 AgREL1 Anopheles gambiae REL1 
MAGYVNGADAAFLPIEGILGESDLLDDIIHVIGKDIREEMPPVPNQRPYVEITEQPHPKALRFRYECEGRS
AGSIPGVNTTAEQKTFPSIQVHGYRGRAVVVVSCVTKEGPEHKPHPHNLVGKEGCKKGVCTVEINSTTMSY
TFNNLGIQCVKKKDVEEALRLRQEIRVDPFRTGFGHAKEPGSIDLNAVRLCFQVFLEGQQRGRFTEPLTPV
VSDIIYDKKAMSDLIICRLSDCTAPVSGGKEIILLCEKVVKEDIKVRFFEKKGNATVWENYAEFSHTDVHK
QVAISFRTPPYRTIDISDPVRVFVQLERPSDNTYSEARDFQFIPLDTVDLRRKRQKLTGSSNVFLPVVTAP
LPGPSPPSSLGMPGNIPNLSQLDATGGQSASTSGLPRGIYTYHNASAFQQMPKEEIKNEPGDSPSHNPSNQ
YQLQPMQPMFTAQSTSPGPDRSPATLTPSPGIGGPISPLDPGNVTPTPPAYTTLGGTGGTMGNLFGQFGTG
FSNAATQPNASVPMFETNLPGPSNGWVQPVPSHTQNGPSQPQPQQQNPFNLLNFGTLPLATGDPLMAMSTA
NTNNQPNVGPPSLGSDFYMNLDLANLDPVFNSSELRSVLGSLSTTDLNRLEQTANMQTSGGNYQQHSASN 
 
>Seq. 9.3.17 PGRP-LA1 
MATNHQNGLSTGNGGNTTVQPAATSVINLSNSSDVVIGPMTQYQGSVTIYQYMDATVEASRIASKFPLPMR
SRSLTEFYDLVFPSHLSFPTAGRNNQNRGLPSAEPSTLRQERYFIYGALIFFAIVGFSTAIYFIVNQVRGP
ADIDREILFDTNYHRRTMPNLGNSHMIIERRNWGSQLDAHASIQLEHPVQYVIVTHIGLRSKNCTGMHECA
NRMRMLQDAAIGERNLPDIPSNFYLGGDGNVYVGRGWDIANSYHNRTLSVCFIGDFQTYEPKESQFSALHH
LLTYGVIQRKLASDYKLVARRQTKPTTASPGDMLYARLVRLSRWNPCGTQAYAHCGAELGFPSVWDDEHDF
NERNGIHNPLLIHRKSTEEE 
 
>Seq. 9.3.18 PGRP-LA2 
MATNHQNGLSTGNGGNTTVQPAATSVINLSNSSDVVIGPMTQYQGSVTIYQYMDATVEASRIAIPNLGNGH
MVIDRHNWGAQQGVHGPYKLPHPIPYVLITHIGVHSEICSDVHVCSIKMRTLQDAAIAEKSLQDIPSNFYV
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 GGDGNVYVGRGWDTANAYANMSLAVCFMGDYGRYEPNDLQLSALDHLLTFGEKHRLLTEDYKIVAHRQART
TRSPGIKLYEKITKLTRWYPCGLPGYAKCGVEIGLPTVWDQEYPKSIPTIVPNASANSTQTN 
 
>Seq. 9.3.19 PGRPS1 (partial CDS) 
MMLFGGILPYLLVLWQLLASVDDLLHILVARAQDEPAQESACPAIVKRAAWGAAKSKNVTYQLKPVANVIV
HHTTGERCATVATCKEMVANIQTYHQTDNRWSDIGYNFLISGQNVYEGIGWHRMGAHLRGYNDKSIGVAFL
GNFDQERPTPRSLNLLARLLQCGVELGELADDYRLYGARQLQSTNSPGRYLYAKLQELDHWQAQ 
 
>Seq. 9.3.20 PGRPS2 (partial CDS) (ENSANGP00000012978/agCP5898) 
MNKFATVLVLASICLAGVSAQCPRIVTRAQWGARAASTSQLPIRPAPWVVMHHTAGASCTTDAACAQQMRN
IQSFHMDGNGWADIGYNFLVGENGAAYEGRGWGRQGAHAPGYNDRSVGMGVIGTFTNAIPNAAARTAARNL
ITCGVSLGHIASNYWLIGHRQAVATACPGNAFFNEIRTWPRFNPNV 
 
>Seq. 9.3.21 PGRPS3 (partial CDS)(ENSANGP00000012979/agCP5906) 
MNKFATVLVLASICLAGVSAQCPRIVTRAQWGARAANTAQLPIRPAPWVVMHHTAGAACTTDAACAQQMRN
IQSFHMDGNGWADIGYNFLVGENGAAYEGRGWGRQGAHAPGYNDRSVGMGVIGTFTNGIPNAAARNAAQQL
ISCGVSLGHIASNYWLIGHRQAVATACPGNAFFNEIRNWPRFNPNV 
 
>Seq. 9.3.22 PGRPLC1 (partial CDS) 
VNAYATIRSSPHRHRAHPVRAHQNGKSVFRNYTRKKLLFLLDKACYHSNTLPRTRICNLCIPVGGGKDVSQ
HFREIKNSHTTNTNKRKLSEILASRVTVTVPVAAVNETRTMALARNLQLENDTSVNTGYHTKAQSMSASGG
DTIAGLNNSGTGTGKSDSAKGSSLSNISASSIKRTDNGGDDDDSSVFDSSSSDTECDDDSIKRAIDRIPGT
LAPGEARVLPNANVKVAVEAIAPGVRPSPAASTIGAIAVHNSSDITFGNKTYIKGQVVIKNIYQDLPSATK
PPEPRTWQSSLKTIIKDKPLISFIVMVSLMIVLCAIVAVISILTASEDDLFPDPRPLRLVTRTEWLAQPPR
EELTDLKLPVNNVIIAHTATEGCTTQQACKALVQSIQRYHVNHTNYGDIGYNFLIGGDEFVYEGRGWLKVG
AHTKNYNTISYGIAFIGNYETINRPTEQQMEQLVLLLRNGTDGGWLAKEYKLCGASQLKGTISPGKYLMEQ
LRLLPHFSERL 
 
>Seq. 9.3.23 PGRPLC2 (partial CDS) 
VNAYATIRSSPHRHRAHPVRAHQNGKSVFRNYTRKKLLFLLDKACYHSNTLPRTRICNLCIPVGGGKDVSQ
HFREIKNSHTTNTNKRKLSEILASRVTVTVPVAAVNETRTMALARNLQLENDTSVNTGYHTKAQSMSASGG
DTIAGLNNSGTGTGKSDSAKGSSLSNISASSIKRTDNGGDDDDSSVFDSSSSDTECDDDSIKRAIDRIPGT
LAPGEARVLPNANVKVAVEAIAPGVRPSPAASTIGAIAVHNSSDITFGNKTYIKGQVVIKNIYQDLPSATK
PPEPRTWQSSLKTIIKDKPLISFIVMVSLMIVLCAIVAVISILTASEDDLFPDPRPLRLVTRTEWLAQPPR
EELTDLKLPVNNVIIAHTATEGCTTQAACRLRVRLIQEFHMDGKNYDDITYNFLIGGDGHIYEGRNWHKIG
ATIPGYNSRSITVAFVGEYNYGGKPTKKQIELLKYLLHFGAKERHLKEGYRIYASEQLDPTVGTGKWLIEA
LHSLPQFVDKEQNKDERPDHE 
 
>Seq. 9.3.24 PGRPLC3 (partial CDS) 
VNAYATIRSSPHRHRAHPVRAHQNGKSVFRNYTRKKLLFLLDKACYHSNTLPRTRICNLCIPVGGGKDVSQ
HFREIKNSHTTNTNKRKLSEILASRVTVTVPVAAVNETRTMALARNLQLENDTSVNTGYHTKAQSMSASGG
DTIAGLNNSGTGTGKSDSAKGSSLSNISASSIKRTDNGGDDDDSSVFDSSSSDTECDDDSIKRAIDRIPGT
LAPGEARVLPNANVKVAVEAIAPGVRPSPAASTIGAIAVHNSSDITFGNKTYIKGQVVIKNIYQDLPSATK
PPEPRTWQSSLKTIIKDKPLISFIVMVSLMIVLCAIVAVISILTASEDDLFPDPRPLRLVTRTEWLAQPPR
EELTDLKLPVNNVIIAHTATEGCTTQTKCMYQVKLIQEFHSSPDSRNFSDIAYQFLVGGDGNAYEGRGWTK
QGAHTKGFNVDSICIAFIGTFIADPPPIAQLSAAQQLILLGMKENYLASNYSLYGHRQLAPFESPGKALFD
IIKTWPHWSNKLGSNHWVEPANDTTNRR
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 9.4 VECTOR SEQUENCES & MAPS 
 
 
pETM-11 
Promoter:   T7/lac 
Selection:   Kanamycin  
Tag:    N-His 
Protease cleavage site:  TEV 
Origin:    pBR322 
host:    BL21 (DE3) 
Source:    G. Stier 
note:    contains MAD insert in modified pET-24d 
 
 
 
 
Fig. 9.4.1 The pETM-11 vector map. 
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>pETM-11; Full length: 6029 bp 
ATCCGGATATAGTTCCTCCTTTCAGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGCT
AGTTATTGCTCAGCGGTGGCAGCAGCCAACTCAGCTTCCTTTCGGGCTTTGTTAGCAGCCGGATCTCAGTG
GTGGTGGTGGTGGTGCTCGAGTGCGGCCGCAAGCTTGTCGACGGAGCTCGAATTCGGATCCGGTACCACTA
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 GTTAGAGACCAAGACACGCCTTGTGACTGTCCTGCAGCTTTATTCTCTTGATGCTGGTGCTGGAATAGCCC
TCATCACTGCCGAGGCTCTGCATGCTGCCCCGCTCGTCAGAGTCGCTCACACTGCTGCTGCTCCAGTCCAG
ATCACCTGTGAGATAGTCCGTGCTCTCCACGTCAACGTCGATTTCTTCCCTGTCGGAGTCGGAGCGCTCCG
AGGAGACGGTGGAGCCGATGCTGTCCATCCGGATCCTCTCAATGCCCAGCTTCTCCAGCTGCCTCTTCAGG
TGTCGCTGCTCTCGCTGAAGCTGGTCGATTTGGTGAACGGCTTTTCTGTCACAATCTTCAAGTTTCTTTAT
GTGCAATTTGGCTTTTGTTAATAAACTCAACGTAGTGTGTCGACTTGATTCGGGTCCCAGTGGCACCAGCC
CCTTCAACTTCTCCAGGCACAAGCGAAGATGAGCCCGTCTATTCTTCTCCATTTCATTGTGAGTTGATCTG
CTACTGCTGTTATTCTTTTTGGATTTGTTCCTCCGTTTTAAGGCATCTCTGTCCTTGTTTTTGTATGGTAA
CATGGAGGCATAACCATGTTCAGCTTCTCTCTCCCGCCGCTCCAGATAGTCGGCCGCCTCCAGCAGCATCT
GGATGTTCATCCGAACCGCCGCCGCCATGGCGCCCTGAAAATAAAGATTCTCAGTAGTGGGGATGTCGTAA
TCGCTCATGGGGTGATGGTGATGGTGATGTTTCATGGTATATCTCCTTCTTAAAGTTAAATCAAAATTATT
TCTAGAGGGGAATTGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATC
TCGATCCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATAT
CGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTA
TGGTGGCAGGCCCCGTGGCCGGGGGACTGTTGGGCGCCATCTCCTTGCATGCACCATTCCTTGCGGCGGCG
GTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTAATGCAGGAGTCGCATAAGGGAGAGCGTCGAGA
TCCCGGACACCATCGAATGGCGCAAAACCTTTCGCGGTATGGCATGATAGCGCCCGGAAGAGAGTCAATTC
AGGGTGGTGAATGTGAAACCAGTAACGTTATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGT
TTCCCGCGTGGTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGG
AGCTGAATTACATTCCCAACCGCGTGGCACAACAACTGGCGGGCAAACAGTCGTTGCTGATTGGCGTTGCC
ACCTCCAGTCTGGCCCTGCACGCGCCGTCGCAAATTGTCGCGGCGATTAAATCTCGCGCCGATCAACTGGG
TGCCAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGCGTCGAAGCCTGTAAAGCGGCGGTGCACAATCTTC
TCGCGCAACGCGTCAGTGGGCTGATCATTAACTATCCGCTGGATGACCAGGATGCCATTGCTGTGGAAGCT
GCCTGCACTAATGTTCCGGCGTTATTTCTTGATGTCTCTGACCAGACACCCATCAACAGTATTATTTTCTC
CCATGAAGACGGTACGCGACTGGGCGTGGAGCATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAG
CGGGCCCATTAAGTTCTGTCTCGGCGCGTCTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAA
ATTCAGCCGATAGCGGAACGGGAAGGCGACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCT
GAATGAGGGCATCGTTCCCACTGCGATGCTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCA
TTACCGAGTCCGGGCTGCGCGTTGGTGCGGATATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCA
TGTTATATCCCGCCGTTAACCACCATCAAACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTT
GCTGCAACTCTCTCAGGGCCAGGCGGTGAAGGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAA
CCACCCTGGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGA
CAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTAAGTTAGCTCACTCATTAGGCAC
CGGGATCTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACT
ATCGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGT
CATTTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCT
TGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATTATC
GCCGGCATGGCGGCCCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGG
TTGCCTTACTGGTTAGCAGAATGAATCACCGATACGCGAGCGAACGTGAAGCGACTGCTGCTGCAAAACGT
CTGCGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGAAACGCGGAAGTCA
GCGCCCTGCACCATTATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTACATC
TGTATTAACGAAGCGCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCCGCATCCATACCGCCAGTT
GTTTACCCTCACAACGTTCCAGTAACCGGGCATGTTCATCATCAGTAACCCGTATCGTGAGCATCCTCTCT
CGTTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTTACACGGAGGCATCAGTGACCAAACAGGA
AAAAACCGCCCTTAACATGGCCCGCTTTATCAGAAGCCAGACATTAACGCTTCTGGAGAAACTCAACGAGC
TGGACGCGGATGAACAGGCAGACATCTGTGAATCGCTTCACGACCACGCTGATGAGCTTTACCGCAGCTGC
CTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCT
GTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAG
CCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTAC
TGAGAGTGCACCATATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCT
CTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCA
AAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCA
AAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATC
ACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCT
- 209 - 
 GGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTC
GGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGC
TGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCC
AACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGT
AGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCT
GCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCT
GGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTT
GATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAACAATA
AAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTC
TAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGC
AATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAA
GGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCC
GACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAG
CATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGC
CGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCA
ATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAAC
AAGTCTGGAAAGAAATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCA
CTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGA
CCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTT
TTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTC
TAAGAATTAATTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCA
CATTTCCCCGAAAAGTGCCACCTGAAATTGTAAACGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGT
TAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGA
GATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAG
GGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCG
AGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGC
GAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCA
CGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCA 
 
   
 
 
 
- 210 - 
 pETM-13 
Promoter:   T7/lac 
Selection:   Kanamycin  
Tag:    none  
Protease cleavage site:  none 
Origin:    pBR322 
host:    BL21 (DE3) 
Source:    G. Stier 
notes:    contains ABD insert in modified pET-24d 
 
 
 
 
Fig. 9.4.2 The pETM-13 vector map. 
 
- 211 - 
  
 
 
>pETM-13; Full length: 6086 bp 
ATCCGGATATAGTTCCTCCTTTCAGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGCT
AGTTATTGCTCAGCGGTGGCAGCAGCCAACTCAGCTTCCTTTCGGGCTTTGTTAGCAGCCGGATCTCAGTG
- 212 - 
 GTGGTGGTGGTGGTGCTCGAGTGCGGCCGCAAGCTTGTCGACGGAGCTCGAATTCGGATCCGGTACCTCAC
CTGTTAGCCGCTGTCTCGGCCTGCTCCGCGCCCGCAAAAGCGTGGTAGAAGCAAGAGACGTACGTCATGAT
GGCTCTTTCATCGGGTTTAGGGGTGTTCACGATGTCTTCAGCATCCAACATTTTAGGAATATCCAGGTGCT
TCTCAGCGATTTCCATAGCCAGGTTAATATTTCCTATGGGGTCATCCTTGTTAAGCTTTGAGTAGTCAATG
AGGTCAGGCCGGTGTCGGTGGATGAGGGCACAGAGTCCAAGGCCATCTTTCCAGCTAGTATGGAAGTTCTG
AATGTTCACATTTCTATAAGGAGCAGTTTTCCTCTGACACCAAAGCAGCAGACCTTCTTTGGCAGATGTTT
CTTCAACCGAAATATCCTGAATAGCAAAGCGAAGGATGATGGTCCAGATCATACCCAGGGTCATTTTCACA
TTGCCATCAACAATTTCTTCAGCGCCGATGGACACCAGTTTCACCCCTTTGCTGGCTATGTAATCCAAAGC
TTTGTTGACATTAGCAATTTTGTGGAACCGCATTTTTCCCCGGTCAGGTTTGGGCAGCCTTTCCCCTGAGA
TGACTTCCAAAAGCAGCATGAGCTTNAGGCCATTCCTGAAGTCTTCCTCGATGTTCTCAATCTGGGTGCCG
GCTTTCCTTAGGTGGGAGTTACACCAGGCAGTGAAGGTCTTCCTCTGCTGCTTCTTCCAGGCTGGGTCCAG
GAGCAGGTCGCGGTCCCACTCCTCCTCCTGGATCATGTACTCATCCTCGTCGTACACGTAGTTGTACTGCA
CGCCGGGCTCTATCTGGCCCATGGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAGGGGAATT
GTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATCTCGATCCTCTACGC
CGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCG
ATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCC
GTGGCCGGGGGACTGTTGGGCGCCATCTCCTTGCATGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCT
CAACCTACTACTGGGCTGCTTCCTAATGCAGGAGTCGCATAAGGGAGAGCGTCGAGATCCCGGACACCATC
GAATGGCGCAAAACCTTTCGCGGTATGGCATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATGT
GAAACCAGTAACGTTATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTCCCGCGTGGTGA
ACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGGAGCTGAATTACATT
CCCAACCGCGTGGCACAACAACTGGCGGGCAAACAGTCGTTGCTGATTGGCGTTGCCACCTCCAGTCTGGC
CCTGCACGCGCCGTCGCAAATTGTCGCGGCGATTAAATCTCGCGCCGATCAACTGGGTGCCAGCGTGGTGG
TGTCGATGGTAGAACGAAGCGGCGTCGAAGCCTGTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTC
AGTGGGCTGATCATTAACTATCCGCTGGATGACCAGGATGCCATTGCTGTGGAAGCTGCCTGCACTAATGT
TCCGGCGTTATTTCTTGATGTCTCTGACCAGACACCCATCAACAGTATTATTTTCTCCCATGAAGACGGTA
CGCGACTGGGCGTGGAGCATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAGCGGGCCCATTAAGT
TCTGTCTCGGCGCGTCTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATTCAGCCGATAGC
GGAACGGGAAGGCGACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGAATGAGGGCATCG
TTCCCACTGCGATGCTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCATTACCGAGTCCGGG
CTGCGCGTTGGTGCGGATATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCATGTTATATCCCGCC
GTTAACCACCATCAAACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTC
AGGGCCAGGCGGTGAAGGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGCGCCC
AATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACT
GGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTAAGTTAGCTCACTCATTAGGCACCGGGATCTCGACCG
ATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCACT
TATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCATTTTCGGCGAGG
ACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCTTGCACGCCCTCGCT
CAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATTATCGCCGGCATGGCGGC
CCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGGTTGCCTTACTGGTT
AGCAGAATGAATCACCGATACGCGAGCGAACGTGAAGCGACTGCTGCTGCAAAACGTCTGCGACCTGAGCA
ACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGAAACGCGGAAGTCAGCGCCCTGCACCAT
TATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTACATCTGTATTAACGAAGC
GCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCCGCATCCATACCGCCAGTTGTTTACCCTCACAA
CGTTCCAGTAACCGGGCATGTTCATCATCAGTAACCCGTATCGTGAGCATCCTCTCTCGTTTCATCGGTAT
CATTACCCCCATGAACAGAAATCCCCCTTACACGGAGGCATCAGTGACCAAACAGGAAAAAACCGCCCTTA
ACATGGCCCGCTTTATCAGAAGCCAGACATTAACGCTTCTGGAGAAACTCAACGAGCTGGACGCGGATGAA
CAGGCAGACATCTGTGAATCGCTTCACGACCACGCTGATGAGCTTTACCGCAGCTGCCTCGCGCGTTTCGG
TGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCG
GGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCA
CGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCAT
ATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCG
CTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACC
- 213 - 
 GTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGC
TCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGT
GCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGC
TTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCAC
GAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACA
CGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAG
AGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAG
CCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTT
TTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAACAATAAAACTGTCTGCTTA
CATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCTAGGCCGCGATTAA
ATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACA
ATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAA
TGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATT
TTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTA
GAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGAT
TCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATA
ACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAA
ATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTAT
TTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATC
TTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGT
ATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAAGAATTAATTCA
TGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAA
GTGCCACCTGAAATTGTAAACGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTG
TTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTC
TATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGC
ACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAA
AGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACC
ACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCA 
 
   
 
- 214 - 
 pETM-60 
Promoter:   T7/lac 
Selection:   Kanamycin  
Tag:    N-NusA, N-His  
Protease cleavage site: TEV 
Origin:    pBR322 
host:    BL21 (DE3) 
Source:    G. Stier 
notes:    contains ABD insert in modified pET-24d 
 
 
 
 
 
Fig. 9.4.3 The pETM-60 vector map. 
 
 
- 215 - 
   
 
 
- 216 - 
 >pETM-60; Full length: 7634 bp 
ATCCGGATATAGTTCCTCCTTTCAGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGCT
AGTTATTGCTCAGCGGTGGCAGCAGCCAACTCAGCTTCCTTTCGGGCTTTGTTAGCAGCCGGATCTCAGTG
GTGGTGGTGGTGGTGCTCGAGTGCGGCCGCAAGCTTGTCGACGGAGCTCGAATTCGGATCCGGTACCTCAC
CTGTTAGCCGCTGTCTCGGCCTGCTCCGCGCCCGCAAAAGCGTGGTAGAAGCAAGAGACGTACGTCATGAT
GGCTCTTTCATCGGGTTTAGGGGTGTTCACGATGTCTTCAGCATCCAACATTTTAGGAATATCCAGGTGCT
TCTCAGCGATTTCCATAGCCAGGTTAATATTTCCTATGGGGTCATCCTTGTTAAGCTTTGAGTAGTCAATG
AGGTCAGGCCGGTGTCGGTGGATGAGGGCACAGAGTCCAAGGCCATCTTTCCAGCTAGTATGGAAGTTCTG
AATGTTCACATTTCTATAAGGAGCAGTTTTCCTCTGACACCAAAGCAGCAGACCTTCTTTGGCAGATGTTT
CTTCAACCGAAATATCCTGAATAGCAAAGCGAAGGATGATGGTCCAGATCATACCCAGGGTCATTTTCACA
TTGCCATCAACAATTTCTTCAGCGCCGATGGACACCAGTTTCACCCCTTTGCTGGCTATGTAATCCAAAGC
TTTGTTGACATTAGCAATTTTGTGGAACCGCATTTTTCCCCGGTCAGGTTTGGGCAGCCTTTCCCCTGAGA
TGACTTCCAAAAGCAGCATGAGCTTAAGGCCATTCCTGAAGTCTTCCTCGATGTTCTCAATCTGGGTGCCG
GCTTTCCTTAGGTGGGAGTTACACCAGGCAGTGAAGGTCTTCCTCTGCTGCTTCTTCCAGGCTGGGTCCAG
GAGCAGGTCGCGGTCCCACTCCTCCTCCTGGATCATGTACTCATCCTCGTCGTACACGTAGTTGTACTGCA
CGCCGGGCTCTATCTGGCCCATGGCGCCCTGAAAATAAAGATTCTCACCCGCGGAGTGATGGTGATGGTGA
TGACCAGAACCACTAGTCGCTTCGTCACCGAACCAGCAAATATTACGGGCAGCCATAATCAGTGCTCCGGC
TTTTTCGTCGGTCAACCCTTCGATATCAGCCAGATCATCAATGCCCTGTTCGGCGAGATCTTCCAGCGTAC
AAACGCCACGGGCGGCCAGTTTGAATGCCAAATCACGATCTACCCCTTCAAGGTTCAGCAGATCGTCAGCC
GGTTTGTTATCACCGAGGCTTTCTTCCTGGGCCTGTGCAATGGTGGCCAGTGCATTTTTAGCACGCTCGCG
CAGTGCTTCAACGGTCGGCTCATCAAGGCCTTCGATTTCCAACAGCTCTTTCATCGGCACATAGGCCAATT
CTTCCAGCGTCGAGAAGCCTTCTTCTACCAGAACAGTCGCGAAGTCTTCGTCGATGTCGAGATATTTGGTG
AAGGTGTCGATCGCTGCGTGCGCTTCCGCCTGATGCTTAGCTTGCAGGTCGTCAACGGTCATCACGTTGAG
TTCCCAACCGCTCAGTTGCGAAGCCAGACGCACGTTCTGACCGTTACGGCCAATCGCCTGCGCCAGATTAC
CGGCTTCAACGGCGATGTCCATAGTGTGTTTATCTTCATCCACCACGATAGAAGCAACGTCTGCCGGTGCC
ATTGCGTTAATCACGAACTGCGCCGGGTTATCATCCCACAGGACGATATCGATACGCTCGCCACCCAGTTC
AGTAGACACCGCCTGAACACGCGCGCCACGCATACCTACGCAAGCACCTACCGGATCGATACGTTTATCGT
TGGTTTTCACCGCGATTTTCGCACGAGAACCCGGATCGCGAGCCGCTGCTTTAATTTCAATCACTTCTTCG
CCGATTTCTGGCACTTCAATACGGAACAGTTCGATCAGCATTTCCGGCTTGGAACGAGTGACGAACAGTTG
CGCGCCACGCGCTTCCGGGCGAACGGAATAGAGCACGCCACGAACGCGGTCGCCAGGGCGGAAGTTTTCAC
GCGGCAGCATATCTTCGCGCAGGATCACGGCTTCAGCGTTGTTGCCCAGATCCAGAGAGATGTTGTCGCGG
TTTACTTTTTTCACCACGCCGGTGATGATTTCACCTTCGTGTTCACGGAACTGATCAACCACCATCGCACG
TTCGGCTTCACGCACTTTCTGCACGATAACCTGTTTTGCCGTCTGGGTAGTGATACGGTCAAAGGTAACAG
ACTCAATCTGATCTTCAACGTAATCGCCCAGGTTCAGGCTTTCATCTTCATAACGTGCGGCTTCAAGGGTG
ATTTCCTTGGTCGGCTGGGTGACTTCATCAACAACTAACCAGCGACGGAAAGTGTCAAAATCACCGCTTTT
GCGATCGATCTGTACGCGGACGTCGATCTCTTGTTCATATTTTTTCTTTGTTGCTGTCGCCAGCGCGCTTT
CCAATGCTTCGAAAATCTTCTCGCGAGGTAGCGCCTTTTCATTGGATACGGCTTCAACTACAGCCAAAATT
TCTTTCATGGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAGGGGAATTGTTATCCGCTCACA
ATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATCTCGATCCTCTACGCCGGACGCATCGTGG
CCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGGAAGATCGG
GCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACT
GTTGGGCGCCATCTCCTTGCATGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGG
GCTGCTTCCTAATGCAGGAGTCGCATAAGGGAGAGCGTCGAGATCCCGGACACCATCGAATGGCGCAAAAC
CTTTCGCGGTATGGCATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATGTGAAACCAGTAACGT
TATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTCCCGCGTGGTGAACCAGGCCAGCCAC
GTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGGAGCTGAATTACATTCCCAACCGCGTGGC
ACAACAACTGGCGGGCAAACAGTCGTTGCTGATTGGCGTTGCCACCTCCAGTCTGGCCCTGCACGCGCCGT
CGCAAATTGTCGCGGCGATTAAATCTCGCGCCGATCAACTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAA
CGAAGCGGCGTCGAAGCCTGTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTCAGTGGGCTGATCAT
TAACTATCCGCTGGATGACCAGGATGCCATTGCTGTGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTC
TTGATGTCTCTGACCAGACACCCATCAACAGTATTATTTTCTCCCATGAAGACGGTACGCGACTGGGCGTG
GAGCATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAGCGGGCCCATTAAGTTCTGTCTCGGCGCG
TCTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATTCAGCCGATAGCGGAACGGGAAGGCG
ACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGAATGAGGGCATCGTTCCCACTGCGATG
- 217 - 
 CTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGCGTTGGTGC
GGATATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCATGTTATATCCCGCCGTTAACCACCATCA
AACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTCAGGGCCAGGCGGTG
AAGGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGCGCCCAATACGCAAACCGC
CTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGT
GAGCGCAACGCAATTAATGTAAGTTAGCTCACTCATTAGGCACCGGGATCTCGACCGATGCCCTTGAGAGC
CTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCT
TTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCATTTTCGGCGAGGACCGCTTTCGCTGG
AGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCTTGCACGCCCTCGCTCAAGCCTTCGTCAC
TGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATTATCGCCGGCATGGCGGCCCCACGGGTGCGCA
TGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGGTTGCCTTACTGGTTAGCAGAATGAATCA
CCGATACGCGAGCGAACGTGAAGCGACTGCTGCTGCAAAACGTCTGCGACCTGAGCAACAACATGAATGGT
CTTCGGTTTCCGTGTTTCGTAAAGTCTGGAAACGCGGAAGTCAGCGCCCTGCACCATTATGTTCCGGATCT
GCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTACATCTGTATTAACGAAGCGCTGGCATTGACCC
TGAGTGATTTTTCTCTGGTCCCGCCGCATCCATACCGCCAGTTGTTTACCCTCACAACGTTCCAGTAACCG
GGCATGTTCATCATCAGTAACCCGTATCGTGAGCATCCTCTCTCGTTTCATCGGTATCATTACCCCCATGA
ACAGAAATCCCCCTTACACGGAGGCATCAGTGACCAAACAGGAAAAAACCGCCCTTAACATGGCCCGCTTT
ATCAGAAGCCAGACATTAACGCTTCTGGAGAAACTCAACGAGCTGGACGCGGATGAACAGGCAGACATCTG
TGAATCGCTTCACGACCACGCTGATGAGCTTTACCGCAGCTGCCTCGCGCGTTTCGGTGATGACGGTGAAA
ACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCC
CGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGG
AGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATATGCGGTGTGAA
ATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCT
GCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAAT
CAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCG
TTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTG
GCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTC
CGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCA
CGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCA
GCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCAC
TGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGG
TGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGG
AAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGC
AGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAG
TGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATA
CAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCTAGGCCGCGATTAAATTCCAACATGGAT
GCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTA
TGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATG
AGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCT
GATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGA
TTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATT
GTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGAT
GCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTT
GCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGA
AATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGG
AACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGA
TATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAAGAATTAATTCATGAGCGGATACATA
TTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGAAAT
TGTAAACGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGG
CCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGG
AACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGG
CCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACC
CTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAA
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 GCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGC
GCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCA 
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 pGEM®-T Easy (Promega) vector 
 
 
Promoter:   T7/SP6 
Selection:   Ampicillin  
Source:    Promega® (www.promega.com) 
notes:     
T7 RNA Polymerase transcription initiation site   1 
SP6 RNA Polymerase transcription initiation site   141 
T7 RNA Polymerase promoter     3002-6 
SP6 RNA Polymerase promoter     136-158 
multiple cloning site      10-128 
lacZ start codon       180 
lacoperon sequences      2839-2999, 166-395 
lacoperator       100-216 
b-lactamase coding region     1337-2197 
phage f1 region       2383-2838 
binding site of pUC/M13 Forward Sequencing Primer 2959-2975 
binding site of pUC/M13 Reverse Sequencing Primer  176-192 
 
 
 
Fig. 9.4.4 The pGEM-T Easy vector map. 
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Fig. 9.4.5 The promoter and multiple cloning sequence of the pGEM®-T Easy vector. The top strand of the 
sequence shown corresponds to the RNA synthesized by T7 RNA Polymerase. The bottom strand 
corresponds to the RNA synthesized by SP6 RNA Polymerase. 
 
 
>pGEM-T Easy; Full length: 3018 bp 
GGGCGAATTGGGCCCGACGTCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATATCACTAGTGA
ATTCGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCT
ATAGTGTCACCTAAATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCA
CAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAAT
CGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGC
GCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCA
GGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTT
GCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGC
GAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCG
ACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACG
CTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGC
CCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTG
GCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTG
GCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAA
AAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTG
GAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAA
ATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTA
ATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTA
GATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCAC
CGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTA
TCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCG
CAACGTTGTTGGCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCG
GTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCT
CCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCT
TACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGT
GTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTA
AAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAG
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 CAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTC
TTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTAT
TTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGTATGCGGTGTGAAAT
ACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGAAATTGTAAACGTTAATATTTTGTTAAAATTC
GCGTTAAATATTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGG
ACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCAAATCA
AGTTTTTTGCGGTCGAGGTGCCGTAAAGCTCTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTG
ACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGG
CAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCC
ATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTG
GCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAA
AACGACGGCCAGTGAATTGTAATACGACTCACTATA 
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 pLL10 
Promoter:   T7  
Selection:   Kanamycin and Ampicillin 
Origin:    pLL17 plus pLL7 polylinker 
Source:    (Blandin, Moita et al. 2002) 
notes:    vector for RNAi; to sequence insert use M13 forward and M13 reverse primers 
 
 
Fig. 9.4.6 The pLL10 vector map. 
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Fig. 9.4.7 The pLL10 restriction enzymes and compatible enzymes. 
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 pUAST 
Promoter:   UAS/GAL4  
Selection:   Ampicillin 
Origin:    pCaSpeR3 
Source:    (Brand and Perrimon 1993) 
notes:    pUAST consists of five tandemly arrayed optimized GAL4 binding sites (red)  
followed by the hsp70 TATA box and transcriptional start (blue), a polylinker 
(green) containing unique restriction sites for EcoRI, Bg/II, NotI, Xho, KpnI and 
XbaI and the SV40 small t intron and polyadenylation site. These features are 
included in a P-element vector (pCaSpeR3) containing the P element ends (P3' and 
P5') and the white gene which acts as a marker for successful incorporation into the 
Drosophila genome. 
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Fig. 9.4.6 The pUAST vector map. 
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